BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tay MZ, Poh CM, Rénia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol 2020;20:363-74. [PMID: 32346093 DOI: 10.1038/s41577-020-0311-8] [Cited by in Crossref: 1506] [Cited by in F6Publishing: 1403] [Article Influence: 753.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang D, Ge Y, Zhong B, Liu D. Specific epitopes form extensive hydrogen-bonding networks to ensure efficient antibody binding of SARS-CoV-2: Implications for advanced antibody design. Comput Struct Biotechnol J 2021;19:1661-71. [PMID: 33777333 DOI: 10.1016/j.csbj.2021.03.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 da Silva da Costa FA, Soares MR, Malagutti-Ferreira MJ, da Silva GR, Lívero FADR, Ribeiro-Paes JT. Three-Dimensional Cell Cultures as a Research Platform in Lung Diseases and COVID-19. Tissue Eng Regen Med 2021. [PMID: 34080133 DOI: 10.1007/s13770-021-00348-x] [Reference Citation Analysis]
3 Motta JC, Novoa DJ, Gómez CC, Moreno JM, Vargas L, Pérez J, Millán H, Arango ÁI. Prognostic factors in hospitalized patients diagnosed with SARS-CoV-2 infection, Bogotá, Colombia. Biomedica 2020;40:116-30. [PMID: 33152195 DOI: 10.7705/biomedica.5764] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Ronan N, Jackson M, Juhasz V, Scarr D. Relapsing Klebsiella pneumoniae meningitis in a patient with COVID-19. Anaesth Rep 2021;9:e12136. [PMID: 34820626 DOI: 10.1002/anr3.12136] [Reference Citation Analysis]
5 Balkrishna A, Solleti SK, Verma S, Varshney A. Application of Humanized Zebrafish Model in the Suppression of SARS-CoV-2 Spike Protein Induced Pathology by Tri-Herbal Medicine Coronil via Cytokine Modulation. Molecules 2020;25:E5091. [PMID: 33147850 DOI: 10.3390/molecules25215091] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
6 Caracciolo M, Correale P, Mangano C, Foti G, Falcone C, Macheda S, Cuzzola M, Conte M, Falzea AC, Iuliano E, Morabito A, Caraglia M, Polimeni N, Ferrarelli A, Labate D, Tescione M, Di Renzo L, Chiricolo G, Romano L, De Lorenzo A. Efficacy and Effect of Inhaled Adenosine Treatment in Hospitalized COVID-19 Patients. Front Immunol 2021;12:613070. [PMID: 33815368 DOI: 10.3389/fimmu.2021.613070] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Chen YM, Zheng Y, Yu Y, Wang Y, Huang Q, Qian F, Sun L, Song ZG, Chen Z, Feng J, An Y, Yang J, Su Z, Sun S, Dai F, Chen Q, Lu Q, Li P, Ling Y, Yang Z, Tang H, Shi L, Jin L, Holmes EC, Ding C, Zhu TY, Zhang YZ. Blood molecular markers associated with COVID-19 immunopathology and multi-organ damage. EMBO J 2020;39:e105896. [PMID: 33140861 DOI: 10.15252/embj.2020105896] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
8 Vatsalya V, Li F, Frimodig J, Gala KS, Srivastava S, Kong M, Ramchandani VA, Feng W, Zhang X, McClain CJ. Repurposing Treatment of Wernicke-Korsakoff Syndrome for Th-17 Cell Immune Storm Syndrome and Neurological Symptoms in COVID-19: Thiamine Efficacy and Safety, In-Vitro Evidence and Pharmacokinetic Profile. Front Pharmacol 2020;11:598128. [PMID: 33737877 DOI: 10.3389/fphar.2020.598128] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
9 Jang Y, Shin JS, Lee MK, Jung E, An T, Kim UI, Kim K, Kim M. Comparison of Antiviral Activity of Gemcitabine with 2'-Fluoro-2'-Deoxycytidine and Combination Therapy with Remdesivir against SARS-CoV-2. Int J Mol Sci 2021;22:1581. [PMID: 33557278 DOI: 10.3390/ijms22041581] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Shibeeb S, Ahmad MN. Thrombotic and Hypercoagulability Complications of COVID-19: An Update. J Blood Med 2021;12:785-93. [PMID: 34512059 DOI: 10.2147/JBM.S316014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Tian M, Liu W, Li X, Zhao P, Shereen MA, Zhu C, Huang S, Liu S, Yu X, Yue M, Pan P, Wang W, Li Y, Chen X, Wu K, Luo Z, Zhang Q, Wu J. HIF-1α promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19. Signal Transduct Target Ther 2021;6:308. [PMID: 34408131 DOI: 10.1038/s41392-021-00726-w] [Reference Citation Analysis]
12 Winkler ES, Gilchuk P, Yu J, Bailey AL, Chen RE, Chong Z, Zost SJ, Jang H, Huang Y, Allen JD, Case JB, Sutton RE, Carnahan RH, Darling TL, Boon ACM, Mack M, Head RD, Ross TM, Crowe JE Jr, Diamond MS. Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection. Cell 2021;184:1804-1820.e16. [PMID: 33691139 DOI: 10.1016/j.cell.2021.02.026] [Cited by in Crossref: 49] [Cited by in F6Publishing: 64] [Article Influence: 49.0] [Reference Citation Analysis]
13 Damiot A, Pinto AJ, Turner JE, Gualano B. Immunological Implications of Physical Inactivity among Older Adults during the COVID-19 Pandemic. Gerontology 2020;66:431-8. [PMID: 32585674 DOI: 10.1159/000509216] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 12.0] [Reference Citation Analysis]
14 Putman M, Chock YPE, Tam H, Kim AHJ, Sattui SE, Berenbaum F, Danila MI, Korsten P, Sanchez-Alvarez C, Sparks JA, Coates LC, Palmerlee C, Peirce A, Jayatilleke A, Johnson SR, Kilian A, Liew J, Prokop LJ, Murad MH, Grainger R, Wallace ZS, Duarte-García A; COVID-19 Global Rheumatology Alliance. Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-Analysis. Arthritis Rheumatol 2021;73:36-47. [PMID: 32741139 DOI: 10.1002/art.41469] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 12.0] [Reference Citation Analysis]
15 Ciabattini A, Garagnani P, Santoro F, Rappuoli R, Franceschi C, Medaglini D. Shelter from the cytokine storm: pitfalls and prospects in the development of SARS-CoV-2 vaccines for an elderly population. Semin Immunopathol 2020;42:619-34. [PMID: 33159214 DOI: 10.1007/s00281-020-00821-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
16 Le Borgne P, Solis M, Severac F, Merdji H, Ruch Y, Alamé Intern K, Bayle E, Hansmann Y, Bilbault P, Fafi-Kremer S, Meziani F; CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis). SARS-CoV-2 viral load in nasopharyngeal swabs in the emergency department does not predict COVID-19 severity and mortality. Acad Emerg Med 2021;28:306-13. [PMID: 33481307 DOI: 10.1111/acem.14217] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
17 Ferrantelli F, Chiozzini C, Manfredi F, Giovannelli A, Leone P, Federico M. Simultaneous CD8+ T-Cell Immune Response against SARS-Cov-2 S, M, and N Induced by Endogenously Engineered Extracellular Vesicles in Both Spleen and Lungs. Vaccines (Basel) 2021;9:240. [PMID: 33801926 DOI: 10.3390/vaccines9030240] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
18 Beeckmans S, Van Driessche E. Scrutinizing Coronaviruses Using Publicly Available Bioinformatic Tools: The Viral Structural Proteins as a Case Study. Front Mol Biosci 2021;8:671923. [PMID: 34109214 DOI: 10.3389/fmolb.2021.671923] [Reference Citation Analysis]
19 Schmiedel BJ, Chandra V, Rocha J, Gonzalez-Colin C, Bhattacharyya S, Madrigal A, Ottensmeier CH, Ay F, Vijayanand P. COVID-19 genetic risk variants are associated with expression of multiple genes in diverse immune cell types. bioRxiv 2020:2020. [PMID: 33299987 DOI: 10.1101/2020.12.01.407429] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Jager KJ, Kramer A, Chesnaye NC, Couchoud C, Sánchez-Álvarez JE, Garneata L, Collart F, Hemmelder MH, Ambühl P, Kerschbaum J, Legeai C, Del Pino Y Pino MD, Mircescu G, Mazzoleni L, Hoekstra T, Winzeler R, Mayer G, Stel VS, Wanner C, Zoccali C, Massy ZA. Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe. Kidney Int 2020;98:1540-8. [PMID: 32979369 DOI: 10.1016/j.kint.2020.09.006] [Cited by in Crossref: 104] [Cited by in F6Publishing: 89] [Article Influence: 52.0] [Reference Citation Analysis]
21 Riveiro-Barciela M, Labrador-Horrillo M, Camps-Relats L, González-Sans D, Ventura-Cots M, Terrones-Peinador M, Nuñez-Conde A, Martínez-Gallo M, Hernández M, Antón A, González A, Pujol-Borrell R, Martínez-Valle F. Simple predictive models identify patients with COVID-19 pneumonia and poor prognosis. PLoS One 2020;15:e0244627. [PMID: 33370397 DOI: 10.1371/journal.pone.0244627] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
22 Fiorino S, Tateo F, Biase D, Gallo CG, Orlandi PE, Corazza I, Budriesi R, Micucci M, Visani M, Loggi E, Hong W, Pica R, Lari F, Zippi M. SARS-CoV-2: lessons from both the history of medicine and from the biological behavior of other well-known viruses. Future Microbiol 2021;16:1105-33. [PMID: 34468163 DOI: 10.2217/fmb-2021-0064] [Reference Citation Analysis]
23 Zhou X, Wang Z, Li S, Liu T, Wang X, Xia J, Zhao Y. Machine Learning-Based Decision Model to Distinguish Between COVID-19 and Influenza: A Retrospective, Two-Centered, Diagnostic Study. Risk Manag Healthc Policy 2021;14:595-604. [PMID: 33623450 DOI: 10.2147/RMHP.S291498] [Reference Citation Analysis]
24 Kaptein SJF, Jacobs S, Langendries L, Seldeslachts L, Ter Horst S, Liesenborghs L, Hens B, Vergote V, Heylen E, Barthelemy K, Maas E, De Keyzer C, Bervoets L, Rymenants J, Van Buyten T, Zhang X, Abdelnabi R, Pang J, Williams R, Thibaut HJ, Dallmeier K, Boudewijns R, Wouters J, Augustijns P, Verougstraete N, Cawthorne C, Breuer J, Solas C, Weynand B, Annaert P, Spriet I, Vande Velde G, Neyts J, Rocha-Pereira J, Delang L. Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity. Proc Natl Acad Sci USA. 2020;117:26955-26965. [PMID: 33037151 DOI: 10.1073/pnas.2014441117] [Cited by in Crossref: 77] [Cited by in F6Publishing: 77] [Article Influence: 38.5] [Reference Citation Analysis]
25 Fenizia C, Biasin M, Cetin I, Vergani P, Mileto D, Spinillo A, Gismondo MR, Perotti F, Callegari C, Mancon A, Cammarata S, Beretta I, Nebuloni M, Trabattoni D, Clerici M, Savasi V. Analysis of SARS-CoV-2 vertical transmission during pregnancy. Nat Commun 2020;11:5128. [PMID: 33046695 DOI: 10.1038/s41467-020-18933-4] [Cited by in Crossref: 85] [Cited by in F6Publishing: 76] [Article Influence: 42.5] [Reference Citation Analysis]
26 Zimmer MM, Kibe A, Rand U, Pekarek L, Ye L, Buck S, Smyth RP, Cicin-Sain L, Caliskan N. The short isoform of the host antiviral protein ZAP acts as an inhibitor of SARS-CoV-2 programmed ribosomal frameshifting. Nat Commun 2021;12:7193. [PMID: 34893599 DOI: 10.1038/s41467-021-27431-0] [Reference Citation Analysis]
27 Horenstein AL, Faini AC, Malavasi F. CD38 in the age of COVID-19: a medical perspective. Physiol Rev 2021;101:1457-86. [PMID: 33787351 DOI: 10.1152/physrev.00046.2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
28 Mohapatra PR, Mishra B, Behera B. BCG vaccination induced protection from COVID-19. Indian J Tuberc 2021;68:119-24. [PMID: 33641831 DOI: 10.1016/j.ijtb.2020.08.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
29 Domínguez-Andrés J, Kuijpers Y, Bakker OB, Jaeger M, Xu CJ, Van der Meer JW, Jakobsson M, Bertranpetit J, Joosten LA, Li Y, Netea MG. Evolution of cytokine production capacity in ancient and modern European populations. Elife 2021;10:e64971. [PMID: 34488939 DOI: 10.7554/eLife.64971] [Reference Citation Analysis]
30 Webb BJ, Peltan ID, Jensen P, Hoda D, Hunter B, Silver A, Starr N, Buckel W, Grisel N, Hummel E, Snow G, Morris D, Stenehjem E, Srivastava R, Brown SM. Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study. Lancet Rheumatol 2020;2:e754-63. [PMID: 33015645 DOI: 10.1016/S2665-9913(20)30343-X] [Cited by in Crossref: 83] [Cited by in F6Publishing: 48] [Article Influence: 41.5] [Reference Citation Analysis]
31 Thandra KC, Barsouk A, Saginala K, Aluru JS, Barsouk A. Epidemiology of lung cancer. Contemp Oncol (Pozn) 2021;25:45-52. [PMID: 33911981 DOI: 10.5114/wo.2021.103829] [Reference Citation Analysis]
32 Zeng Q, Li YZ, Dong SY, Chen ZT, Gao XY, Zhang H, Huang G, Xu Y. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension. Front Immunol 2020;11:596684. [PMID: 33362779 DOI: 10.3389/fimmu.2020.596684] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Prasad A, Prasad M. Single Virus Targeting Multiple Organs: What We Know and Where We Are Heading? Front Med (Lausanne) 2020;7:370. [PMID: 32850890 DOI: 10.3389/fmed.2020.00370] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
34 Malhotra A, Sturgill M, Whitley-Williams P, Lee YH, Esochaghi C, Rajasekhar H, Olson B, Gaur S. Pediatric COVID-19 and Appendicitis: A Gut Reaction to SARS-CoV-2? Pediatr Infect Dis J 2021;40:e49-55. [PMID: 33298761 DOI: 10.1097/INF.0000000000002998] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
35 Mahil SK, Dand N, Mason KJ, Yiu ZZN, Tsakok T, Meynell F, Coker B, McAteer H, Moorhead L, Mackenzie T, Rossi MT, Rivera R, Mahe E, Carugno A, Magnano M, Rech G, Balogh EA, Feldman SR, De La Cruz C, Choon SE, Naldi L, Lambert J, Spuls P, Jullien D, Bachelez H, McMahon DE, Freeman EE, Gisondi P, Puig L, Warren RB, Di Meglio P, Langan SM, Capon F, Griffiths CEM, Barker JN, Smith CH; PsoProtect study group. Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based study. J Allergy Clin Immunol 2021;147:60-71. [PMID: 33075408 DOI: 10.1016/j.jaci.2020.10.007] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 19.5] [Reference Citation Analysis]
36 Shah S, Danda D, Kavadichanda C, Das S, Adarsh MB, Negi VS. Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment. Rheumatol Int 2020;40:1539-54. [PMID: 32666137 DOI: 10.1007/s00296-020-04639-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 11.5] [Reference Citation Analysis]
37 Minamimoto R, Hotta M, Ishikane M, Inagaki T. FDG-PET/CT images of COVID-19: a comprehensive review. Glob Health Med 2020;2:221-6. [PMID: 33330811 DOI: 10.35772/ghm.2020.01056] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
38 Bastopcu M. Extensive Arterial Thrombus Following Discharge after a Covid-19 Infection. Ann Vasc Surg 2021;72:205-8. [PMID: 33333188 DOI: 10.1016/j.avsg.2020.11.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
39 Bossù P, Toppi E, Sterbini V, Spalletta G. Implication of Aging Related Chronic Neuroinflammation on COVID-19 Pandemic. J Pers Med 2020;10:E102. [PMID: 32858874 DOI: 10.3390/jpm10030102] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
40 Ramos-Lopez O, San-Cristobal R, Martinez-Urbistondo D, Micó V, Colmenarejo G, Villares-Fernandez P, Daimiel L, Martinez JA. Proinflammatory and Hepatic Features Related to Morbidity and Fatal Outcomes in COVID-19 Patients. J Clin Med 2021;10:3112. [PMID: 34300279 DOI: 10.3390/jcm10143112] [Reference Citation Analysis]
41 Martínez-Urbistondo M, Gutiérrez-Rojas Á, Andrés A, Gutiérrez I, Escudero G, García S, Gutiérrez A, Sánchez E, Herráiz J, De La Fuente S, Callejas A, De Mendoza C, Moreno-Torres V. Severe Lymphopenia as a Predictor of COVID-19 Mortality in Immunosuppressed Patients. J Clin Med 2021;10:3595. [PMID: 34441891 DOI: 10.3390/jcm10163595] [Reference Citation Analysis]
42 Anand SV, Shuy YK, Lee PSS, Lee ES. One Year on: An Overview of Singapore's Response to COVID-19-What We Did, How We Fared, How We Can Move Forward. Int J Environ Res Public Health 2021;18:9125. [PMID: 34501718 DOI: 10.3390/ijerph18179125] [Reference Citation Analysis]
43 Bach JF, Berche P, Chatenoud L, Costagliola D, Valleron AJ. COVID-19: individual and herd immunity. C R Biol 2021;344:7-18. [PMID: 34213845 DOI: 10.5802/crbiol.41] [Reference Citation Analysis]
44 Luis García de Guadiana Romualdo, Mulero MDR, Olivo MH, Rojas CR, Arenas VR, Morales MG, Abellán AB, Conesa-Zamora P, García-García J, Hernández AC, Morell-García D, Dolores Albaladejo-Otón M, Consuegra-Sánchez L. Circulating levels of GDF-15 and calprotectin for prediction of in-hospital mortality in COVID-19 patients: A case series. J Infect 2021;82:e40-2. [PMID: 32795482 DOI: 10.1016/j.jinf.2020.08.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
45 Emadi-Baygi M, Ehsanifard M, Afrashtehpour N, Norouzi M, Joz-Abbasalian Z. Corona Virus Disease 2019 (COVID-19) as a System-Level Infectious Disease With Distinct Sex Disparities. Front Immunol 2021;12:778913. [PMID: 34912345 DOI: 10.3389/fimmu.2021.778913] [Reference Citation Analysis]
46 Ramezankhani R, Solhi R, Chai YC, Vosough M, Verfaillie C. Organoid and microfluidics-based platforms for drug screening in COVID-19. Drug Discov Today 2021:S1359-6446(21)00565-1. [PMID: 34954328 DOI: 10.1016/j.drudis.2021.12.014] [Reference Citation Analysis]
47 Khalil BA, Elemam NM, Maghazachi AA. Chemokines and chemokine receptors during COVID-19 infection. Comput Struct Biotechnol J 2021;19:976-88. [PMID: 33558827 DOI: 10.1016/j.csbj.2021.01.034] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
48 Hanchard J, Capó-Vélez CM, Deusch K, Lidington D, Bolz SS. Stabilizing Cellular Barriers: Raising the Shields Against COVID-19. Front Endocrinol (Lausanne) 2020;11:583006. [PMID: 33101215 DOI: 10.3389/fendo.2020.583006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
49 Ehara H. Detailed Analysis of Immune Tolerance Mechanisms to SARS-CoV-2 in Children Is Needed. Front Pediatr 2021;9:652838. [PMID: 34796148 DOI: 10.3389/fped.2021.652838] [Reference Citation Analysis]
50 Merlo A, Severeijns NR, Benson S, Scholey A, Garssen J, Bruce G, Verster JC. Mood and Changes in Alcohol Consumption in Young Adults during COVID-19 Lockdown: A Model Explaining Associations with Perceived Immune Fitness and Experiencing COVID-19 Symptoms. Int J Environ Res Public Health 2021;18:10028. [PMID: 34639330 DOI: 10.3390/ijerph181910028] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Renu K, Subramaniam MD, Chakraborty R, Myakala H, Iyer M, Bharathi G, Siva K, Vellingiri B, Valsala Gopalakrishnan A. The role of Interleukin-4 in COVID-19 associated male infertility - A hypothesis. J Reprod Immunol 2020;142:103213. [PMID: 33080435 DOI: 10.1016/j.jri.2020.103213] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
52 Vechi HT, Maia LR, Alves MDM, Rodrigues-Neto JF. Favorable outcome of COVID-19 in a young woman with severe Crohn's disease on regular use of adalimumab and prednisone: a case report. Rev Inst Med Trop Sao Paulo 2020;62:e102. [PMID: 33331521 DOI: 10.1590/S1678-9946202062102] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
53 Ting M, Suzuki JB. SARS-CoV-2: Overview and Its Impact on Oral Health. Biomedicines 2021;9:1690. [PMID: 34829919 DOI: 10.3390/biomedicines9111690] [Reference Citation Analysis]
54 Vohwinkel CU, Coit EJ, Burns N, Elajaili H, Hernandez-Saavedra D, Yuan X, Eckle T, Nozik E, Tuder RM, Eltzschig HK. Targeting alveolar-specific succinate dehydrogenase A attenuates pulmonary inflammation during acute lung injury. FASEB J 2021;35:e21468. [PMID: 33687752 DOI: 10.1096/fj.202002778R] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
55 Soni B, Kabra R, Singh S. Quantitative Insight into Immunopathology of SARS-CoV-2 Infection. J Interferon Cytokine Res 2021;41:244-57. [PMID: 34280026 DOI: 10.1089/jir.2020.0156] [Reference Citation Analysis]
56 Khoshkam Z, Aftabi Y, Stenvinkel P, Paige Lawrence B, Rezaei MH, Ichihara G, Fereidouni S. Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection. J Adv Res 2021;31:49-60. [PMID: 33520309 DOI: 10.1016/j.jare.2020.12.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
57 Wang Z, Wang W, Wang P, Song X, Mao Z, Liu Z. Highly Sensitive Near-Infrared Imaging of Peroxynitrite Fluxes in Inflammation Progress. Anal Chem 2021;93:3035-41. [PMID: 33494590 DOI: 10.1021/acs.analchem.0c05118] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
58 Brandão SCS, Godoi ETAM, Ramos JOX, de Melo LMMP, Sarinho ESC. Severe COVID-19: understanding the role of immunity, endothelium, and coagulation in clinical practice. J Vasc Bras 2020;19:e20200131. [PMID: 34211530 DOI: 10.1590/1677-5449.200131] [Reference Citation Analysis]
59 Junapudi SS, Junapudi S, Ega K, Chidipi B. Major cardiac concerns in therapy and vaccinations for COVID-19. Metabol Open 2021;11:100102. [PMID: 34222851 DOI: 10.1016/j.metop.2021.100102] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
60 Fu Y, Chen F, Cui L, Zhao Y, Zhang H, Fu S, Zhang J. Immunological Analysis of People in Northeast China after SARS-CoV-2 Inactivated Vaccine Injection. Vaccines (Basel) 2021;9:1028. [PMID: 34579267 DOI: 10.3390/vaccines9091028] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Wang L, Muneer A, Xie L, Zhang F, Wu B, Mei L, Lenarcic EM, Feng EH, Song J, Xiong Y, Yu X, Wang C, Gheorghe C, Torralba K, Cook JG, Wan YY, Moorman NJ, Song H, Jin J, Chen X. Novel gene-specific translation mechanism of dysregulated, chronic inflammation reveals promising, multifaceted COVID-19 therapeutics. bioRxiv 2020:2020. [PMID: 33236014 DOI: 10.1101/2020.11.14.382416] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
62 Trevisan M, Riccetti S, Sinigaglia A, Barzon L. SARS-CoV-2 Infection and Disease Modelling Using Stem Cell Technology and Organoids. Int J Mol Sci 2021;22:2356. [PMID: 33652988 DOI: 10.3390/ijms22052356] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Canal B, Fujisawa R, McClure AW, Deegan TD, Wu M, Ulferts R, Weissmann F, Drury LS, Bertolin AP, Zeng J, Beale R, Howell M, Labib K, Diffley JFX. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease. Biochem J 2021;478:2465-79. [PMID: 34198324 DOI: 10.1042/BCJ20210199] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
64 Zubiaur P, Koller D, Saiz-Rodríguez M, Navares-Gómez M, Abad-Santos F. Important Pharmacogenetic Information for Drugs Prescribed During the SARS-CoV-2 Infection (COVID-19). Clin Transl Sci 2020;13:1023-33. [PMID: 32936528 DOI: 10.1111/cts.12866] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
65 Brothers EM, Lidsky K, Simmons J, Nakagawa T. A Child With COVID-19, Type 1 Diabetes, and Candida glabrata: A Case Report and Literature Review. Clin Pediatr (Phila) 2021;60:554-8. [PMID: 34636691 DOI: 10.1177/00099228211052471] [Reference Citation Analysis]
66 Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: An overview. Diabetes Metab Syndr 2021;15:869-75. [PMID: 33892403 DOI: 10.1016/j.dsx.2021.04.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
67 Schultheiss HP, Baumeier C, Pietsch H, Bock CT, Poller W, Escher F. Cardiovascular consequences of viral infections: from COVID to other viral diseases. Cardiovasc Res 2021:cvab315. [PMID: 34609508 DOI: 10.1093/cvr/cvab315] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Goldman N, Fink D, Cai J, Lee YN, Davies Z. High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care. Diabetes Res Clin Pract 2020;166:108291. [PMID: 32615280 DOI: 10.1016/j.diabres.2020.108291] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 13.0] [Reference Citation Analysis]
69 Lee SR, Roh JY, Ryu J, Shin H, Hong E. Activation of TCA cycle restrains virus-metabolic hijacking and viral replication in mouse hepatitis virus-infected cells. Cell Biosci 2022;12. [DOI: 10.1186/s13578-021-00740-z] [Reference Citation Analysis]
70 Mahyuddin AP, Kanneganti A, Wong JJL, Dimri PS, Su LL, Biswas A, Illanes SE, Mattar CNZ, Huang RY, Choolani M. Mechanisms and evidence of vertical transmission of infections in pregnancy including SARS-CoV-2s. Prenat Diagn 2020;40:1655-70. [PMID: 32529643 DOI: 10.1002/pd.5765] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
71 Yasmin H, Saha S, Butt MT, Modi RK, George AJT, Kishore U. SARS-CoV-2: Pathogenic Mechanisms and Host Immune Response. Adv Exp Med Biol 2021;1313:99-134. [PMID: 34661893 DOI: 10.1007/978-3-030-67452-6_6] [Reference Citation Analysis]
72 Zhang Q, Honko A, Zhou J, Gong H, Downs SN, Vasquez JH, Fang RH, Gao W, Griffiths A, Zhang L. Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity. Nano Lett 2020;20:5570-4. [PMID: 32551679 DOI: 10.1021/acs.nanolett.0c02278] [Cited by in Crossref: 95] [Cited by in F6Publishing: 85] [Article Influence: 47.5] [Reference Citation Analysis]
73 Yang J, Zhang P, Cheng WX, Lu Y, Gang W, Ren G. Exposing structural variations in SARS-CoV-2 evolution. Sci Rep 2021;11:22042. [PMID: 34764391 DOI: 10.1038/s41598-021-01650-3] [Reference Citation Analysis]
74 Yang Z, Bogdan P, Nazarian S. An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study. Sci Rep 2021;11:3238. [PMID: 33547334 DOI: 10.1038/s41598-021-81749-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 14.0] [Reference Citation Analysis]
75 Korsukewitz C, Reddel SW, Bar-Or A, Wiendl H. Neurological immunotherapy in the era of COVID-19 - looking for consensus in the literature. Nat Rev Neurol 2020;16:493-505. [PMID: 32641860 DOI: 10.1038/s41582-020-0385-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 13.0] [Reference Citation Analysis]
76 Cafiero C, Re A, Micera A, Palmirotta R, Monaco D, Romano F, Fabrizio C, Di Francia R, Cacciamani A, Surico PL, D'Amato G, Pisconti S. Pharmacogenomics and Pharmacogenetics: In Silico Prediction of Drug Effects in Treatments for Novel Coronavirus SARS-CoV2 Disease. Pharmgenomics Pers Med 2020;13:463-84. [PMID: 33116761 DOI: 10.2147/PGPM.S270069] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Vale AJM, Fernandes ACL, Guzen FP, Pinheiro FI, de Azevedo EP, Cobucci RN. Susceptibility to COVID-19 in Pregnancy, Labor, and Postpartum Period: Immune System, Vertical Transmission, and Breastfeeding. Front Glob Womens Health 2021;2:602572. [PMID: 34816177 DOI: 10.3389/fgwh.2021.602572] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
78 Carmo A, Pereira-Vaz J, Mota V, Mendes A, Morais C, da Silva AC, Camilo E, Pinto CS, Cunha E, Pereira J, Coucelo M, Martinho P, Correia L, Marques G, Araújo L, Rodrigues F. Clearance and persistence of SARS-CoV-2 RNA in patients with COVID-19. J Med Virol 2020;92:2227-31. [PMID: 32484958 DOI: 10.1002/jmv.26103] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 15.0] [Reference Citation Analysis]
79 Pedrosa CDSG, Goto-Silva L, Temerozo JR, Souza LRQ, Vitória G, Ornelas IM, Karmirian K, Mendes MA, Gomes IC, Sacramento CQ, Fintelman-Rodrigues N, Cardoso Soares V, Silva Gomes Dias SD, Salerno JA, Puig-Pijuan T, Oliveira JT, Aragão LGHS, Torquato TCQ, Veríssimo C, Biagi D, Cruvinel EM, Dariolli R, Furtado DR, Borges HL, Bozza PT, Rehen S, Moreno L Souza T, Guimarães MZP. Non-permissive SARS-CoV-2 infection in human neurospheres. Stem Cell Res 2021;54:102436. [PMID: 34186311 DOI: 10.1016/j.scr.2021.102436] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Staats LAN, Pfeiffer H, Knopf J, Lindemann A, Fürst J, Kremer AE, Hackstein H, Neurath MF, Muñoz LE, Achenbach S, Leppkes M, Herrmann M, Schett G, Steffen U. IgA2 Antibodies against SARS-CoV-2 Correlate with NET Formation and Fatal Outcome in Severely Diseased COVID-19 Patients. Cells 2020;9:E2676. [PMID: 33322797 DOI: 10.3390/cells9122676] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
81 Cardenas MC, Bustos SS, Enninga EAL, Mofenson L, Chakraborty R. Characterising and managing paediatric SARSCoV-2 infection: Learning about the virus in a global classroom. Acta Paediatr 2021;110:409-22. [PMID: 33175403 DOI: 10.1111/apa.15662] [Reference Citation Analysis]
82 de Almondes KM, Marín Agudelo HA, Jiménez-Correa U. Impact of Sleep Deprivation on Emotional Regulation and the Immune System of Healthcare Workers as a Risk Factor for COVID 19: Practical Recommendations From a Task Force of the Latin American Association of Sleep Psychology. Front Psychol 2021;12:564227. [PMID: 34093295 DOI: 10.3389/fpsyg.2021.564227] [Reference Citation Analysis]
83 Faghri PD, Dobson M, Landsbergis P, Schnall PL. COVID-19 Pandemic: What Has Work Got to Do With It? J Occup Environ Med 2021;63:e245-9. [PMID: 33560072 DOI: 10.1097/JOM.0000000000002154] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
84 Wang L, Wang X, Yang F, Liu Y, Meng L, Pang Y, Zhang M, Chen F, Pan C, Lin S, Zhu X, Leong KW, Liu J. Systemic antiviral immunization by virus-mimicking nanoparticles-decorated erythrocytes. Nano Today 2021;40:101280. [PMID: 34512795 DOI: 10.1016/j.nantod.2021.101280] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
85 Veenhuis RT, Zeiss CJ. Animal Models of COVID-19 II. Comparative Immunology. ILAR J 2021:ilab010. [PMID: 33914873 DOI: 10.1093/ilar/ilab010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
86 Ventura-Carmenate Y, Alkaabi FM, Castillo-Aleman YM, Villegas-Valverde CA, Ahmed YM, Sanna P, Almarzooqi AA, Abdelrazik A, Torres-Zambrano GM, Wade-Mateo M, Quesada-Saliba D, Abdel Hadi L, Bencomo-Hernandez AA, Rivero-Jimenez RA. Safety and efficacy of autologous non-hematopoietic enriched stem cell nebulization in COVID-19 patients: a randomized clinical trial, Abu Dhabi 2020. Transl Med Commun 2021;6:25. [PMID: 34746417 DOI: 10.1186/s41231-021-00101-5] [Reference Citation Analysis]
87 Qin M, Cao Z, Wen J, Yu Q, Liu C, Wang F, Zhang J, Yang F, Li Y, Fishbein G, Yan S, Xu B, Hou Y, Ning Z, Nie K, Jiang N, Liu Z, Wu J, Yu Y, Li H, Zheng H, Li J, Jin W, Pang S, Wang S, Chen J, Gan Z, He Z, Lu Y. An Antioxidant Enzyme Therapeutic for COVID‐19. Adv Mater 2020;32:2004901. [DOI: 10.1002/adma.202004901] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
88 Li S, Zhang Y, Guan Z, Li H, Ye M, Chen X, Shen J, Zhou Y, Shi ZL, Zhou P, Peng K. SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation. Signal Transduct Target Ther 2020;5:235. [PMID: 33037188 DOI: 10.1038/s41392-020-00334-0] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 26.5] [Reference Citation Analysis]
89 Mazzini L, Martinuzzi D, Hyseni I, Benincasa L, Molesti E, Casa E, Lapini G, Piu P, Trombetta CM, Marchi S, Razzano I, Manenti A, Montomoli E. Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples. J Immunol Methods 2021;489:112937. [PMID: 33253698 DOI: 10.1016/j.jim.2020.112937] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 7.5] [Reference Citation Analysis]
90 Gadotti AC, Lipinski AL, Vasconcellos FT, Marqueze LF, Cunha EB, Campos AC, Oliveira CF, Amaral AN, Baena CP, Telles JP, Tuon FF, Pinho RA. Susceptibility of the patients infected with Sars-Cov2 to oxidative stress and possible interplay with severity of the disease. Free Radic Biol Med 2021;165:184-90. [PMID: 33524532 DOI: 10.1016/j.freeradbiomed.2021.01.044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
91 Iannaccone G, Scacciavillani R, Del Buono MG, Camilli M, Ronco C, Lavie CJ, Abbate A, Crea F, Massetti M, Aspromonte N. Weathering the Cytokine Storm in COVID-19: Therapeutic Implications. Cardiorenal Med 2020;10:277-87. [PMID: 32599589 DOI: 10.1159/000509483] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 12.5] [Reference Citation Analysis]
92 Nguyen FT, van den Akker T, Lally K, Lam H, Lenskaya V, Liu STH, Bouvier NM, Aberg JA, Rodriguez D, Krammer F, Strauss D, Shaz BH, Rudon L, Galdon P, Jhang JS, Arinsburg SA, Baine I; Mount Sinai Health System Convalescent Plasma Team. Transfusion reactions associated with COVID-19 convalescent plasma therapy for SARS-CoV-2. Transfusion 2021;61:78-93. [PMID: 33125158 DOI: 10.1111/trf.16177] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
93 Hozayen SM, Zychowski D, Benson S, Lutsey PL, Haslbauer J, Tzankov A, Kaltenborn Z, Usher M, Shah S, Tignanelli CJ, Demmer RT. Outpatient and inpatient anticoagulation therapy and the risk for hospital admission and death among COVID-19 patients. EClinicalMedicine 2021;41:101139. [PMID: 34585129 DOI: 10.1016/j.eclinm.2021.101139] [Reference Citation Analysis]
94 Kashour T, Halwani R, Arabi YM, Sohail MR, O'Horo JC, Badley AD, Tleyjeh IM. Statins as an adjunctive therapy for COVID-19: the biological and clinical plausibility. Immunopharmacol Immunotoxicol 2021;43:37-50. [PMID: 33406943 DOI: 10.1080/08923973.2020.1863984] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
95 Calvet J, Gratacós J, Amengual MJ, Llop M, Navarro M, Moreno A, Berenguer-Llergo A, Serrano A, Orellana C, Cervantes M. CD4 and CD8 Lymphocyte Counts as Surrogate Early Markers for Progression in SARS-CoV-2 Pneumonia: A Prospective Study. Viruses 2020;12:E1277. [PMID: 33182268 DOI: 10.3390/v12111277] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
96 Alefishat E, Jelinek HF, Mousa M, Tay GK, Alsafar HS. Immune response to SARS-CoV-2 Variants: A focus on severity, susceptibility, and preexisting immunity. Journal of Infection and Public Health 2022. [DOI: 10.1016/j.jiph.2022.01.007] [Reference Citation Analysis]
97 Mohan M, Perry BI, Saravanan P, Singh SP. COVID-19 in People With Schizophrenia: Potential Mechanisms Linking Schizophrenia to Poor Prognosis. Front Psychiatry 2021;12:666067. [PMID: 34079487 DOI: 10.3389/fpsyt.2021.666067] [Reference Citation Analysis]
98 Schultheiss HP, Baumeier C, Aleshcheva G, Bock CT, Escher F. Viral Myocarditis-From Pathophysiology to Treatment. J Clin Med 2021;10:5240. [PMID: 34830522 DOI: 10.3390/jcm10225240] [Reference Citation Analysis]
99 Valencia-Enciso N, Ortiz-Pereira M, Zafra-Sierra MP, Espinel-Gómez L, Bayona H. Time of Stroke Onset in Coronavirus Disease 2019 Patients Around the Globe: A Systematic Review and Analysis. J Stroke Cerebrovasc Dis 2020;29:105325. [PMID: 32992196 DOI: 10.1016/j.jstrokecerebrovasdis.2020.105325] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
100 Mesentier-Louro LA, Rangel B, Stell L, Shariati MA, Dalal R, Nathan A, Yuan K, de Jesus Perez V, Liao YJ. Hypoxia-induced inflammation: Profiling the first 24-hour posthypoxic plasma and central nervous system changes. PLoS One 2021;16:e0246681. [PMID: 33661927 DOI: 10.1371/journal.pone.0246681] [Reference Citation Analysis]
101 Tseng HT, Wu XC, Huang CY, Shih CM, Lin YW, Lin FY. The Impact of SARS-CoV-2 Infection, and Application of Immunosuppressive Agents in Kidney Transplant Recipients Suffering from COVID-19. Pharmaceuticals (Basel) 2021;14:1054. [PMID: 34681278 DOI: 10.3390/ph14101054] [Reference Citation Analysis]
102 Zhu W, Zheng Y, Yu M, Wei J, Zhang Y, Topchyan P, Nguyen C, Janecke R, Kreuziger LB, White GC, Hari P, Aster R, Cui W, Jobe S, Graham MB, Wang D, Wen R. SARS-CoV-2 receptor binding domain-specific antibodies activate platelets with features resembling the pathogenic antibodies in heparin-induced thrombocytopenia. Res Sq 2021:rs. [PMID: 34013243 DOI: 10.21203/rs.3.rs-462080/v1] [Reference Citation Analysis]
103 Pecora ND, Zand MS. Measuring the Serologic Response to Severe Acute Respiratory Syndrome Coronavirus 2: Methods and Meaning. Clin Lab Med 2020;40:603-14. [PMID: 33121625 DOI: 10.1016/j.cll.2020.08.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
104 Vivar-Sierra A, Araiza-Macías MJ, Hernández-Contreras JP, Vergara-Castañeda A, Ramírez-Vélez G, Pinto-Almazán R, Salazar JR, Loza-Mejía MA. In Silico Study of Polyunsaturated Fatty Acids as Potential SARS-CoV-2 Spike Protein Closed Conformation Stabilizers: Epidemiological and Computational Approaches. Molecules 2021;26:711. [PMID: 33573088 DOI: 10.3390/molecules26030711] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
105 Zhou B, Li S, Ye J, Liu Y, Hu L, Tang Y, Wu Z, Zhang P. Immunopathological events surrounding IL-6 and IFN-α: A bridge for anti-lupus erythematosus drugs used to treat COVID-19. Int Immunopharmacol 2021;101:108254. [PMID: 34710657 DOI: 10.1016/j.intimp.2021.108254] [Reference Citation Analysis]
106 Beura SK, Panigrahi AR, Yadav P, Singh SK. Phytochemicals as Potential Therapeutics for SARS-CoV-2-Induced Cardiovascular Complications: Thrombosis and Platelet Perspective. Front Pharmacol 2021;12:658273. [PMID: 33981235 DOI: 10.3389/fphar.2021.658273] [Reference Citation Analysis]
107 Jafarpour R, Pashangzadeh S, Dowran R. Host factors: Implications in immunopathogenesis of COVID-19. Pathol Res Pract 2021;228:153647. [PMID: 34749207 DOI: 10.1016/j.prp.2021.153647] [Reference Citation Analysis]
108 Radanliev P, De Roure D, Walton R. Data mining and analysis of scientific research data records on Covid-19 mortality, immunity, and vaccine development - In the first wave of the Covid-19 pandemic. Diabetes Metab Syndr 2020;14:1121-32. [PMID: 32659695 DOI: 10.1016/j.dsx.2020.06.063] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
109 Luo MH, Qian YQ, Huang DL, Luo JC, Su Y, Wang H, Yu SJ, Liu K, Tu GW, Luo Z. Tailoring glucocorticoids in patients with severe COVID-19: a narrative review. Ann Transl Med 2021;9:1261. [PMID: 34532398 DOI: 10.21037/atm-21-1783] [Reference Citation Analysis]
110 Rizkita LD, Astuti I. The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A review. J Pharm Anal 2021;11:265-71. [PMID: 33782640 DOI: 10.1016/j.jpha.2021.03.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
111 Berte' R, Mazza S, Stefanucci MR, Noviello D, Costa S, Ciafardini C, Mileti E, Mapelli M, Pasqualato S, Pinto S, Favale A, Vecchi M, Neurath MF, Atreya R, Fantini MC, Facciotti F, Caprioli F. Seroprevalence of SARS-CoV2 in IBD Patients Treated with Biologic Therapy. J Crohns Colitis 2021;15:864-8. [PMID: 33211810 DOI: 10.1093/ecco-jcc/jjaa237] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
112 Lani-Louzada R, Ramos CDVF, Cordeiro RM, Sadun AA. Retinal changes in COVID-19 hospitalized cases. PLoS One 2020;15:e0243346. [PMID: 33270751 DOI: 10.1371/journal.pone.0243346] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
113 El-Hachem N, Eid E, Nemer G, Dbaibo G, Abbas O, Rubeiz N, Zeineldine S, Matar GM, Bikorimana JP, Shammaa R, Haibe-Kains B, Kurban M, Rafei M. Integrative Transcriptome Analyses Empower the Anti-COVID-19 Drug Arsenal. iScience 2020;23:101697. [PMID: 33103068 DOI: 10.1016/j.isci.2020.101697] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
114 Talotta R, Robertson E. Autoimmunity as the comet tail of COVID-19 pandemic. World J Clin Cases 2020; 8(17): 3621-3644 [PMID: 32953841 DOI: 10.12998/wjcc.v8.i17.3621] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 13] [Article Influence: 12.5] [Reference Citation Analysis]
115 Burra P, Soto-Díaz K, Chalen I, Gonzalez-Ricon RJ, Istanto D, Caetano-Anollés G. Temperature and Latitude Correlate with SARS-CoV-2 Epidemiological Variables but not with Genomic Change Worldwide. Evol Bioinform Online 2021;17:1176934321989695. [PMID: 33551640 DOI: 10.1177/1176934321989695] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
116 Al-Hatamleh MAI, Hatmal MM, Sattar K, Ahmad S, Mustafa MZ, Bittencourt MC, Mohamud R. Antiviral and Immunomodulatory Effects of Phytochemicals from Honey against COVID-19: Potential Mechanisms of Action and Future Directions. Molecules 2020;25:E5017. [PMID: 33138197 DOI: 10.3390/molecules25215017] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
117 Okada Y, Yoshimura K, Toya S, Tsuchimochi M. Pathogenesis of taste impairment and salivary dysfunction in COVID-19 patients. Jpn Dent Sci Rev 2021;57:111-22. [PMID: 34257762 DOI: 10.1016/j.jdsr.2021.07.001] [Reference Citation Analysis]
118 Nassar A, Ibrahim IM, Amin FG, Magdy M, Elgharib AM, Azzam EB, Nasser F, Yousry K, Shamkh IM, Mahdy SM, Elfiky AA. A Review of Human Coronaviruses' Receptors: The Host-Cell Targets for the Crown Bearing Viruses. Molecules 2021;26:6455. [PMID: 34770863 DOI: 10.3390/molecules26216455] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
119 Guervilly C, Burtey S, Sabatier F, Cauchois R, Lano G, Abdili E, Daviet F, Arnaud L, Brunet P, Hraiech S, Jourde-Chiche N, Koubi M, Lacroix R, Pietri L, Berda Y, Robert T, Degioanni C, Velier M, Papazian L, Kaplanski G, Dignat-George F. Circulating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID -19. J Infect Dis 2020;222:1789-93. [PMID: 32812049 DOI: 10.1093/infdis/jiaa528] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 19.0] [Reference Citation Analysis]
120 Khan S, Shafiei MS, Longoria C, Schoggins JW, Savani RC, Zaki H. SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-κB pathway. Elife 2021;10:e68563. [PMID: 34866574 DOI: 10.7554/eLife.68563] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
121 Gyebi GA, Ogunyemi OM, Ibrahim IM, Afolabi SO, Adebayo JO. Dual targeting of cytokine storm and viral replication in COVID-19 by plant-derived steroidal pregnanes: An in silico perspective. Comput Biol Med 2021;134:104406. [PMID: 33915479 DOI: 10.1016/j.compbiomed.2021.104406] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
122 Azzi Y, Bartash R, Scalea J, Loarte-Campos P, Akalin E. COVID-19 and Solid Organ Transplantation: A Review Article. Transplantation 2021;105:37-55. [PMID: 33148977 DOI: 10.1097/TP.0000000000003523] [Cited by in Crossref: 34] [Cited by in F6Publishing: 21] [Article Influence: 34.0] [Reference Citation Analysis]
123 Bhattacharya S, Paul SMN. Efficacy of phytochemicals as immunomodulators in managing COVID-19: a comprehensive view. Virusdisease 2021;:1-11. [PMID: 34189187 DOI: 10.1007/s13337-021-00706-2] [Reference Citation Analysis]
124 Fadai NT, Sachak-Patwa R, Byrne HM, Maini PK, Bafadhel M, Nicolau DV Jr. Infection, inflammation and intervention: mechanistic modelling of epithelial cells in COVID-19. J R Soc Interface 2021;18:20200950. [PMID: 33593209 DOI: 10.1098/rsif.2020.0950] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
125 Soliman S, Faris ME, Ratemi Z, Halwani R. Switching Host Metabolism as an Approach to Dampen SARS-CoV-2 Infection. Ann Nutr Metab 2020;76:297-303. [PMID: 32950986 DOI: 10.1159/000510508] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
126 Bonyek-Silva I, Machado AFA, Cerqueira-Silva T, Nunes S, Silva Cruz MR, Silva J, Santos RL, Barral A, Oliveira PRS, Khouri R, Serezani CH, Brodskyn C, Caldas JR, Barral-Netto M, Boaventura V, Tavares NM. LTB4-Driven Inflammation and Increased Expression of ALOX5/ACE2 During Severe COVID-19 in Individuals With Diabetes. Diabetes 2021;70:2120-30. [PMID: 34417262 DOI: 10.2337/db20-1260] [Reference Citation Analysis]
127 Wettstein L, Weil T, Conzelmann C, Müller JA, Groß R, Hirschenberger M, Seidel A, Klute S, Zech F, Prelli Bozzo C, Preising N, Fois G, Lochbaum R, Knaff PM, Mailänder V, Ständker L, Thal DR, Schumann C, Stenger S, Kleger A, Lochnit G, Mayer B, Ruiz-Blanco YB, Hoffmann M, Sparrer KMJ, Pöhlmann S, Sanchez-Garcia E, Kirchhoff F, Frick M, Münch J. Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection. Nat Commun 2021;12:1726. [PMID: 33741941 DOI: 10.1038/s41467-021-21972-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
128 Sharma P, Reddy PK, Kumar B. Trace Element Zinc, a Nature's Gift to Fight Unprecedented Global Pandemic COVID-19. Biol Trace Elem Res 2021;199:3213-21. [PMID: 33170448 DOI: 10.1007/s12011-020-02462-8] [Reference Citation Analysis]
129 Mornese Pinna S, Lupia T, Scabini S, Vita D, De Benedetto I, Gaviraghi A, Colasanto I, Varese A, Cattel F, De Rosa FG, Corcione S. Monoclonal antibodies for the treatment of COVID-19 patients: An umbrella to overcome the storm? Int Immunopharmacol 2021;101:108200. [PMID: 34607231 DOI: 10.1016/j.intimp.2021.108200] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
130 Cárdenas G, Torres-García D, Cervantes-Torres J, Rosales-Mendoza S, Fleury A, Fragoso G, Laclette JP, Sciutto E. Role of Systemic and Nasal Glucocorticoid Treatment in the Regulation of the Inflammatory Response in Patients with SARS-Cov-2 Infection. Arch Med Res 2021;52:143-50. [PMID: 33160751 DOI: 10.1016/j.arcmed.2020.10.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
131 [DOI: 10.1101/2020.04.23.056838] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
132 Chaves Filho AJM, Gonçalves F, Mottin M, Andrade CH, Fonseca SNS, Macedo DS. Repurposing of Tetracyclines for COVID-19 Neurological and Neuropsychiatric Manifestations: A Valid Option to Control SARS-CoV-2-Associated Neuroinflammation? J Neuroimmune Pharmacol 2021;16:213-8. [PMID: 33534108 DOI: 10.1007/s11481-021-09986-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
133 Fu YZ, Wang SY, Zheng ZQ, Yi Huang, Li WW, Xu ZS, Wang YY. SARS-CoV-2 membrane glycoprotein M antagonizes the MAVS-mediated innate antiviral response. Cell Mol Immunol 2021;18:613-20. [PMID: 33110251 DOI: 10.1038/s41423-020-00571-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 12.5] [Reference Citation Analysis]
134 Leão Batista Simões J, Fornari Basso H, Cristine Kosvoski G, Gavioli J, Marafon F, Elias Assmann C, Barbosa Carvalho F, Dulce Bagatini M. Targeting purinergic receptors to suppress the cytokine storm induced by SARS-CoV-2 infection in pulmonary tissue. Int Immunopharmacol 2021;100:108150. [PMID: 34537482 DOI: 10.1016/j.intimp.2021.108150] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
135 Choudhuri S, Chowdhury IH, Garg NJ. Mitochondrial Regulation of Macrophage Response Against Pathogens. Front Immunol 2020;11:622602. [PMID: 33679710 DOI: 10.3389/fimmu.2020.622602] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
136 Mohsen MO, Balke I, Zinkhan S, Zeltina V, Liu X, Chang X, Krenger PS, Plattner K, Gharailoo Z, Vogt AS, Augusto G, Zwicker M, Roongta S, Rothen DA, Josi R, Costa JJD, Sobczak JM, Nonic A, Brand LA, Nuss K, Martina B, Speiser DE, Kündig T, Jennings GT, Walton SM, Vogel M, Zeltins A, Bachmann MF. A scalable and highly immunogenic virus-like particle-based vaccine against SARS-CoV-2. Allergy 2021. [PMID: 34496033 DOI: 10.1111/all.15080] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
137 Hartenian E, Nandakumar D, Lari A, Ly M, Tucker JM, Glaunsinger BA. The molecular virology of coronaviruses. J Biol Chem 2020;295:12910-34. [PMID: 32661197 DOI: 10.1074/jbc.REV120.013930] [Cited by in Crossref: 91] [Cited by in F6Publishing: 60] [Article Influence: 45.5] [Reference Citation Analysis]
138 Muhammad M, Ibrahim SA, Yarube IU, Bello B. A REVIEW ON EMERGING PATHOGENESIS OF COVID-19 AND POINTS OF CONCERN FOR RESEARCH COMMUNITIES IN NIGERIA. Afr J Infect Dis 2021;15:36-43. [PMID: 33889801 DOI: 10.21010/ajid.v15i2.7] [Reference Citation Analysis]
139 Jin K, Bardes EE, Mitelpunkt A, Wang JY, Bhatnagar S, Sengupta S, Krummel DP, Rothenberg ME, Aronow BJ. An Interactive Single Cell Web Portal Identifies Gene and Cell Networks in COVID-19 Host Responses. iScience 2021;:103115. [PMID: 34522848 DOI: 10.1016/j.isci.2021.103115] [Reference Citation Analysis]
140 Rea IM, Alexander HD. Triple jeopardy in ageing: COVID-19, co-morbidities and inflamm-ageing. Ageing Res Rev 2021;73:101494. [PMID: 34688926 DOI: 10.1016/j.arr.2021.101494] [Reference Citation Analysis]
141 Cecon E, Izabelle C, Poder SL, Real F, Zhu A, Tu L, Ghigna MR, Klonjkowski B, Bomsel M, Jockers R, Dam J. Therapeutic potential of melatonin and melatonergic drugs on K18-hACE2 mice infected with SARS-CoV-2. J Pineal Res 2022;72:e12772. [PMID: 34586649 DOI: 10.1111/jpi.12772] [Reference Citation Analysis]
142 Spinetti T, Hirzel C, Fux M, Walti LN, Schober P, Stueber F, Luedi MM, Schefold JC. Reduced Monocytic Human Leukocyte Antigen-DR Expression Indicates Immunosuppression in Critically Ill COVID-19 Patients. Anesth Analg 2020;131:993-9. [PMID: 32925314 DOI: 10.1213/ANE.0000000000005044] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
143 Mok DZL, Chan CYY, Ooi EE, Chan KR. The effects of aging on host resistance and disease tolerance to SARS-CoV-2 infection. FEBS J 2021;288:5055-70. [PMID: 33124149 DOI: 10.1111/febs.15613] [Reference Citation Analysis]
144 Muyayalo KP, Huang DH, Zhao SJ, Xie T, Mor G, Liao AH. COVID-19 and Treg/Th17 imbalance: Potential relationship to pregnancy outcomes. Am J Reprod Immunol 2020;84:e13304. [PMID: 32662111 DOI: 10.1111/aji.13304] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
145 Werion A, Belkhir L, Perrot M, Schmit G, Aydin S, Chen Z, Penaloza A, De Greef J, Yildiz H, Pothen L, Yombi JC, Dewulf J, Scohy A, Gérard L, Wittebole X, Laterre PF, Miller SE, Devuyst O, Jadoul M, Morelle J; Cliniques universitaires Saint-Luc (CUSL) COVID-19 Research Group. SARS-CoV-2 causes a specific dysfunction of the kidney proximal tubule. Kidney Int 2020;98:1296-307. [PMID: 32791255 DOI: 10.1016/j.kint.2020.07.019] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 29.5] [Reference Citation Analysis]
146 Hembram P. An outline of SARS-CoV-2 pathogenesis and the complement cascade of immune system. Bull Natl Res Cent 2021;45:123. [PMID: 34257504 DOI: 10.1186/s42269-021-00582-2] [Reference Citation Analysis]
147 Kimura Y, Nakai Y, Shin J, Hara M, Takeda Y, Kubo S, Jeremiah SS, Ino Y, Akiyama T, Moriyama K, Sakai K, Saji R, Nishii M, Kitamura H, Murohashi K, Yamamoto K, Kaneko T, Takeuchi I, Hagiwara E, Ogura T, Hasegawa H, Tamura T, Yamanaka T, Ryo A. Identification of serum prognostic biomarkers of severe COVID-19 using a quantitative proteomic approach. Sci Rep 2021;11:20638. [PMID: 34667241 DOI: 10.1038/s41598-021-98253-9] [Reference Citation Analysis]
148 Al-Zaidan L, Mestiri S, Raza A, Merhi M, Inchakalody VP, Fernandes Q, Taib N, Uddin S, Dermime S. The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target. Tumour Biol 2021;43:177-96. [PMID: 34420993 DOI: 10.3233/TUB-200084] [Reference Citation Analysis]
149 Udovicic I, Stanojevic I, Djordjevic D, Zeba S, Rondovic G, Abazovic T, Lazic S, Vojvodic D, To K, Abazovic D, Khan W, Surbatovic M. Immunomonitoring of Monocyte and Neutrophil Function in Critically Ill Patients: From Sepsis and/or Trauma to COVID-19. J Clin Med 2021;10:5815. [PMID: 34945111 DOI: 10.3390/jcm10245815] [Reference Citation Analysis]
150 Ladani AP, Loganathan M, Danve A. Managing rheumatic diseases during COVID-19. Clin Rheumatol 2020;39:3245-54. [PMID: 32895747 DOI: 10.1007/s10067-020-05387-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
151 Villa A, Sankar V, Shazib MA, Ramos D, Veluppillai P, Wu A, Shiboski C. Patient and providers' satisfaction with tele(oral)medicine during the COVID-19 pandemic. Oral Dis 2020. [PMID: 33043546 DOI: 10.1111/odi.13678] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
152 Schurink B, Roos E, Radonic T, Barbe E, Bouman CSC, de Boer HH, de Bree GJ, Bulle EB, Aronica EM, Florquin S, Fronczek J, Heunks LMA, de Jong MD, Guo L, du Long R, Lutter R, Molenaar PCG, Neefjes-Borst EA, Niessen HWM, van Noesel CJM, Roelofs JJTH, Snijder EJ, Soer EC, Verheij J, Vlaar APJ, Vos W, van der Wel NN, van der Wal AC, van der Valk P, Bugiani M. Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study. Lancet Microbe 2020;1:e290-9. [PMID: 33015653 DOI: 10.1016/S2666-5247(20)30144-0] [Cited by in Crossref: 141] [Cited by in F6Publishing: 99] [Article Influence: 70.5] [Reference Citation Analysis]
153 Barrios Y, Franco A, Sánchez-Machín I, Poza-Guedes P, González-Pérez R, Matheu V. The Beauty of Simplicity: Delayed-Type Hypersensitivity Reaction to Measure Cellular Immune Responses in RNA-SARS-Cov-2 Vaccinated Individuals. Vaccines (Basel) 2021;9:575. [PMID: 34205888 DOI: 10.3390/vaccines9060575] [Reference Citation Analysis]
154 Vodovotz Y, Barnard N, Hu FB, Jakicic J, Lianov L, Loveland D, Buysse D, Szigethy E, Finkel T, Sowa G, Verschure P, Williams K, Sanchez E, Dysinger W, Maizes V, Junker C, Phillips E, Katz D, Drant S, Jackson RJ, Trasande L, Woolf S, Salive M, South-Paul J, States SL, Roth L, Fraser G, Stout R, Parkinson MD. Prioritized Research for the Prevention, Treatment, and Reversal of Chronic Disease: Recommendations From the Lifestyle Medicine Research Summit. Front Med (Lausanne) 2020;7:585744. [PMID: 33415115 DOI: 10.3389/fmed.2020.585744] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
155 Rendeiro AF, Ravichandran H, Bram Y, Chandar V, Kim J, Meydan C, Park J, Foox J, Hether T, Warren S, Kim Y, Reeves J, Salvatore S, Mason CE, Swanson EC, Borczuk AC, Elemento O, Schwartz RE. The spatial landscape of lung pathology during COVID-19 progression. Nature 2021;593:564-9. [PMID: 33780969 DOI: 10.1038/s41586-021-03475-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 23.0] [Reference Citation Analysis]
156 Zothantluanga JH, Gogoi N, Shakya A, Chetia D, Lalthanzara H. Computational guided identification of potential leads from Acacia pennata (L.) Willd. as inhibitors for cellular entry and viral replication of SARS-CoV-2. Futur J Pharm Sci 2021;7:201. [PMID: 34660817 DOI: 10.1186/s43094-021-00348-7] [Reference Citation Analysis]
157 Goshen-Lago T, Szwarcwort-Cohen M, Benguigui M, Almog R, Turgeman I, Zaltzman N, Halberthal M, Shaked Y, Ben-Aharon I. The Potential Role of Immune Alteration in the Cancer-COVID19 Equation-A Prospective Longitudinal Study. Cancers (Basel) 2020;12:E2421. [PMID: 32859016 DOI: 10.3390/cancers12092421] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
158 Sarzani R, Spannella F, Giulietti F, Di Pentima C, Giordano P, Giacometti A. Possible harm from glucocorticoid drugs misuse in the early phase of SARS-CoV-2 infection: a narrative review of the evidence. Intern Emerg Med 2021. [PMID: 34718937 DOI: 10.1007/s11739-021-02860-3] [Reference Citation Analysis]
159 Ten-Caten F, Gonzalez-Dias P, Castro Í, Ogava RLT, Giddaluru J, Silva JCS, Martins F, Gonçalves ANA, Costa-Martins AG, Araujo JD, Viegas AC, Cunha FQ, Farsky S, Bozza FA, Levin AS, Pannaraj PS, de Silva TI, Minoprio P, Pinheiro da Silva F, Andrade BB, Nakaya HI. In-depth analysis of laboratory parameters reveals the interplay between sex, age, and systemic inflammation in individuals with COVID-19. Int J Infect Dis 2021;105:579-87. [PMID: 33713813 DOI: 10.1016/j.ijid.2021.03.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
160 Lafarge A, Martin JE, Longval T, Dupont T, De Jong A, Azoulay E. Two different patterns of lymphocyte alterations in critically ill COVID-19 patients. Intern Emerg Med 2021;16:1411-4. [PMID: 33386601 DOI: 10.1007/s11739-020-02575-x] [Reference Citation Analysis]
161 Phadke VK, Scanlon N, Jordan SC, Rouphael NG. Immune Responses to SARS-CoV-2 in Solid Organ Transplant Recipients. Curr Transplant Rep 2021;:1-13. [PMID: 33688459 DOI: 10.1007/s40472-021-00322-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
162 Gu Y, Cao J, Zhang X, Gao H, Wang Y, Wang J, He J, Jiang X, Zhang J, Shen G, Yang J, Zheng X, Hu G, Zhu Y, Du S, Zhu Y, Zhang R, Xu J, Lan F, Qu D, Xu G, Zhao Y, Gao D, Xie Y, Luo M, Lu Z. Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2. Cell Res 2021. [PMID: 34837059 DOI: 10.1038/s41422-021-00595-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
163 Greenhalgh T, Knight M, A’court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. [DOI: 10.1136/bmj.m3026] [Cited by in Crossref: 311] [Cited by in F6Publishing: 259] [Article Influence: 155.5] [Reference Citation Analysis]
164 Wu CL, Jules-Elysee KM, Kirksey MA, Liguori GA. Perioperative Nonsteroidal Anti-Inflammatory Agents in the COVID-19 Orthopedic Patient. HSS J 2020;:1-5. [PMID: 32952464 DOI: 10.1007/s11420-020-09783-3] [Reference Citation Analysis]
165 Pillalamarri N, Abdullah, Ren G, Khan L, Ullah A, Jonnakuti S, Ullah M. Exploring the utility of extracellular vesicles in ameliorating viral infection-associated inflammation, cytokine storm and tissue damage. Transl Oncol. 2021;14:101095. [PMID: 33887552 DOI: 10.1016/j.tranon.2021.101095] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
166 Chiappalupi S, Salvadori L, Vukasinovic A, Donato R, Sorci G, Riuzzi F. Targeting RAGE to prevent SARS-CoV-2-mediated multiple organ failure: Hypotheses and perspectives. Life Sci 2021;272:119251. [PMID: 33636175 DOI: 10.1016/j.lfs.2021.119251] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
167 Schaub JM, Chou CW, Kuo HC, Javanmardi K, Hsieh CL, Goldsmith J, DiVenere AM, Le KC, Wrapp D, Byrne PO, Hjorth CK, Johnson NV, Ludes-Meyers J, Nguyen AW, Wang N, Lavinder JJ, Ippolito GC, Maynard JA, McLellan JS, Finkelstein IJ. Expression and characterization of SARS-CoV-2 spike proteins. Nat Protoc 2021;16:5339-56. [PMID: 34611365 DOI: 10.1038/s41596-021-00623-0] [Reference Citation Analysis]
168 Zeng F, Huang Y, Guo Y, Yin M, Chen X, Xiao L, Deng G. Association of inflammatory markers with the severity of COVID-19: A meta-analysis. Int J Infect Dis 2020;96:467-74. [PMID: 32425643 DOI: 10.1016/j.ijid.2020.05.055] [Cited by in Crossref: 137] [Cited by in F6Publishing: 120] [Article Influence: 68.5] [Reference Citation Analysis]
169 de Campos-Mata L, Tejedor Vaquero S, Tachó-Piñot R, Piñero J, Grasset EK, Arrieta Aldea I, Rodrigo Melero N, Carolis C, Horcajada JP, Cerutti A, Villar-García J, Magri G. SARS-CoV-2 sculpts the immune system to induce sustained virus-specific naïve-like and memory B-cell responses. Clin Transl Immunology 2021;10:e1339. [PMID: 34504693 DOI: 10.1002/cti2.1339] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
170 Costantini C, van de Veerdonk FL, Romani L. Covid-19-Associated Pulmonary Aspergillosis: The Other Side of the Coin. Vaccines (Basel) 2020;8:E713. [PMID: 33271780 DOI: 10.3390/vaccines8040713] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
171 Hu S, Jiang S, Qi X, Bai R, Ye XY, Xie T. Races of small molecule clinical trials for the treatment of COVID-19: An up-to-date comprehensive review. Drug Dev Res 2021. [PMID: 34762760 DOI: 10.1002/ddr.21895] [Reference Citation Analysis]
172 Munitz A, Edry-Botzer L, Itan M, Tur-Kaspa R, Dicker D, Marcoviciu D, Goren MG, Mor M, Lev S, Gottesman T, Muhsen K, Cohen D, Stein M, Qimron U, Freund NT, Wine Y, Gerlic M. Rapid seroconversion and persistent functional IgG antibodies in severe COVID-19 patients correlates with an IL-12p70 and IL-33 signature. Sci Rep 2021;11:3461. [PMID: 33568715 DOI: 10.1038/s41598-021-83019-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
173 Codo AC, Davanzo GG, Monteiro LB, de Souza GF, Muraro SP, Virgilio-da-Silva JV, Prodonoff JS, Carregari VC, de Biagi Junior CAO, Crunfli F, Jimenez Restrepo JL, Vendramini PH, Reis-de-Oliveira G, Bispo Dos Santos K, Toledo-Teixeira DA, Parise PL, Martini MC, Marques RE, Carmo HR, Borin A, Coimbra LD, Boldrini VO, Brunetti NS, Vieira AS, Mansour E, Ulaf RG, Bernardes AF, Nunes TA, Ribeiro LC, Palma AC, Agrela MV, Moretti ML, Sposito AC, Pereira FB, Velloso LA, Vinolo MAR, Damasio A, Proença-Módena JL, Carvalho RF, Mori MA, Martins-de-Souza D, Nakaya HI, Farias AS, Moraes-Vieira PM. Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis. Cell Metab 2020;32:437-446.e5. [PMID: 32697943 DOI: 10.1016/j.cmet.2020.07.007] [Cited by in Crossref: 134] [Cited by in F6Publishing: 141] [Article Influence: 67.0] [Reference Citation Analysis]
174 Chen D, Sun J, Zhu J, Ding X, Lan T, Wang X, Wu W, Ou Z, Zhu L, Ding P, Wang H, Luo L, Xiang R, Wang X, Qiu J, Wang S, Li H, Chai C, Liang L, An F, Zhang L, Han L, Zhu Y, Wang F, Yuan Y, Wu W, Sun C, Lu H, Wu J, Sun X, Zhang S, Sahu SK, Liu P, Xia J, Zhang L, Chen H, Fang D, Zeng Y, Wu Y, Cui Z, He Q, Jiang S, Ma X, Feng W, Xu Y, Li F, Liu Z, Chen L, Chen F, Jin X, Qiu W, Wang T, Li Y, Xing X, Yang H, Xu Y, Hua Y, Liu Y, Liu H, Xu X. Single cell atlas for 11 non-model mammals, reptiles and birds. Nat Commun 2021;12:7083. [PMID: 34873160 DOI: 10.1038/s41467-021-27162-2] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
175 Reis RF, Pigozzo AB, Bonin CRB, Quintela BM, Pompei LT, Vieira AC, Silva LLE, Xavier MP, Weber Dos Santos R, Lobosco M. A Validated Mathematical Model of the Cytokine Release Syndrome in Severe COVID-19. Front Mol Biosci 2021;8:639423. [PMID: 34355020 DOI: 10.3389/fmolb.2021.639423] [Reference Citation Analysis]
176 Wendel S, Kutner JM, Machado R, Fontão-Wendel R, Bub C, Fachini R, Yokoyama A, Candelaria G, Sakashita A, Achkar R, Hamerschlak N, Scuracchio P, Amaral M, Dal Ben M, Araujo D, Soares C, Camargo A, Kallás E, Durigon E, Reis LF, Rizzo LV. Screening for SARS-CoV-2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program. Transfusion 2020;60:2938-51. [PMID: 32935877 DOI: 10.1111/trf.16065] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 11.5] [Reference Citation Analysis]
177 Chakafana G, Mutithu D, Hoevelmann J, Ntusi N, Sliwa K. Interplay of COVID-19 and cardiovascular diseases in Africa: an observational snapshot. Clin Res Cardiol 2020;109:1460-8. [PMID: 32809116 DOI: 10.1007/s00392-020-01720-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
178 Nobile B, Durand M, Olié E, Guillaume S, Molès JP, Haffen E, Courtet P. The Anti-inflammatory Effect of the Tricyclic Antidepressant Clomipramine and Its High Penetration in the Brain Might Be Useful to Prevent the Psychiatric Consequences of SARS-CoV-2 Infection. Front Pharmacol 2021;12:615695. [PMID: 33767623 DOI: 10.3389/fphar.2021.615695] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
179 Gheware A, Dholakia D, Kannan S, Panda L, Rani R, Pattnaik BR, Jain V, Parekh Y, Enayathullah MG, Bokara KK, Subramanian V, Mukerji M, Agrawal A, Prasher B. Adhatoda Vasica attenuates inflammatory and hypoxic responses in preclinical mouse models: potential for repurposing in COVID-19-like conditions. Respir Res 2021;22:99. [PMID: 33823870 DOI: 10.1186/s12931-021-01698-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
180 Azkur AK, Akdis M, Azkur D, Sokolowska M, van de Veen W, Brüggen MC, O'Mahony L, Gao Y, Nadeau K, Akdis CA. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy 2020;75:1564-81. [PMID: 32396996 DOI: 10.1111/all.14364] [Cited by in Crossref: 346] [Cited by in F6Publishing: 306] [Article Influence: 173.0] [Reference Citation Analysis]
181 Shi MJ, Lv JG, Lin L, Guo JY. Trends in Coronavirus Disease 2019 Hospitalization and Prognosis: Gender Effect. Curr Med Sci 2021;41:312-7. [PMID: 33877547 DOI: 10.1007/s11596-021-2348-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
182 Segrelles-Calvo G, Araújo GRS, Llopis-Pastor E, Carrillo J, Hernández-Hernández M, Rey L, Rodríguez Melean N, Escribano I, Antón E, Zamarro C, García-Salmones M, Frases S. Prevalence of opportunistic invasive aspergillosis in COVID-19 patients with severe pneumonia. Mycoses 2021;64:144-51. [PMID: 33217071 DOI: 10.1111/myc.13219] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
183 Lutchman D. PIMS-TS and Kawasaki Disease: The Mystery Deepens. Pediatr Infect Dis J 2020;39:e215-6. [PMID: 32675759 DOI: 10.1097/INF.0000000000002801] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
184 Fakhoury HMA, Kvietys PR, Shakir I, Shams H, Grant WB, Alkattan K. Lung-Centric Inflammation of COVID-19: Potential Modulation by Vitamin D. Nutrients 2021;13:2216. [PMID: 34203190 DOI: 10.3390/nu13072216] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
185 Buehrle DJ, Sutton RR, McCann EL, Lucas AE. A Review of Treatment and Prevention of Coronavirus Disease 2019 among Solid Organ Transplant Recipients. Viruses 2021;13:1706. [PMID: 34578287 DOI: 10.3390/v13091706] [Reference Citation Analysis]
186 Schmidt N, Lareau CA, Keshishian H, Ganskih S, Schneider C, Hennig T, Melanson R, Werner S, Wei Y, Zimmer M, Ade J, Kirschner L, Zielinski S, Dölken L, Lander ES, Caliskan N, Fischer U, Vogel J, Carr SA, Bodem J, Munschauer M. The SARS-CoV-2 RNA-protein interactome in infected human cells. Nat Microbiol 2021;6:339-53. [PMID: 33349665 DOI: 10.1038/s41564-020-00846-z] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 23.5] [Reference Citation Analysis]
187 Omori R, Matsuyama R, Nakata Y. The age distribution of mortality from novel coronavirus disease (COVID-19) suggests no large difference of susceptibility by age. Sci Rep 2020;10:16642. [PMID: 33024235 DOI: 10.1038/s41598-020-73777-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 20.0] [Reference Citation Analysis]
188 Singh L, Bajaj S, Gadewar M, Verma N, Ansari MN, Saeedan AS, Kaithwas G, Singh M. Modulation of Host Immune Response Is an Alternative Strategy to Combat SARS-CoV-2 Pathogenesis. Front Immunol 2021;12:660632. [PMID: 34305892 DOI: 10.3389/fimmu.2021.660632] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
189 Bostanci Ceran B, Ozates S. Ocular manifestations of coronavirus disease 2019. Graefes Arch Clin Exp Ophthalmol 2020;258:1959-63. [PMID: 32504100 DOI: 10.1007/s00417-020-04777-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]
190 Fainardi V, Longo F, Chetta A, Esposito S, Pisi G. Sars-CoV-2 infection in patients with cystic fibrosis. An overview. Acta Biomed 2020;91:e2020035. [PMID: 32921729 DOI: 10.23750/abm.v91i3.10391] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
191 Carrillo Hernandez-Rubio J, Sanchez-Carpintero Abad M, Yordi Leon A, Doblare Higuera G, Garcia Rodriguez L, Garcia Torrejon C, Mayor Cacho A, Jimenez Rodriguez A, Garcia-Salmones Martin M. Outcomes of an intermediate respiratory care unit in the COVID-19 pandemic. PLoS One 2020;15:e0243968. [PMID: 33326484 DOI: 10.1371/journal.pone.0243968] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
192 Tagliamento M, Spagnolo F, Poggio F, Soldato D, Conte B, Ruelle T, Barisione E, De Maria A, Del Mastro L, Di Maio M, Lambertini M. Italian survey on managing immune checkpoint inhibitors in oncology during COVID-19 outbreak. Eur J Clin Invest 2020;50:e13315. [PMID: 32535890 DOI: 10.1111/eci.13315] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
193 Schultz B, Zaliani A, Ebeling C, Reinshagen J, Bojkova D, Lage-Rupprecht V, Karki R, Lukassen S, Gadiya Y, Ravindra NG, Das S, Baksi S, Domingo-Fernández D, Lentzen M, Strivens M, Raschka T, Cinatl J, DeLong LN, Gribbon P, Geisslinger G, Ciesek S, van Dijk D, Gardner S, Kodamullil AT, Fröhlich H, Peitsch M, Jacobs M, Hoeng J, Eils R, Claussen C, Hofmann-Apitius M. A method for the rational selection of drug repurposing candidates from multimodal knowledge harmonization. Sci Rep 2021;11:11049. [PMID: 34040048 DOI: 10.1038/s41598-021-90296-2] [Reference Citation Analysis]
194 Maldonado MD, Romero-Aibar J, Pérez-San-Gregorio MA. COVID-19 pandemic as a risk factor for the reactivation of herpes viruses. Epidemiol Infect 2021;149:e145. [PMID: 34130765 DOI: 10.1017/S0950268821001333] [Reference Citation Analysis]
195 Gkouskou K, Vasilogiannakopoulou T, Andreakos E, Davanos N, Gazouli M, Sanoudou D, Eliopoulos AG. COVID-19 enters the expanding network of apolipoprotein E4-related pathologies. Redox Biol 2021;41:101938. [PMID: 33730676 DOI: 10.1016/j.redox.2021.101938] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
196 Kalia V, Studzinski GP, Sarkar S. Role of vitamin D in regulating COVID-19 severity-An immunological perspective. J Leukoc Biol 2021. [PMID: 33464639 DOI: 10.1002/JLB.4COVR1020-698R] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
197 Semeraro N, Colucci M. The Prothrombotic State Associated with SARS-CoV-2 Infection: Pathophysiological Aspects. Mediterr J Hematol Infect Dis 2021;13:e2021045. [PMID: 34276914 DOI: 10.4084/MJHID.2021.045] [Reference Citation Analysis]
198 AbdelMassih A, Hassan AA, Abou-Zeid AS, Hassan A, Hussein E, Gadalla M, Hussein M, Eid MA, Elahmady M, El Nahhas N, Emad N, Zahra N, Aboushadi N, Ibrahim N, Mokhtar S, Ismail HA, El-Husseiny N, Moharam RK, Menshawey E, Menshawey R. Salivary markers and coronavirus disease 2019: insights from cross-talk between the oral microbiome and pulmonary and systemic low-grade inflammation and implications for vascular complications. Cardiovasc Endocrinol Metab 2021;10:162-7. [PMID: 34386717 DOI: 10.1097/XCE.0000000000000242] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
199 Jager MJ, Seddon JM. Eye Diseases Direct Interest to Complement Pathway and Macrophages as Regulators of Inflammation in COVID-19. Asia-Pacific Journal of Ophthalmology 2021;10:114-20. [DOI: 10.1097/apo.0000000000000346] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
200 Marchiano S, Hsiang TY, Khanna A, Higashi T, Whitmore LS, Bargehr J, Davaapil H, Chang J, Smith E, Ong LP, Colzani M, Reinecke H, Yang X, Pabon L, Sinha S, Najafian B, Sniadecki NJ, Bertero A, Gale M Jr, Murry CE. SARS-CoV-2 Infects Human Pluripotent Stem Cell-Derived Cardiomyocytes, Impairing Electrical and Mechanical Function. Stem Cell Reports 2021;16:478-92. [PMID: 33657418 DOI: 10.1016/j.stemcr.2021.02.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
201 Mulay A, Konda B, Garcia G, Yao C, Beil S, Sen C, Purkayastha A, Kolls JK, Pociask DA, Pessina P, Sainz de Aja J, Garcia-de-Alba C, Kim CF, Gomperts B, Arumugaswami V, Stripp BR. SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery. bioRxiv 2020:2020. [PMID: 32637946 DOI: 10.1101/2020.06.29.174623] [Cited by in Crossref: 21] [Cited by in F6Publishing: 5] [Article Influence: 10.5] [Reference Citation Analysis]
202 Speranza E, Williamson BN, Feldmann F, Sturdevant GL, Pérez-Pérez L, Meade-White K, Smith BJ, Lovaglio J, Martens C, Munster VJ, Okumura A, Shaia C, Feldmann H, Best SM, de Wit E. Single-cell RNA sequencing reveals SARS-CoV-2 infection dynamics in lungs of African green monkeys. Sci Transl Med 2021;13:eabe8146. [PMID: 33431511 DOI: 10.1126/scitranslmed.abe8146] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 25.0] [Reference Citation Analysis]
203 Tiyo BT, Schmitz GJH, Ortega MM, da Silva LT, de Almeida A, Oshiro TM, Duarte AJDS. What Happens to the Immune System after Vaccination or Recovery from COVID-19? Life (Basel) 2021;11:1152. [PMID: 34833028 DOI: 10.3390/life11111152] [Reference Citation Analysis]
204 Shoumariyeh K, Biavasco F, Ihorst G, Rieg S, Nieters A, Kern WV, Miething C, Duyster J, Engelhardt M, Bertz H. Covid-19 in patients with hematological and solid cancers at a Comprehensive Cancer Center in Germany. Cancer Med 2020;9:8412-22. [PMID: 32931637 DOI: 10.1002/cam4.3460] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
205 Bordallo B, Bellas M, Cortez AF, Vieira M, Pinheiro M. Severe COVID-19: what have we learned with the immunopathogenesis? Adv Rheumatol 2020;60:50. [PMID: 32962761 DOI: 10.1186/s42358-020-00151-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
206 Adesanya TMA, Campbell CM, Cheng L, Ogbogu PU, Kahwash R. C1 Esterase Inhibition: Targeting Multiple Systems in COVID-19. J Clin Immunol 2021;41:729-32. [PMID: 33474624 DOI: 10.1007/s10875-021-00972-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
207 De Giorgio MR, Di Noia S, Morciano C, Conte D. The impact of SARS-CoV-2 on skeletal muscles. Acta Myol 2020;39:307-12. [PMID: 33458586 DOI: 10.36185/2532-1900-034] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
208 Alberca RW, Teixeira FME, Beserra DR, de Oliveira EA, Andrade MMS, Pietrobon AJ, Sato MN. Perspective: The Potential Effects of Naringenin in COVID-19. Front Immunol. 2020;11:570919. [PMID: 33101291 DOI: 10.3389/fimmu.2020.570919] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
209 Malone B, Simovski B, Moliné C, Cheng J, Gheorghe M, Fontenelle H, Vardaxis I, Tennøe S, Malmberg JA, Stratford R, Clancy T. Artificial intelligence predicts the immunogenic landscape of SARS-CoV-2 leading to universal blueprints for vaccine designs. Sci Rep 2020;10:22375. [PMID: 33361777 DOI: 10.1038/s41598-020-78758-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
210 Yammine H, Ballast JK, Poulsen N, Arko FR 3rd. Endovascular aortic repair in an asymptomatic COVID-19-positive patient with a symptomatic inflammatory abdominal aortic aneurysm. J Vasc Surg Cases Innov Tech 2020;6:531-3. [PMID: 32904956 DOI: 10.1016/j.jvscit.2020.08.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
211 Umeh C, Maguwudze S, Torbela A, Saigal S, Kaur H, Kazourra S, Aseri M, Gupta R, Chaudhuri S, Gupta R. Predictors of Mortality in COVID-19 Patients in Southern California - Retrospective Multicenter Study. Cureus 2021;13:e18137. [PMID: 34692345 DOI: 10.7759/cureus.18137] [Reference Citation Analysis]
212 Giorgi M, Cardarelli S, Ragusa F, Saliola M, Biagioni S, Poiana G, Naro F, Massimi M. Phosphodiesterase Inhibitors: Could They Be Beneficial for the Treatment of COVID-19? Int J Mol Sci 2020;21:E5338. [PMID: 32727145 DOI: 10.3390/ijms21155338] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
213 Pinotti F, Wikramaratna PS, Obolski U, Paton RS, Damineli DSC, Alcantara LCJ, Giovanetti M, Gupta S, Lourenço J. Potential impact of individual exposure histories to endemic human coronaviruses on age-dependent severity of COVID-19. BMC Med 2021;19:19. [PMID: 33430856 DOI: 10.1186/s12916-020-01887-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
214 Dos Santos GA, Pimenta R, Viana NI, Guimarães VR, Romão P, Candido P, de Camargo JA, Hatanaka DM, Queiroz PG, Teruya A, Leite KRM, Srougi V, Srougi M, Reis ST. Shorter leukocyte telomere length is associated with severity of COVID-19 infection. Biochem Biophys Rep 2021;27:101056. [PMID: 34151032 DOI: 10.1016/j.bbrep.2021.101056] [Reference Citation Analysis]
215 Bai Z, Li P, Wen J, Han Y, Cui Y, Zhou Y, Shi Z, Chen S, Li Q, Zhao X, Wang Z, Li R, Guo Y, Zhan X, Xu G, Ding K, Wang J, Xiao X. Inhibitory effects and mechanisms of the anti-covid-19 traditional Chinese prescription, Keguan-1, on acute lung injury. J Ethnopharmacol 2021;285:114838. [PMID: 34788645 DOI: 10.1016/j.jep.2021.114838] [Reference Citation Analysis]
216 Nateghi S, Gomari MM, Hosamirudsari H, Behnoush B, Razmjoofard A, Azimi G, Ordookhani S, Jafarpour A, Faraji N. A historical cohort study to investigation of statins safety in COVID-19 hospitalized patients. Therapie 2021:S0040-5957(21)00211-0. [PMID: 34776254 DOI: 10.1016/j.therap.2021.10.006] [Reference Citation Analysis]
217 De La Flor JC, Valga F, Marschall A, Monzon T, Albarracín C, Ruiz E, Rodeles M. Targeting Cytokine Storm in COVID-19: A Role of Online Hemodiafiltration with Asymmetric Cellulose Triacetate in Maintenance Hemodialysis Patients-A Report of 10 Cases. Case Rep Nephrol 2021;2021:5575928. [PMID: 33747583 DOI: 10.1155/2021/5575928] [Reference Citation Analysis]
218 Filgueira TO, Castoldi A, Santos LER, de Amorim GJ, de Sousa Fernandes MS, Anastácio WLDN, Campos EZ, Santos TM, Souto FO. The Relevance of a Physical Active Lifestyle and Physical Fitness on Immune Defense: Mitigating Disease Burden, With Focus on COVID-19 Consequences. Front Immunol 2021;12:587146. [PMID: 33613573 DOI: 10.3389/fimmu.2021.587146] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
219 Myint PK, Carter B, Barlow-Pay F, Short R, Einarsson AG, Bruce E, McCarthy K, Verduri A, Collins J, Hesford J, Rickard F, Mitchell E, Holloway M, McGovern A, Vilches-Moraga A, Braude P, Pearce L, Stechman M, Price A, Quinn TJ, Clini E, Moug S, Hewitt J. Routine use of immunosuppressants is associated with mortality in hospitalised patients with COVID-19. Ther Adv Drug Saf 2021;12:2042098620985690. [PMID: 33680426 DOI: 10.1177/2042098620985690] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
220 Bassatne A, Basbous M, Chakhtoura M, El Zein O, Rahme M, El-Hajj Fuleihan G. The link between COVID-19 and VItamin D (VIVID): A systematic review and meta-analysis. Metabolism 2021;119:154753. [PMID: 33774074 DOI: 10.1016/j.metabol.2021.154753] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 17.0] [Reference Citation Analysis]
221 Patelli G, Paganoni S, Besana F, Codazzi F, Ronzoni M, Manini S, Remuzzi A. Preliminary detection of lung hypoperfusion in discharged Covid-19 patients during recovery. Eur J Radiol 2020;129:109121. [PMID: 32540586 DOI: 10.1016/j.ejrad.2020.109121] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
222 Smith E, Davis-Gardner ME, Garcia-Ordonez RD, Nguyen TT, Hull M, Chen E, Baillargeon P, Scampavia L, Strutzenberg T, Griffin PR, Farzan M, Spicer TP. High-Throughput Screening for Drugs That Inhibit Papain-Like Protease in SARS-CoV-2. SLAS Discov 2020;25:1152-61. [PMID: 33043784 DOI: 10.1177/2472555220963667] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
223 Shalash AO, Hussein WM, Skwarczynski M, Toth I. Key Considerations for the Development of Safe and Effective SARS-CoV-2 Subunit Vaccine: A Peptide-Based Vaccine Alternative. Adv Sci (Weinh) 2021;8:e2100985. [PMID: 34176237 DOI: 10.1002/advs.202100985] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
224 Junaid K, Ejaz H, Abdalla AE, Abosalif KOA, Ullah MI, Yasmeen H, Younas S, Hamam SSM, Rehman A. Effective Immune Functions of Micronutrients against SARS-CoV-2. Nutrients 2020;12:E2992. [PMID: 33003648 DOI: 10.3390/nu12102992] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
225 McClain MT, Constantine FJ, Henao R, Liu Y, Tsalik EL, Burke TW, Steinbrink JM, Petzold E, Nicholson BP, Rolfe R, Kraft BD, Kelly MS, Sempowski GD, Denny TN, Ginsburg GS, Woods CW. Dysregulated transcriptional responses to SARS-CoV-2 in the periphery support novel diagnostic approaches. medRxiv 2020:2020. [PMID: 32743603 DOI: 10.1101/2020.07.20.20155507] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
226 Paolacci S, Ceccarini MR, Codini M, Manara E, Tezzele S, Percio M, Capodicasa N, Kroni D, Dundar M, Ergoren MC, Sanlidag T, Beccari T, Farronato M, Farronato G, Tartaglia GM, Bertelli M. Pilot study for the evaluation of safety profile of a potential inhibitor of SARS-CoV-2 endocytosis. Acta Biomed 2020;91:e2020009. [PMID: 33170175 DOI: 10.23750/abm.v91i13-S.10583] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
227 Gustine JN, Jones D. Immunopathology of Hyperinflammation in COVID-19. Am J Pathol 2021;191:4-17. [PMID: 32919977 DOI: 10.1016/j.ajpath.2020.08.009] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 27.0] [Reference Citation Analysis]
228 Li CX, Gao J, Zhang Z, Chen L, Li X, Zhou M, Wheelock ÅM. Multiomics integration-based molecular characterizations of COVID-19. Brief Bioinform 2021:bbab485. [PMID: 34864875 DOI: 10.1093/bib/bbab485] [Reference Citation Analysis]
229 [DOI: 10.1101/2020.06.18.20131326] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
230 Vora SM, Lieberman J, Wu H. Inflammasome activation at the crux of severe COVID-19. Nat Rev Immunol 2021. [PMID: 34373622 DOI: 10.1038/s41577-021-00588-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
231 Ascierto PA, Fu B, Wei H. IL-6 modulation for COVID-19: the right patients at the right time? J Immunother Cancer 2021;9:e002285. [PMID: 33837054 DOI: 10.1136/jitc-2020-002285] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
232 Pereira-Silva M, Chauhan G, Shin MD, Hoskins C, Madou MJ, Martinez-Chapa SO, Steinmetz NF, Veiga F, Paiva-Santos AC. Unleashing the potential of cell membrane-based nanoparticles for COVID-19 treatment and vaccination. Expert Opin Drug Deliv 2021;:1-20. [PMID: 33944644 DOI: 10.1080/17425247.2021.1922387] [Reference Citation Analysis]
233 Abdelnabi R, Foo CS, Kaptein SJF, Zhang X, Do TND, Langendries L, Vangeel L, Breuer J, Pang J, Williams R, Vergote V, Heylen E, Leyssen P, Dallmeier K, Coelmont L, Chatterjee AK, Mols R, Augustijns P, De Jonghe S, Jochmans D, Weynand B, Neyts J. The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model. EBioMedicine 2021;72:103595. [PMID: 34571361 DOI: 10.1016/j.ebiom.2021.103595] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
234 Kwee TC, Kwee RM. Chest CT in COVID-19: What the Radiologist Needs to Know. Radiographics. 2020;40:1848-1865. [PMID: 33095680 DOI: 10.1148/rg.2020200159] [Cited by in Crossref: 59] [Cited by in F6Publishing: 39] [Article Influence: 29.5] [Reference Citation Analysis]
235 Oliveira J, Gameiro J, Bernardo J, Marques F, Costa C, Branco C, Duarte I, Fonseca J, Carreiro C, Braz S, Lopes JA. Impact of Chronic RAAS Use in Elderly COVID-19 Patients: A Retrospective Analysis. J Clin Med 2021;10:3147. [PMID: 34300311 DOI: 10.3390/jcm10143147] [Reference Citation Analysis]
236 Nimavat N, Singh S, Singh P, Singh SK, Sinha N. Vitamin D deficiency and COVID-19: A case-control study at a tertiary care hospital in India. Ann Med Surg (Lond) 2021;68:102661. [PMID: 34377451 DOI: 10.1016/j.amsu.2021.102661] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
237 Tippairote T, Peana M, Chirumbolo S, Bjørklund G. Individual risk management strategy for SARS-CoV-2 infection: A step toward personalized healthcare. Int Immunopharmacol 2021;96:107629. [PMID: 33862554 DOI: 10.1016/j.intimp.2021.107629] [Reference Citation Analysis]
238 Valizadeh H, Abdolmohammadi-Vahid S, Danshina S, Ziya Gencer M, Ammari A, Sadeghi A, Roshangar L, Aslani S, Esmaeilzadeh A, Ghaebi M, Valizadeh S, Ahmadi M. Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients. Int Immunopharmacol 2020;89:107088. [PMID: 33129099 DOI: 10.1016/j.intimp.2020.107088] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 17.0] [Reference Citation Analysis]
239 Bora VR, Patel BM. The Deadly Duo of COVID-19 and Cancer! Front Mol Biosci 2021;8:643004. [PMID: 33912588 DOI: 10.3389/fmolb.2021.643004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
240 Wanhella KJ, Fernandez-Patron C. Biomarkers of ageing and frailty may predict COVID-19 severity. Ageing Res Rev 2022;73:101513. [PMID: 34838734 DOI: 10.1016/j.arr.2021.101513] [Reference Citation Analysis]
241 Munnur D, Teo Q, Eggermont D, Lee HHY, Thery F, Ho J, van Leur SW, Ng WWS, Siu LYL, Beling A, Ploegh H, Pinto-Fernandez A, Damianou A, Kessler B, Impens F, Mok CKP, Sanyal S. Altered ISGylation drives aberrant macrophage-dependent immune responses during SARS-CoV-2 infection. Nat Immunol 2021;22:1416-27. [PMID: 34663977 DOI: 10.1038/s41590-021-01035-8] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
242 van der Made CI, Simons A, Schuurs-Hoeijmakers J, van den Heuvel G, Mantere T, Kersten S, van Deuren RC, Steehouwer M, van Reijmersdal SV, Jaeger M, Hofste T, Astuti G, Corominas Galbany J, van der Schoot V, van der Hoeven H, Hagmolen Of Ten Have W, Klijn E, van den Meer C, Fiddelaers J, de Mast Q, Bleeker-Rovers CP, Joosten LAB, Yntema HG, Gilissen C, Nelen M, van der Meer JWM, Brunner HG, Netea MG, van de Veerdonk FL, Hoischen A. Presence of Genetic Variants Among Young Men With Severe COVID-19. JAMA 2020;324:663-73. [PMID: 32706371 DOI: 10.1001/jama.2020.13719] [Cited by in Crossref: 216] [Cited by in F6Publishing: 191] [Article Influence: 216.0] [Reference Citation Analysis]
243 Altendahl M, Afshar Y, de St Maurice A, Fajardo V, Chu A. Perinatal Maternal-Fetal/Neonatal Transmission of COVID-19: A Guide to Safe Maternal and Neonatal Care in the Era of COVID-19 and Physical Distancing. Neoreviews 2020;21:e783-94. [PMID: 33262205 DOI: 10.1542/neo.21-12-e783] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
244 Ronco C, Reis T, Cozzolino M. Rationale for Medium Cutoff Membranes in COVID-19 Patients Requiring Renal Replacement Therapy. Nephron 2020;144:550-4. [PMID: 32750694 DOI: 10.1159/000509807] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
245 Saleki K, Banazadeh M, Miri NS, Azadmehr A. Triangle of cytokine storm, central nervous system involvement, and viral infection in COVID-19: the role of sFasL and neuropilin-1. Rev Neurosci 2021. [PMID: 34225390 DOI: 10.1515/revneuro-2021-0047] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
246 Tiwari R, Mishra AR, Gupta A, Nayak D. Structural similarity-based prediction of host factors associated with SARS-CoV-2 infection and pathogenesis. J Biomol Struct Dyn 2021;:1-12. [PMID: 33506741 DOI: 10.1080/07391102.2021.1874532] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
247 Schultz IC, Bertoni APS, Wink MR. Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying miRNA as a Potential Multi Target Therapy to COVID-19: an In Silico Analysis. Stem Cell Rev Rep 2021;17:341-56. [PMID: 33511519 DOI: 10.1007/s12015-021-10122-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
248 Khuu MA. Lessons from neuronal HIF1a: Understanding its role in ventilatory acclimatization to hypoxia. J Physiol 2020;598:4751-2. [PMID: 32697343 DOI: 10.1113/JP280205] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
249 [DOI: 10.1101/2020.07.09.196519] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
250 Zheng HY, He XY, Li W, Song TZ, Han JB, Yang X, Liu FL, Luo RH, Tian RR, Feng XL, Ma YH, Liu C, Li MH, Zheng YT. Pro-inflammatory microenvironment and systemic accumulation of CXCR3+ cell exacerbate lung pathology of old rhesus macaques infected with SARS-CoV-2. Signal Transduct Target Ther 2021;6:328. [PMID: 34471088 DOI: 10.1038/s41392-021-00734-w] [Reference Citation Analysis]
251 Geretti AM, Stockdale AJ, Kelly SH, Cevik M, Collins S, Waters L, Villa G, Docherty A, Harrison EM, Turtle L, Openshaw PJM, Baillie JK, Sabin CA, Semple MG. Outcomes of COVID-19 related hospitalization among people with HIV in the ISARIC WHO Clinical Characterization Protocol (UK): a prospective observational study. Clin Infect Dis 2020:ciaa1605. [PMID: 33095853 DOI: 10.1093/cid/ciaa1605] [Cited by in Crossref: 31] [Cited by in F6Publishing: 42] [Article Influence: 15.5] [Reference Citation Analysis]
252 Du M, Garcia JGN, Christie JD, Xin J, Cai G, Meyer NJ, Zhu Z, Yuan Q, Zhang Z, Su L, Shen S, Dong X, Li H, Hutchinson JN, Tejera P, Lin X, Wang M, Chen F, Christiani DC. Integrative omics provide biological and clinical insights into acute respiratory distress syndrome. Intensive Care Med 2021;47:761-71. [PMID: 34032881 DOI: 10.1007/s00134-021-06410-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
253 Wiggill TM, Mayne ES, Vaughan JL, Louw S. Overview of the Haematological Effects of COVID-19 Infection. Adv Exp Med Biol 2021;1321:163-72. [PMID: 33656722 DOI: 10.1007/978-3-030-59261-5_14] [Reference Citation Analysis]
254 Ferraro E, Germanò M, Mollace R, Mollace V, Malara N. HIF-1, the Warburg Effect, and Macrophage/Microglia Polarization Potential Role in COVID-19 Pathogenesis. Oxid Med Cell Longev 2021;2021:8841911. [PMID: 33815663 DOI: 10.1155/2021/8841911] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
255 Herman L, De Smedt SC, Raemdonck K. Pulmonary surfactant as a versatile biomaterial to fight COVID-19. J Control Release 2021:S0168-3659(21)00618-0. [PMID: 34813878 DOI: 10.1016/j.jconrel.2021.11.023] [Reference Citation Analysis]
256 Mao B, Le-Trilling VTK, Wang K, Mennerich D, Hu J, Zhao Z, Zheng J, Deng Y, Katschinski B, Xu S, Zhang G, Cai X, Hu Y, Wang J, Lu M, Huang A, Tang N, Trilling M, Lin Y. Obatoclax inhibits SARS-CoV-2 entry by altered endosomal acidification and impaired cathepsin and furin activity in vitro. Emerg Microbes Infect 2022;:1-29. [PMID: 34989664 DOI: 10.1080/22221751.2022.2026739] [Reference Citation Analysis]
257 Yu WL, Toh HS, Liao CT, Chang WT. Cardiovascular Complications of COVID-19 and Associated Concerns: A Review. Acta Cardiol Sin 2021;37:9-17. [PMID: 33488023 DOI: 10.6515/ACS.202101_37(1).20200913A] [Reference Citation Analysis]
258 Garcia-Muñoz R, Feliu J, Anton-Remirez J, Metola L, Sosa-Campos E, Sanz MP, Farfan G, Labrador-Sanchez E, Ibarra V, Peña JL, Pascual A, Hermosa MJ, Blasco M, Llerena-Garcia L, Najera MJ, Oteo JA. Peripheral blood natural killer cell depletion is associated with severe pneumonia in coronavirus disease-2019 (COVID-19). Ir J Med Sci 2021. [PMID: 34215960 DOI: 10.1007/s11845-021-02701-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
259 Yan B, Yang J, Xie Y, Tang X. Relationship between blood eosinophil levels and COVID-19 mortality. World Allergy Organ J 2021;14:100521. [PMID: 33589865 DOI: 10.1016/j.waojou.2021.100521] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
260 Ahsan H, Sonn JK, Lee YS, Islam SU, Khalil SK. An Overview About the Role of Adaptive Immunity in Keeping SARS-CoV-2 Reinfections at Bay. Viral Immunol 2021. [PMID: 34101517 DOI: 10.1089/vim.2021.0017] [Reference Citation Analysis]
261 Ajdžanovic V, Filipovic B, Šošic-Jurjevic B, Miler M, Miloševic V. Margins of beneficial daily dosage of supplements in prevention of COVID-19. EXCLI J 2021;20:828-34. [PMID: 34177405 DOI: 10.17179/excli2021-3790] [Reference Citation Analysis]
262 Huang C, Jiang Y, Yan J. Comparative analyses of ACE2 and TMPRSS2 gene: Implications for the risk to which vertebrate animals are susceptible to SARS-CoV-2. J Med Virol 2021;93:5487-504. [PMID: 33974296 DOI: 10.1002/jmv.27073] [Reference Citation Analysis]
263 Megiorni F, Pontecorvi P, Gerini G, Anastasiadou E, Marchese C, Ceccarelli S. Sex-Related Factors in Cardiovascular Complications Associated to COVID-19. Biomolecules 2022;12:21. [DOI: 10.3390/biom12010021] [Reference Citation Analysis]
264 Chavarot N, Gueguen J, Bonnet G, Jdidou M, Trimaille A, Burger C, Amrouche L, Weizman O, Pommier T, Aubert O, Celier J, Sberro-Soussan R, Geneste L, Panagides V, Delahousse M, Marsou W, Aguilar C, Deney A, Zuber J, Fauvel C, Legendre C, Mika D, Pezel T, Anglicheau D, Sutter W, Zaidan M, Snanoudj R, Cohen A, Scemla A; Critical COVID-19 France Investigators. COVID-19 severity in kidney transplant recipients is similar to nontransplant patients with similar comorbidities. Am J Transplant 2021;21:1285-94. [PMID: 33252201 DOI: 10.1111/ajt.16416] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
265 Mazzoni A, Salvati L, Maggi L, Annunziato F, Cosmi L. Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion. Semin Immunol 2021;:101508. [PMID: 34728121 DOI: 10.1016/j.smim.2021.101508] [Reference Citation Analysis]
266 Deb C, Salinas AN, Zheng T, Middleton A, Kern K, Penoyer D, Borsadia R, Hunley C, Abomoelak B, Mehta V, Irastorza L, Mehta DI, Huo Q. A 1-minute blood test detects decreased immune function and increased clinical risk in COVID-19 patients. Sci Rep 2021;11:23491. [PMID: 34873223 DOI: 10.1038/s41598-021-02863-2] [Reference Citation Analysis]
267 Chiara M, D'Erchia AM, Gissi C, Manzari C, Parisi A, Resta N, Zambelli F, Picardi E, Pavesi G, Horner DS, Pesole G. Next generation sequencing of SARS-CoV-2 genomes: challenges, applications and opportunities. Brief Bioinform 2021;22:616-30. [PMID: 33279989 DOI: 10.1093/bib/bbaa297] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
268 [DOI: 10.1101/2020.10.15.340612] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
269 Mehta OP, Bhandari P, Raut A, Kacimi SEO, Huy NT. Coronavirus Disease (COVID-19): Comprehensive Review of Clinical Presentation. Front Public Health 2020;8:582932. [PMID: 33520910 DOI: 10.3389/fpubh.2020.582932] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
270 [DOI: 10.1101/2020.08.30.274464] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
271 Popova AY, Smirnov VS, Ezhlova EB, Mel'nikova AA, Samoilova LV, Lyalina LV, Semenova EV, Gurskiy MA, Aksenova EA, Arbuzova TV, Totolian AA. [Herd immunity to SARS-CoV-2 in the Novosibirsk Region population amid the COVID-19 pandemic]. Vopr Virusol 2021;66:299-309. [PMID: 34545722 DOI: 10.36233/0507-4088-54] [Reference Citation Analysis]
272 Bery AI, Kulkarni HS, Kreisel D. Editorial: COVID-19 immunology and organ transplantation. Curr Opin Organ Transplant 2021;26:258-65. [PMID: 33651004 DOI: 10.1097/MOT.0000000000000862] [Reference Citation Analysis]
273 [DOI: 10.1101/2020.06.24.20121905] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
274 Yu J, Sun X, Goie JYG, Zhang Y. Regulation of Host Immune Responses against Influenza A Virus Infection by Mitogen-Activated Protein Kinases (MAPKs). Microorganisms 2020;8:E1067. [PMID: 32709018 DOI: 10.3390/microorganisms8071067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
275 Sigel K, Swartz T, Golden E, Paranjpe I, Somani S, Richter F, De Freitas JK, Miotto R, Zhao S, Polak P, Mutetwa T, Factor S, Mehandru S, Mullen M, Cossarini F, Bottinger E, Fayad Z, Merad M, Gnjatic S, Aberg J, Charney A, Nadkarni G, Glicksberg BS. Coronavirus 2019 and People Living With Human Immunodeficiency Virus: Outcomes for Hospitalized Patients in New York City. Clin Infect Dis 2020;71:2933-8. [PMID: 32594164 DOI: 10.1093/cid/ciaa880] [Cited by in Crossref: 60] [Cited by in F6Publishing: 65] [Article Influence: 60.0] [Reference Citation Analysis]
276 McAlpine LS, Fesharaki-Zadeh A, Spudich S. Coronavirus disease 2019 and neurodegenerative disease: what will the future bring? Curr Opin Psychiatry 2021;34:177-85. [PMID: 33395100 DOI: 10.1097/YCO.0000000000000688] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
277 Shirazi S, Stanford CM, Cooper LF. Testing for COVID-19 in dental offices: Mechanism of action, application, and interpretation of laboratory and point-of-care screening tests. J Am Dent Assoc 2021;152:514-525.e8. [PMID: 34176567 DOI: 10.1016/j.adaj.2021.04.019] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
278 Wang Y, Sang X, Shao R, Qin H, Chen X, Xue Z, Li L, Wang Y, Zhu Y, Chang Y, Gao X, Zhang B, Zhang H, Yang J. Xuanfei Baidu Decoction protects against macrophages induced inflammation and pulmonary fibrosis via inhibiting IL-6/STAT3 signaling pathway. J Ethnopharmacol 2022;283:114701. [PMID: 34606948 DOI: 10.1016/j.jep.2021.114701] [Reference Citation Analysis]
279 Motta NAV, Autran LJ, Brazão SC, Lopes RO, Scaramello CBV, Lima GF, Brito FCF. Could cilostazol be beneficial in COVID-19 treatment? Thinking about phosphodiesterase-3 as a therapeutic target. Int Immunopharmacol 2021;92:107336. [PMID: 33418248 DOI: 10.1016/j.intimp.2020.107336] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
280 Mohit, Shrivastava A, Dutt P, Singh MK, Chand P. COVID-19 exposure and obstructive sleep apnea: a therapeutic approach. Sleep Med 2021;81:123. [PMID: 33667997 DOI: 10.1016/j.sleep.2021.02.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
281 Bonavita AG. Ac2-26 mimetic peptide of annexin A1 to treat severe COVID-19: A hypothesis. Med Hypotheses 2020;145:110352. [PMID: 33129009 DOI: 10.1016/j.mehy.2020.110352] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
282 Zhou Y, Xu J, Hou Y, Leverenz JB, Kallianpur A, Mehra R, Liu Y, Yu H, Pieper AA, Jehi L, Cheng F. Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment. bioRxiv 2021:2021. [PMID: 33791705 DOI: 10.1101/2021.03.15.435423] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
283 Didangelos A. COVID-19 Hyperinflammation: What about Neutrophils? mSphere 2020;5:e00367-20. [PMID: 32581077 DOI: 10.1128/mSphere.00367-20] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 20.5] [Reference Citation Analysis]
284 Delaveris CS, Wilk AJ, Riley NM, Stark JC, Yang SS, Rogers AJ, Ranganath T, Nadeau KC, Blish CA, Bertozzi CR; Stanford COVID-19 Biobank. Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19. ChemRxiv 2020. [PMID: 33469569 DOI: 10.26434/chemrxiv.13378148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
285 Marchi S, Viviani S, Remarque EJ, Ruello A, Bombardieri E, Bollati V, Milani GP, Manenti A, Lapini G, Rebuffat A, Montomoli E, Trombetta CM. Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection. PLoS One 2021;16:e0253977. [PMID: 34214116 DOI: 10.1371/journal.pone.0253977] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
286 Katz-Agranov N, Zandman-Goddard G. Autoimmunity and COVID-19 - The microbiotal connection. Autoimmun Rev 2021;20:102865. [PMID: 34118455 DOI: 10.1016/j.autrev.2021.102865] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
287 Stasi A, Castellano G, Ranieri E, Infante B, Stallone G, Gesualdo L, Netti GS. SARS-CoV-2 and Viral Sepsis: Immune Dysfunction and Implications in Kidney Failure. J Clin Med 2020;9:E4057. [PMID: 33334050 DOI: 10.3390/jcm9124057] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
288 Chisari CG, Sgarlata E, Arena S, Toscano S, Luca M, Patti F. Rituximab for the treatment of multiple sclerosis: a review. J Neurol 2021. [PMID: 33416999 DOI: 10.1007/s00415-020-10362-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
289 Nagoor Meeran MF, Javed H, Sharma C, Goyal SN, Kumar S, Jha NK, Ojha S. Can Echinacea be a potential candidate to target immunity, inflammation, and infection - The trinity of coronavirus disease 2019. Heliyon 2021;7:e05990. [PMID: 33585706 DOI: 10.1016/j.heliyon.2021.e05990] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
290 Pacheco-Herrero M, Soto-Rojas LO, Harrington CR, Flores-Martinez YM, Villegas-Rojas MM, León-Aguilar AM, Martínez-Gómez PA, Campa-Córdoba BB, Apátiga-Pérez R, Corniel-Taveras CN, Dominguez-García JJ, Blanco-Alvarez VM, Luna-Muñoz J. Elucidating the Neuropathologic Mechanisms of SARS-CoV-2 Infection. Front Neurol 2021;12:660087. [PMID: 33912129 DOI: 10.3389/fneur.2021.660087] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
291 Arjmand B, Alavi-Moghadam S, Parhizkar Roudsari P, Rezaei-Tavirani M, Rahim F, Gilany K, Mohamadi-Jahani F, Adibi H, Larijani B. COVID-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions. Front Cell Dev Biol 2021;9:675310. [PMID: 34195193 DOI: 10.3389/fcell.2021.675310] [Reference Citation Analysis]
292 Peddapalli A, Gehani M, Kalle AM, Peddapalli SR, Peter AE, Sharad S. Demystifying Excess Immune Response in COVID-19 to Reposition an Orphan Drug for Down-Regulation of NF-κB: A Systematic Review. Viruses 2021;13:378. [PMID: 33673529 DOI: 10.3390/v13030378] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
293 Neri P, Lamperti M, Pichi F. SARS-COV-2 and eye immunity: the lesson was learned but we are not done yet. Brainstorming on possible pathophysiology inspired by ocular models. Int Ophthalmol 2020;40:1879-83. [PMID: 32621017 DOI: 10.1007/s10792-020-01495-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
294 Aziz M, Brenner M, Wang P. Therapeutic Potential of B-1a Cells in COVID-19. Shock 2020;54:586-94. [PMID: 32604223 DOI: 10.1097/SHK.0000000000001610] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
295 Zhou L, Huntington K, Zhang S, Carlsen L, So EY, Parker C, Sahin I, Safran H, Kamle S, Lee CM, Lee CG, Elias JA, Campbell KS, Naik MT, Atwood WJ, Youssef E, Pachter JA, Navaraj A, Seyhan AA, Liang O, El-Deiry WS. Natural Killer cell activation, reduced ACE2, TMPRSS2, cytokines G-CSF, M-CSF and SARS-CoV-2-S pseudovirus infectivity by MEK inhibitor treatment of human cells. bioRxiv 2020:2020. [PMID: 32793908 DOI: 10.1101/2020.08.02.230839] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
296 Sadhukhan P, Ugurlu MT, Hoque MO. Effect of COVID-19 on Lungs: Focusing on Prospective Malignant Phenotypes. Cancers (Basel) 2020;12:E3822. [PMID: 33352869 DOI: 10.3390/cancers12123822] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
297 Tan Q, He L, Meng X, Wang W, Pan H, Yin W, Zhu T, Huang X, Shan H. Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19. J Nanobiotechnology 2021;19:173. [PMID: 34112203 DOI: 10.1186/s12951-021-00926-0] [Reference Citation Analysis]
298 Lee JL, Linterman MA. Mechanisms underpinning poor antibody responses to vaccines in ageing. Immunol Lett 2021;241:1-14. [PMID: 34767859 DOI: 10.1016/j.imlet.2021.11.001] [Reference Citation Analysis]
299 Ranjbar S, Fatahi Y, Atyabi F. The quest for a better fight: How can nanomaterials address the current therapeutic and diagnostic obstacles in the fight against COVID-19? J Drug Deliv Sci Technol 2021;:102899. [PMID: 34630635 DOI: 10.1016/j.jddst.2021.102899] [Reference Citation Analysis]
300 Machado IFR, Menezes IQ, Figueiredo SR, Coelho FMA, Terrabuio DRB, Ramos DV, Fagundes GFC, Maciel AAW, Latronico AC, Fragoso MCBV, Cancado ELR, Mendonca BB, Almeida MQ. Primary adrenal insufficiency due to bilateral adrenal infarction in COVID-19: a case report. J Clin Endocrinol Metab 2021:dgab557. [PMID: 34324679 DOI: 10.1210/clinem/dgab557] [Reference Citation Analysis]
301 Al Kassaa I, El Omari S, Abbas N, Papon N, Drider D, Kassem II, Osman M. High association of COVID-19 severity with poor gut health score in Lebanese patients. PLoS One 2021;16:e0258913. [PMID: 34673813 DOI: 10.1371/journal.pone.0258913] [Reference Citation Analysis]
302 Grinshpun A, Merlet I, Fruchtman H, Nachman D. A Protracted Course of COVID19 Infection in a Metastatic Breast Cancer Patient During CDK4/6 Inhibitor Therapy. Front Oncol 2020;10:1085. [PMID: 32582559 DOI: 10.3389/fonc.2020.01085] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
303 Mercola J, Grant WB, Wagner CL. Evidence Regarding Vitamin D and Risk of COVID-19 and Its Severity. Nutrients 2020;12:E3361. [PMID: 33142828 DOI: 10.3390/nu12113361] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 20.5] [Reference Citation Analysis]
304 Abraham RS, Marshall JM, Kuehn HS, Rueda CM, Gibbs A, Guider W, Stewart C, Rosenzweig SD, Wang H, Jean S, Peeples M, King T, Hunt WG, Honegger JR, Ramilo O, Mustillo PJ, Mejias A, Ardura MI, Shimamura M. Severe SARS-CoV-2 disease in the context of a NF-κB2 loss-of-function pathogenic variant. J Allergy Clin Immunol 2021;147:532-544.e1. [PMID: 33007327 DOI: 10.1016/j.jaci.2020.09.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
305 Ferreira AO, Polonini HC, Dijkers ECF. Postulated Adjuvant Therapeutic Strategies for COVID-19. J Pers Med 2020;10:E80. [PMID: 32764275 DOI: 10.3390/jpm10030080] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
306 Dupuis C, de Montmollin E, Buetti N, Goldgran-Toledano D, Reignier J, Schwebel C, Domitile J, Neuville M, Ursino M, Siami S, Ruckly S, Alberti C, Mourvillier B, Bailly S, Laurent V, Gainnier M, Souweine B, Timsit JF; OutcomeReaTM research network. Impact of early corticosteroids on 60-day mortality in critically ill patients with COVID-19: A multicenter cohort study of the OUTCOMEREA network. PLoS One 2021;16:e0255644. [PMID: 34347836 DOI: 10.1371/journal.pone.0255644] [Reference Citation Analysis]
307 Mallon PWG, Tinago W, Leon AG, McCann K, Kenny G, McGettrick P, Green S, Inzitari R, Cottere AG, Feeney ER, Savinelli S, Doran P; All Ireland Infectious Diseases Cohort Study Group . Dynamic Change and Clinical Relevance of Postinfectious SARS-CoV-2 Antibody Responses. Open Forum Infect Dis 2021;8:ofab122. [PMID: 34377721 DOI: 10.1093/ofid/ofab122] [Reference Citation Analysis]
308 Egol KA, Konda SR, Bird ML, Dedhia N, Landes EK, Ranson RA, Solasz SJ, Aggarwal VK, Bosco JA 3rd, Furgiuele DL, Ganta A, Gould J, Lyon TR, McLaurin TM, Tejwani NC, Zuckerman JD, Leucht P;  NYU COVID Hip Fracture Research Group. Increased Mortality and Major Complications in Hip Fracture Care During the COVID-19 Pandemic: A New York City Perspective. J Orthop Trauma. 2020;34:395-402. [PMID: 32482976 DOI: 10.1097/bot.0000000000001845] [Cited by in Crossref: 56] [Cited by in F6Publishing: 39] [Article Influence: 28.0] [Reference Citation Analysis]
309 Hensel A, Bauer R, Heinrich M, Spiegler V, Kayser O, Hempel G, Kraft K. Challenges at the Time of COVID-19: Opportunities and Innovations in Antivirals from Nature. Planta Med. 2020;86:659-664. [PMID: 32434254 DOI: 10.1055/a-1177-4396] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 13.0] [Reference Citation Analysis]
310 Hasan A, Al-Ozairi E, Al-Baqsumi Z, Ahmad R, Al-Mulla F. Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches. Immunotargets Ther 2021;10:63-85. [PMID: 33728277 DOI: 10.2147/ITT.S280706] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
311 Erel Ö, Neşelioğlu S, Ergin Tunçay M, Fırat Oğuz E, Eren F, Akkuş MS, Güner HR, Ateş İ. A sensitive indicator for the severity of COVID-19: thiol. Turk J Med Sci 2021;51:921-8. [PMID: 33306332 DOI: 10.3906/sag-2011-139] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
312 Alothaid H, Aldughaim MSK, El Bakkouri K, AlMashhadi S, Al-Qahtani AA. Similarities between the effect of SARS-CoV-2 and HCV on the cellular level, and the possible role of ion channels in COVID19 progression: a review of potential targets for diagnosis and treatment. Channels (Austin) 2020;14:403-12. [PMID: 33092458 DOI: 10.1080/19336950.2020.1837439] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
313 Souza PFN, Lopes FES, Amaral JL, Freitas CDT, Oliveira JTA. A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor. Int J Biol Macromol 2020;164:66-76. [PMID: 32693122 DOI: 10.1016/j.ijbiomac.2020.07.174] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
314 Hughes R, Whitley L, Fitovski K, Schneble HM, Muros E, Sauter A, Craveiro L, Dillon P, Bonati U, Jessop N, Pedotti R, Koendgen H. COVID-19 in ocrelizumab-treated people with multiple sclerosis. Mult Scler Relat Disord 2021;49:102725. [PMID: 33482590 DOI: 10.1016/j.msard.2020.102725] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
315 Amaral JL, Oliveira JTA, Lopes FES, Freitas CDT, Freire VN, Abreu LV, Souza PFN. Quantum biochemistry, molecular docking, and dynamics simulation revealed synthetic peptides induced conformational changes affecting the topology of the catalytic site of SARS-CoV-2 main protease. J Biomol Struct Dyn 2021;:1-13. [PMID: 33949286 DOI: 10.1080/07391102.2021.1920464] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
316 Kim D, Wu Y, Kim YB, Oh YK. Advances in vaccine delivery systems against viral infectious diseases. Drug Deliv Transl Res 2021;11:1401-19. [PMID: 33694083 DOI: 10.1007/s13346-021-00945-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
317 Monreal E, Sainz de la Maza S, Natera-Villalba E, Beltrán-Corbellini Á, Rodríguez-Jorge F, Fernández-Velasco JI, Walo-Delgado P, Muriel A, Zamora J, Alonso-Canovas A, Fortún J, Manzano L, Montero-Errasquín B, Costa-Frossard L, Masjuan J, Villar LM; COVID-HRC group. High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study. Eur J Clin Microbiol Infect Dis 2021;40:761-9. [PMID: 33083917 DOI: 10.1007/s10096-020-04078-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
318 Mattioli M, Benfaremo D, Mancini M, Mucci L, Mainquà P, Polenta A, Baldini PM, Fulgenzi F, Dennetta D, Bedetta S, Gasperoni L, Caraffa A, Frausini G. Safety of intermediate dose of low molecular weight heparin in COVID-19 patients. J Thromb Thrombolysis 2021;51:286-92. [PMID: 32794132 DOI: 10.1007/s11239-020-02243-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 15.0] [Reference Citation Analysis]
319 Mann ER, Menon M, Knight SB, Konkel JE, Jagger C, Shaw TN, Krishnan S, Rattray M, Ustianowski A, Bakerly ND, Dark P, Lord G, Simpson A, Felton T, Ho LP, Feldmann M, Grainger JR, Hussell T; NIHR Respiratory TRC,., CIRCO,. Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19. Sci Immunol 2020;5:eabd6197. [PMID: 32943497 DOI: 10.1126/sciimmunol.abd6197] [Cited by in Crossref: 71] [Cited by in F6Publishing: 60] [Article Influence: 35.5] [Reference Citation Analysis]
320 Yuan S, Wang R, Chan JF, Zhang AJ, Cheng T, Chik KK, Ye ZW, Wang S, Lee AC, Jin L, Li H, Jin DY, Yuen KY, Sun H. Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters. Nat Microbiol 2020;5:1439-48. [PMID: 33028965 DOI: 10.1038/s41564-020-00802-x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 18.5] [Reference Citation Analysis]
321 Sarkar S, Kannan S, Khanna P, Singh AK. Role of platelet-to-lymphocyte count ratio (PLR), as a prognostic indicator in COVID-19: A systematic review and meta-analysis. J Med Virol 2022;94:211-21. [PMID: 34436785 DOI: 10.1002/jmv.27297] [Reference Citation Analysis]
322 Kirkegaard C, Falcó-Roget A, Sánchez-Montalvá A, Valls Á, Clofent D, Campos-Varela I, García-García S, Leguízamo LM, Sellarès-Nadal J, Eremiev S, Villamarín M, Marzo B, Almirante B, Len Ò. Incidence and risk factors for early readmission after hospitalization for SARS-CoV-2 infection: results from a retrospective cohort study. Infection 2021. [PMID: 34331263 DOI: 10.1007/s15010-021-01662-1] [Reference Citation Analysis]
323 Pérez-Martínez A, Mora-Rillo M, Ferreras C, Guerra-García P, Pascual-Miguel B, Mestre-Durán C, Borobia AM, Carcas AJ, Queiruga-Parada J, García I, Sánchez-Zapardiel E, Gasior M, De Paz R, Marcos A, Vicario JL, Balas A, Moreno MA, Eguizabal C, Solano C, Arribas JR, Buckley RM, Montejano R, Soria B. Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE). EClinicalMedicine 2021;39:101086. [PMID: 34405140 DOI: 10.1016/j.eclinm.2021.101086] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
324 Young BE, Ong SWX, Ng LFP, Anderson DE, Chia WN, Chia PY, Ang LW, Mak TM, Kalimuddin S, Chai LYA, Pada S, Tan SY, Sun L, Parthasarathy P, Fong SW, Chan YH, Tan CW, Lee B, Rötzschke O, Ding Y, Tambyah P, Low JGH, Cui L, Barkham T, Lin RTP, Leo YS, Renia L, Wang LF, Lye DC; Singapore 2019 Novel Coronavirus Outbreak Research team. Viral dynamics and immune correlates of COVID-19 disease severity.Clin Infect Dis. 2020;. [PMID: 32856707 DOI: 10.1093/cid/ciaa1280] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 17.5] [Reference Citation Analysis]
325 Amruta N, Chastain WH, Paz M, Solch RJ, Murray-Brown IC, Befeler JB, Gressett TE, Longo MT, Engler-Chiurazzi EB, Bix G. SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders. Cytokine Growth Factor Rev 2021;58:1-15. [PMID: 33674185 DOI: 10.1016/j.cytogfr.2021.02.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
326 Serag A, Hasan MA, Tolba EH, Abdelzaher AM, Elmaaty AA. Analysis of the ternary antiretroviral therapy dolutegravir, lamivudine and abacavir using UV spectrophotometry and chemometric tools. Spectrochim Acta A Mol Biomol Spectrosc 2022;264:120334. [PMID: 34481252 DOI: 10.1016/j.saa.2021.120334] [Reference Citation Analysis]
327 Im JH, Je YS, Baek J, Chung MH, Kwon HY, Lee JS. Nutritional status of patients with COVID-19. Int J Infect Dis. 2020;100:390-393. [PMID: 32795605 DOI: 10.1016/j.ijid.2020.08.018] [Cited by in Crossref: 60] [Cited by in F6Publishing: 65] [Article Influence: 30.0] [Reference Citation Analysis]
328 Adrielle Dos Santos L, Filho PGG, Silva AMF, Santos JVG, Santos DS, Aquino MM, de Jesus RM, Almeida MLD, da Silva JS, Altmann DM, Boyton RJ, Alves Dos Santos C, Santos CNO, Alves JC, Santos IL, Magalhães LS, Belitardo EMMA, Rocha DJPG, Almeida JPP, Pacheco LGC, Aguiar ERGR, Campos GS, Sardi SI, Carvalho RH, de Jesus AR, Rezende KF, de Almeida RP. Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers. J Infect 2021;82:399-406. [PMID: 33589297 DOI: 10.1016/j.jinf.2021.01.020] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 23.0] [Reference Citation Analysis]
329 Mostaza JM, García-Iglesias F, González-Alegre T, Blanco F, Varas M, Hernández-Blanco C, Hontañón V, Jaras-Hernández MJ, Martínez-Prieto M, Menéndez-Saldaña A, Cachán ML, Estirado E, Lahoz C; Carlos III COVID Working Group. Clinical course and prognostic factors of COVID-19 infection in an elderly hospitalized population. Arch Gerontol Geriatr 2020;91:104204. [PMID: 32771883 DOI: 10.1016/j.archger.2020.104204] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
330 Bienvenu LA, Noonan J, Wang X, Peter K. Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities. Cardiovasc Res 2020;116:2197-206. [PMID: 33063089 DOI: 10.1093/cvr/cvaa284] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 11.5] [Reference Citation Analysis]
331 Bhavana V, Thakor P, Singh SB, Mehra NK. COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic. Life Sci 2020;261:118336. [PMID: 32846164 DOI: 10.1016/j.lfs.2020.118336] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 13.0] [Reference Citation Analysis]
332 Forns X, Navasa M. Liver transplant immunosuppression during the covid-19 pandemic. Gastroenterol Hepatol 2020;43:457-63. [PMID: 32646657 DOI: 10.1016/j.gastrohep.2020.06.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
333 Ricci D, Etna MP, Rizzo F, Sandini S, Severa M, Coccia EM. Innate Immune Response to SARS-CoV-2 Infection: From Cells to Soluble Mediators. Int J Mol Sci 2021;22:7017. [PMID: 34209845 DOI: 10.3390/ijms22137017] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
334 Hernández JL, Nan D, Fernandez-Ayala M, García-Unzueta M, Hernández-Hernández MA, López-Hoyos M, Muñoz-Cacho P, Olmos JM, Gutiérrez-Cuadra M, Ruiz-Cubillán JJ, Crespo J, Martínez-Taboada VM. Vitamin D Status in Hospitalized Patients with SARS-CoV-2 Infection. J Clin Endocrinol Metab 2021;106:e1343-53. [PMID: 33159440 DOI: 10.1210/clinem/dgaa733] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 53.0] [Reference Citation Analysis]
335 Mishra D, Mishra A, Chaturvedi VK, Singh MP. An overview of COVID-19 with an emphasis on computational approach for its preventive intervention. 3 Biotech 2020;10:435. [PMID: 32959007 DOI: 10.1007/s13205-020-02425-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
336 Varghese PM, Tsolaki AG, Yasmin H, Shastri A, Ferluga J, Vatish M, Madan T, Kishore U. Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies. Immunobiology 2020;225:152008. [PMID: 33130519 DOI: 10.1016/j.imbio.2020.152008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
337 Mercer TR, Salit M. Testing at scale during the COVID-19 pandemic. Nat Rev Genet 2021;22:415-26. [PMID: 33948037 DOI: 10.1038/s41576-021-00360-w] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 16.0] [Reference Citation Analysis]
338 Al-Jighefee HT, Yassine HM, Nasrallah GK. Evaluation of Antibody Response in Symptomatic and Asymptomatic COVID-19 Patients and Diagnostic Assessment of New IgM/IgG ELISA Kits. Pathogens 2021;10:161. [PMID: 33546341 DOI: 10.3390/pathogens10020161] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
339 Bénard A, Jacobsen A, Brunner M, Krautz C, Klösch B, Swierzy I, Naschberger E, Podolska MJ, Kouhestani D, David P, Birkholz T, Castellanos I, Trufa D, Sirbu H, Vetter M, Kremer AE, Hildner K, Hecker A, Edinger F, Tenbusch M, Mühl-Zürbes P, Steinkasserer A, Richter E, Streeck H, Berger MM, Brenner T, Weigand MA, Swirski FK, Schett G, Grützmann R, Weber GF. Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections. Nat Commun 2021;12:1112. [PMID: 33602937 DOI: 10.1038/s41467-021-21310-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
340 Kanjanasirirat P, Suksatu A, Manopwisedjaroen S, Munyoo B, Tuchinda P, Jearawuttanakul K, Seemakhan S, Charoensutthivarakul S, Wongtrakoongate P, Rangkasenee N, Pitiporn S, Waranuch N, Chabang N, Khemawoot P, Sa-Ngiamsuntorn K, Pewkliang Y, Thongsri P, Chutipongtanate S, Hongeng S, Borwornpinyo S, Thitithanyanont A. High-content screening of Thai medicinal plants reveals Boesenbergia rotunda extract and its component Panduratin A as anti-SARS-CoV-2 agents. Sci Rep 2020;10:19963. [PMID: 33203926 DOI: 10.1038/s41598-020-77003-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
341 Bobkova NV. The Balance between Two Branches of RAS Can Protect from Severe COVID-19 Course. Biochem (Mosc) Suppl Ser A Membr Cell Biol 2021;15:36-51. [PMID: 33643542 DOI: 10.1134/S1990747821010037] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
342 Ebrahim-Saraie HS, Dehghani B, Mojtahedi A, Shenagari M, Hasannejad-Bibalan M. Functional and Structural Characterization of SARS-Cov-2 Spike Protein: An In Silico Study. Ethiop J Health Sci 2021;31:213-22. [PMID: 34158771 DOI: 10.4314/ejhs.v31i2.2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
343 Pinto G, Illiano A, Ferrucci V, Quarantelli F, Fontanarosa C, Siciliano R, Di Domenico C, Izzo B, Pucci P, Marino G, Zollo M, Amoresano A. Identification of SARS-CoV-2 Proteins from Nasopharyngeal Swabs Probed by Multiple Reaction Monitoring Tandem Mass Spectrometry. ACS Omega 2021;6:34945-53. [PMID: 34926968 DOI: 10.1021/acsomega.1c05587] [Reference Citation Analysis]
344 [DOI: 10.1101/2020.09.09.287508] [Cited by in Crossref: 23] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
345 Meckiff BJ, Ramírez-Suástegui C, Fajardo V, Chee SJ, Kusnadi A, Simon H, Eschweiler S, Grifoni A, Pelosi E, Weiskopf D, Sette A, Ay F, Seumois G, Ottensmeier CH, Vijayanand P. Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4+ T Cells in COVID-19. Cell 2020;183:1340-1353.e16. [PMID: 33096020 DOI: 10.1016/j.cell.2020.10.001] [Cited by in Crossref: 97] [Cited by in F6Publishing: 105] [Article Influence: 48.5] [Reference Citation Analysis]
346 Rodrigues JPGLM, Barrera-Vilarmau S, M C Teixeira J, Sorokina M, Seckel E, Kastritis PL, Levitt M. Insights on cross-species transmission of SARS-CoV-2 from structural modeling. PLoS Comput Biol 2020;16:e1008449. [PMID: 33270653 DOI: 10.1371/journal.pcbi.1008449] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
347 Raybould MIJ, Kovaltsuk A, Marks C, Deane CM. CoV-AbDab: the coronavirus antibody database. Bioinformatics 2021;37:734-5. [PMID: 32805021 DOI: 10.1093/bioinformatics/btaa739] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 43.0] [Reference Citation Analysis]
348 Zheng M. The Gradient of Immune/Inflammatory Response and COVID-19 Prognosis with Therapeutic Implications. Front Immunol 2021;12:739482. [PMID: 34777350 DOI: 10.3389/fimmu.2021.739482] [Reference Citation Analysis]
349 Rodriguez L, Brodin P. Unraveling the Immune Response in Severe COVID-19. J Clin Immunol 2020;40:958-9. [PMID: 32827284 DOI: 10.1007/s10875-020-00849-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
350 Chiappalupi S, Salvadori L, Donato R, Riuzzi F, Sorci G. Hyperactivated RAGE in Comorbidities as a Risk Factor for Severe COVID-19-The Role of RAGE-RAS Crosstalk. Biomolecules 2021;11:876. [PMID: 34204735 DOI: 10.3390/biom11060876] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
351 Mantravadi V, Nguyen ST, Morley SC, Bednarski JJ, Kitcharoensakkul M, Cooper MA. Recovery from COVID-19 in a Child with Chronic Granulomatous Disease and T Cell Lymphopenia. J Clin Immunol 2021;41:23-5. [PMID: 33108551 DOI: 10.1007/s10875-020-00896-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
352 Hightower LE, Santoro MG. Coronaviruses and stress: from cellular to global. Cell Stress Chaperones 2020;25:701-5. [PMID: 32889638 DOI: 10.1007/s12192-020-01155-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
353 Lopez Angel CJ, Pham EA, Du H, Vallania F, Fram BJ, Perez K, Nguyen T, Rosenberg-Hasson Y, Ahmed A, Dekker CL, Grant PM, Khatri P, Maecker HT, Glenn JS, Davis MM, Furman D. Signatures of immune dysfunction in HIV and HCV infection share features with chronic inflammation in aging and persist after viral reduction or elimination. Proc Natl Acad Sci U S A 2021;118:e2022928118. [PMID: 33811141 DOI: 10.1073/pnas.2022928118] [Reference Citation Analysis]
354 López-Cortés A, Guevara-Ramírez P, Kyriakidis NC, Barba-Ostria C, León Cáceres Á, Guerrero S, Ortiz-Prado E, Munteanu CR, Tejera E, Cevallos-Robalino D, Gómez-Jaramillo AM, Simbaña-Rivera K, Granizo-Martínez A, Pérez-M G, Moreno S, García-Cárdenas JM, Zambrano AK, Pérez-Castillo Y, Cabrera-Andrade A, Puig San Andrés L, Proaño-Castro C, Bautista J, Quevedo A, Varela N, Quiñones LA, Paz-Y-Miño C. In silico Analyses of Immune System Protein Interactome Network, Single-Cell RNA Sequencing of Human Tissues, and Artificial Neural Networks Reveal Potential Therapeutic Targets for Drug Repurposing Against COVID-19. Front Pharmacol 2021;12:598925. [PMID: 33716737 DOI: 10.3389/fphar.2021.598925] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
355 Pitakbut T, Nguyen GN, Kayser O. Activity of THC, CBD, and CBN on Human ACE2 and SARS-CoV1/2 Main Protease to Understand Antiviral Defense Mechanism. Planta Med 2021. [PMID: 34638139 DOI: 10.1055/a-1581-3707] [Reference Citation Analysis]
356 Daryabor G, Atashzar MR, Kabelitz D, Meri S, Kalantar K. The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System. Front Immunol 2020;11:1582. [PMID: 32793223 DOI: 10.3389/fimmu.2020.01582] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
357 Nguyen T. Investigating the mouth-COVID connection. Nature 2021. [PMID: 34707275 DOI: 10.1038/d41586-021-02922-8] [Reference Citation Analysis]
358 Bagheri HS, Karimipour M, Heidarzadeh M, Rajabi H, Sokullu E, Rahbarghazi R. Does the Global Outbreak of COVID-19 or Other Viral Diseases Threaten the Stem Cell Reservoir Inside the Body? Stem Cell Rev Rep 2021;17:214-30. [PMID: 33403490 DOI: 10.1007/s12015-020-10108-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
359 Novaes Rocha V. Viral replication of SARS-CoV-2 could be self-limitative - The role of the renin-angiotensin system on COVID-19 pathophysiology. Med Hypotheses 2020;145:110330. [PMID: 33049594 DOI: 10.1016/j.mehy.2020.110330] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
360 Al-Zahrani J. SARS-CoV-2 associated COVID-19 in geriatric population: A brief narrative review. Saudi J Biol Sci 2021;28:738-43. [PMID: 33169063 DOI: 10.1016/j.sjbs.2020.11.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
361 Young B, Tan TT, Leo YS. The place for remdesivir in COVID-19 treatment. Lancet Infect Dis. 2021;21:20-21. [PMID: 33248473 DOI: 10.1016/s1473-3099(20)30911-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
362 Kovalchuk A, Wang B, Li D, Rodriguez-Juarez R, Ilnytskyy S, Kovalchuk I, Kovalchuk O. Fighting the storm: could novel anti-TNFα and anti-IL-6 C. sativa cultivars tame cytokine storm in COVID-19? Aging (Albany NY) 2021;13:1571-90. [PMID: 33465050 DOI: 10.18632/aging.202500] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
363 Sütlüoğlu H, Özdemir Ö. May mesenchymal stem cell transplantation be a solution for COVID-19 induced cytokine storm? World J Transplant 2021; 11(8): 344-355 [PMID: 34447671 DOI: 10.5500/wjt.v11.i8.344] [Reference Citation Analysis]
364 Ruscitti P, Conforti A, Cipriani P, Giacomelli R, Tasso M, Costa L, Caso F. Pathogenic implications, incidence, and outcomes of COVID-19 in autoimmune inflammatory joint diseases and autoinflammatory disorders. Adv Rheumatol 2021;61:45. [PMID: 34238376 DOI: 10.1186/s42358-021-00204-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
365 Acuña-Castroviejo D, Escames G, Figueira JC, de la Oliva P, Borobia AM, Acuña-Fernández C. Clinical trial to test the efficacy of melatonin in COVID-19. J Pineal Res 2020;69:e12683. [PMID: 32770854 DOI: 10.1111/jpi.12683] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 11.5] [Reference Citation Analysis]
366 Serafim MSM, Gertrudes JC, Costa DMA, Oliveira PR, Maltarollo VG, Honorio KM. Knowing and combating the enemy: a brief review on SARS-CoV-2 and computational approaches applied to the discovery of drug candidates. Biosci Rep 2021;41:BSR20202616. [PMID: 33624754 DOI: 10.1042/BSR20202616] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
367 Ortiz-Prado E, Simbaña-Rivera K, Gómez-Barreno L, Rubio-Neira M, Guaman LP, Kyriakidis NC, Muslin C, Jaramillo AMG, Barba-Ostria C, Cevallos-Robalino D, Sanches-SanMiguel H, Unigarro L, Zalakeviciute R, Gadian N, López-Cortés A. Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review. Diagn Microbiol Infect Dis 2020;98:115094. [PMID: 32623267 DOI: 10.1016/j.diagmicrobio.2020.115094] [Cited by in Crossref: 99] [Cited by in F6Publishing: 89] [Article Influence: 49.5] [Reference Citation Analysis]
368 Salimi-Jeda A, Abbassi S, Mousavizadeh A, Esghaie M, Bokharaei-Salim F, Jeddi F, Shafaati M, Abdoli A. SARS-CoV-2: Current trends in emerging variants, pathogenesis, immune responses, potential therapeutic, and vaccine development strategies. Int Immunopharmacol 2021;101:108232. [PMID: 34673335 DOI: 10.1016/j.intimp.2021.108232] [Reference Citation Analysis]
369 Ouyang W, Xie T, Fang H, Gao C, Stantchev T, Clouse KA, Yuan K, Ju T, Frucht DM. Variable Induction of Pro-Inflammatory Cytokines by Commercial SARS CoV-2 Spike Protein Reagents: Potential Impacts of LPS on In Vitro Modeling and Pathogenic Mechanisms In Vivo. Int J Mol Sci 2021;22:7540. [PMID: 34299155 DOI: 10.3390/ijms22147540] [Reference Citation Analysis]
370 Camp OG, Bai D, Gonullu DC, Nayak N, Abu-Soud HM. Melatonin interferes with COVID-19 at several distinct ROS-related steps. J Inorg Biochem 2021;223:111546. [PMID: 34304092 DOI: 10.1016/j.jinorgbio.2021.111546] [Reference Citation Analysis]
371 Cueno ME, Imai K. Structural Insights on the SARS-CoV-2 Variants of Concern Spike Glycoprotein: A Computational Study With Possible Clinical Implications. Front Genet 2021;12:773726. [PMID: 34745235 DOI: 10.3389/fgene.2021.773726] [Reference Citation Analysis]
372 Nizamudeen ZA, Xu ER, Karthik V, Halawa M, Arkill KP, Jackson AM, Bates DO, Emsley J. Structural assessment of SARS-CoV2 accessory protein ORF7a predicts LFA-1 and Mac-1 binding potential. Biosci Rep 2021;41:BSR20203837. [PMID: 33305306 DOI: 10.1042/BSR20203837] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
373 [DOI: 10.1101/2020.08.10.243717] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
374 Nitulescu GM, Paunescu H, Moschos SA, Petrakis D, Nitulescu G, Ion GND, Spandidos DA, Nikolouzakis TK, Drakoulis N, Tsatsakis A. Comprehensive analysis of drugs to treat SARS‑CoV‑2 infection: Mechanistic insights into current COVID‑19 therapies (Review). Int J Mol Med 2020;46:467-88. [PMID: 32468014 DOI: 10.3892/ijmm.2020.4608] [Cited by in Crossref: 46] [Cited by in F6Publishing: 53] [Article Influence: 23.0] [Reference Citation Analysis]
375 Niemeyer BF, Miller CM, Ledesma-Feliciano C, Morrison JH, Jimenez-Valdes R, Clifton C, Poeschla EM, Benam KH. Broad antiviral and anti-inflammatory efficacy of nafamostat against SARS-CoV-2 and seasonal coronaviruses in primary human bronchiolar epithelia. Nano Sel 2021. [PMID: 34541574 DOI: 10.1002/nano.202100123] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
376 Eltemamy E, Salama S, Salem SM, Abdel-Rasheed M, Salama E, Elsirgany S, Elnahas T. Assessment of fetal growth and anomalies in the era of COVID-19 pandemic: an Egyptian pilot study. Middle East Fertil Soc J 2021;26:32. [PMID: 34483650 DOI: 10.1186/s43043-021-00075-2] [Reference Citation Analysis]
377 Xie T, He Z, Liang C, Dong H, Zhou J, Fan S, Guo X. An integrative bioinformatics analysis for identifying hub genes associated with infection of lung samples in patients infected with SARS-CoV-2. Eur J Med Res 2021;26. [DOI: 10.1186/s40001-021-00609-4] [Reference Citation Analysis]
378 Signorini C, Pignatti P, Coccini T. How Do Inflammatory Mediators, Immune Response and Air Pollution Contribute to COVID-19 Disease Severity? A Lesson to Learn. Life (Basel) 2021;11:182. [PMID: 33669011 DOI: 10.3390/life11030182] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
379 Shahbaz S, Xu L, Osman M, Sligl W, Shields J, Joyce M, Tyrrell DL, Oyegbami O, Elahi S. Erythroid precursors and progenitors suppress adaptive immunity and get invaded by SARS-CoV-2. Stem Cell Reports 2021;16:1165-81. [PMID: 33979601 DOI: 10.1016/j.stemcr.2021.04.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
380 Inchingolo AD, Inchingolo AM, Bordea IR, Malcangi G, Xhajanka E, Scarano A, Lorusso F, Farronato M, Tartaglia GM, Isacco CG, Marinelli G, D'Oria MT, Hazballa D, Santacroce L, Ballini A, Contaldo M, Inchingolo F, Dipalma G. SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention. Microorganisms 2021;9:525. [PMID: 33806624 DOI: 10.3390/microorganisms9030525] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
381 Bezemer GFG, Garssen J. TLR9 and COVID-19: A Multidisciplinary Theory of a Multifaceted Therapeutic Target. Front Pharmacol 2020;11:601685. [PMID: 33519463 DOI: 10.3389/fphar.2020.601685] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
382 Sahebnasagh A, Nabavi SM, Kashani HRK, Abdollahian S, Habtemariam S, Rezabakhsh A. Anti-VEGF agents: As appealing targets in the setting of COVID-19 treatment in critically ill patients. Int Immunopharmacol 2021;101:108257. [PMID: 34673299 DOI: 10.1016/j.intimp.2021.108257] [Reference Citation Analysis]
383 Majolo F, Silva GLD, Vieira L, Anli C, Timmers LFSM, Laufer S, Goettert MI. Neuropsychiatric Disorders and COVID-19: What We Know So Far. Pharmaceuticals (Basel) 2021;14:933. [PMID: 34577633 DOI: 10.3390/ph14090933] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
384 Nicol T, Lefeuvre C, Serri O, Pivert A, Joubaud F, Dubée V, Kouatchet A, Ducancelle A, Lunel-Fabiani F, Le Guillou-Guillemette H. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech). J Clin Virol 2020;129:104511. [PMID: 32593133 DOI: 10.1016/j.jcv.2020.104511] [Cited by in Crossref: 114] [Cited by in F6Publishing: 88] [Article Influence: 57.0] [Reference Citation Analysis]
385 Manivannan J, Sundaresan L. Systems level insights into the impact of airborne exposure on SARS-CoV-2 pathogenesis and COVID-19 outcome - A multi-omics big data study. Gene Rep 2021;25:101312. [PMID: 34401607 DOI: 10.1016/j.genrep.2021.101312] [Reference Citation Analysis]
386 Mahmoud Salehi Khesht A, Karpisheh V, Qubais Saeed B, Olegovna Zekiy A, Yapanto LM, Nabi Afjadi M, Aksoun M, Nasr Esfahani M, Aghakhani F, Movahed M, Joshi N, Abbaszadeh-Goudarzi K, Hallaj S, Ahmadi M, Dolati S, Mahmoodpoor A, Hashemi V, Jadidi-Niaragh F. Different T cell related immunological profiles in COVID-19 patients compared to healthy controls. Int Immunopharmacol 2021;97:107828. [PMID: 34091116 DOI: 10.1016/j.intimp.2021.107828] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
387 Ahn JH, Kim J, Hong SP, Choi SY, Yang MJ, Ju YS, Kim YT, Kim HM, Rahman MDT, Chung MK, Hong SD, Bae H, Lee CS, Koh GY. Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19. J Clin Invest 2021;131:148517. [PMID: 34003804 DOI: 10.1172/JCI148517] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
388 Minakshi R, Jan AT, Rahman S, Kim J. A Testimony of the Surgent SARS-CoV-2 in the Immunological Panorama of the Human Host. Front Cell Infect Microbiol 2020;10:575404. [PMID: 33262955 DOI: 10.3389/fcimb.2020.575404] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
389 Rammohan A. Post-transplant immunosuppression and COVID-19: From a double whammy to a mixed blessing. World J Transplant 2020; 10(9): 267-276 [PMID: 32995321 DOI: 10.5500/wjt.v10.i9.267] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
390 McCarthy C, O'Donnell CP, Kelly NEW, O'Shea D, Hogan AE. COVID-19 severity and obesity: are MAIT cells a factor? Lancet Respir Med 2021;9:445-7. [PMID: 33844997 DOI: 10.1016/S2213-2600(21)00140-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
391 Sadanandam A, Bopp T, Dixit S, Knapp DJHF, Emperumal CP, Vergidis P, Rajalingam K, Melcher A, Kannan N. A blood transcriptome-based analysis of disease progression, immune regulation, and symptoms in coronavirus-infected patients. Cell Death Discov 2020;6:141. [PMID: 33293514 DOI: 10.1038/s41420-020-00376-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
392 Lafon E, Diem G, Witting C, Zaderer V, Bellmann-Weiler RM, Reindl M, Bauer A, Griesmacher A, Fux V, Hoermann G, Miller C, Zabernigg A, Wöll E, Wilflingseder D, Lass-Flörl C, Posch W. Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients. Front Immunol 2021;12:684014. [PMID: 34194438 DOI: 10.3389/fimmu.2021.684014] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
393 Garcia-Flores V, Romero R, Xu Y, Theis K, Arenas-Hernandez M, Miller D, Peyvandipour A, Galaz J, Levenson D, Bhatti G, Gershater M, Pusod E, Kracht D, Florova V, Leng Y, Tao L, Faucett M, Para R, Hsu CD, Zhang G, Tarca A, Pique-Regi R, Gomez-Lopez N. Maternal-Fetal Immune Responses in Pregnant Women Infected with SARS-CoV-2. Res Sq 2021:rs. [PMID: 33821263 DOI: 10.21203/rs.3.rs-362886/v1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
394 Di Stadio A, Costantini C, Renga G, Pariano M, Ricci G, Romani L. The Microbiota/Host Immune System Interaction in the Nose to Protect from COVID-19. Life (Basel) 2020;10:E345. [PMID: 33322584 DOI: 10.3390/life10120345] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
395 Brendler T, Al‐harrasi A, Bauer R, Gafner S, Hardy ML, Heinrich M, Hosseinzadeh H, Izzo AA, Michaelis M, Nassiri‐asl M, Panossian A, Wasser SP, Williamson EM. Botanical drugs and supplements affecting the immune response in the time of COVID ‐19: Implications for research and clinical practice. Phytotherapy Research 2021;35:3013-31. [DOI: 10.1002/ptr.7008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
396 Singh U, Hernandez KM, Aronow BJ, Wurtele ES. African Americans and European Americans exhibit distinct gene expression patterns across tissues and tumors associated with immunologic functions and environmental exposures. Sci Rep 2021;11:9905. [PMID: 33972602 DOI: 10.1038/s41598-021-89224-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
397 Dilek SÖ, Gürbüz F, Turan İ, Celiloğlu C, Yüksel B. Changes in the presentation of newly diagnosed type 1 diabetes in children during the COVID-19 pandemic in a tertiary center in Southern Turkey. J Pediatr Endocrinol Metab 2021. [PMID: 34291625 DOI: 10.1515/jpem-2021-0287] [Reference Citation Analysis]
398 Khalil A, Tazeddinova D. The upshot of Polyphenolic compounds on immunity amid COVID-19 pandemic and other emerging communicable diseases: An appraisal. Nat Prod Bioprospect 2020;10:411-29. [PMID: 33057955 DOI: 10.1007/s13659-020-00271-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
399 Zhu FC, Guan XH, Li YH, Huang JY, Jiang T, Hou LH, Li JX, Yang BF, Wang L, Wang WJ, Wu SP, Wang Z, Wu XH, Xu JJ, Zhang Z, Jia SY, Wang BS, Hu Y, Liu JJ, Zhang J, Qian XA, Li Q, Pan HX, Jiang HD, Deng P, Gou JB, Wang XW, Wang XH, Chen W. Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet 2020;396:479-88. [PMID: 32702299 DOI: 10.1016/S0140-6736(20)31605-6] [Cited by in Crossref: 425] [Cited by in F6Publishing: 277] [Article Influence: 212.5] [Reference Citation Analysis]
400 Benetos A, Lai TP, Toupance S, Labat C, Verhulst S, Perret-Guillaume C, Gautier S, Ungeheuer MN, Levy D, Susser E, Aviv A. A Mechanism for Severity of Disease in Older Patients with COVID-19: The Nexus between Telomere Length and Lymphopenia. medRxiv 2020:2020. [PMID: 33024983 DOI: 10.1101/2020.10.01.20205393] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
401 Eedara BB, Alabsi W, Encinas-Basurto D, Polt R, Ledford JG, Mansour HM. Inhalation Delivery for the Treatment and Prevention of COVID-19 Infection. Pharmaceutics 2021;13:1077. [PMID: 34371768 DOI: 10.3390/pharmaceutics13071077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
402 Ferrucci V, Kong DY, Asadzadeh F, Marrone L, Boccia A, Siciliano R, Criscuolo G, Anastasio C, Quarantelli F, Comegna M, Pisano I, Passariello M, Iacobucci I, Monica RD, Izzo B, Cerino P, Fusco G, Viscardi M, Brandi S, Pierri BM, Borriello G, Tiberio C, Atripaldi L, Bianchi M, Paolella G, Capoluongo E, Castaldo G, Chiariotti L, Monti M, De Lorenzo C, Yun KS, Pascarella S, Cheong JH, Kim HY, Zollo M. Long-chain polyphosphates impair SARS-CoV-2 infection and replication. Sci Signal 2021;14:eabe5040. [PMID: 34230209 DOI: 10.1126/scisignal.abe5040] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
403 Rosa BA, Ahmed M, Singh DK, Choreño-Parra JA, Cole J, Jiménez-Álvarez LA, Rodríguez-Reyna TS, Singh B, Gonzalez O, Carrion R Jr, Schlesinger LS, Martin J, Zúñiga J, Mitreva M, Kaushal D, Khader SA. IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection. Commun Biol 2021;4:290. [PMID: 33674719 DOI: 10.1038/s42003-021-01829-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
404 Franciosi MLM, Lima MDM, Schetinger MRC, Cardoso AM. Possible role of purinergic signaling in COVID-19. Mol Cell Biochem 2021;476:2891-8. [PMID: 33740184 DOI: 10.1007/s11010-021-04130-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
405 Ray S, Srivastava S. COVID-19 Pandemic: Hopes from Proteomics and Multiomics Research. OMICS: A Journal of Integrative Biology 2020;24:457-9. [DOI: 10.1089/omi.2020.0073] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
406 Kos I, Balensiefer B, Lesan V, Kaddu-Mulindwa D, Thurner L, Christofyllakis K, Bittenbring JT, Ahlgrimm M, Seiffert M, Wagenpfeil S, Bewarder Y, Neumann F, Rixecker T, Smola S, Link A, Krawczyk M, Lammert F, Lepper PM, Bals R, Stilgenbauer S, Bewarder M. Increased B-cell activity with consumption of activated monocytes in severe COVID-19 patients. Eur J Immunol 2021;51:1449-60. [PMID: 33788264 DOI: 10.1002/eji.202049163] [Reference Citation Analysis]
407 Zhang JY, Wang XM, Xing X, Xu Z, Zhang C, Song JW, Fan X, Xia P, Fu JL, Wang SY, Xu RN, Dai XP, Shi L, Huang L, Jiang TJ, Shi M, Zhang Y, Zumla A, Maeurer M, Bai F, Wang FS. Single-cell landscape of immunological responses in patients with COVID-19. Nat Immunol. 2020;21:1107-1118. [PMID: 32788748 DOI: 10.1038/s41590-020-0762-x] [Cited by in Crossref: 155] [Cited by in F6Publishing: 135] [Article Influence: 77.5] [Reference Citation Analysis]
408 Ramos SG, Rattis BADC, Ottaviani G, Celes MRN, Dias EP. ACE2 Down-Regulation May Act as a Transient Molecular Disease Causing RAAS Dysregulation and Tissue Damage in the Microcirculatory Environment Among COVID-19 Patients. Am J Pathol 2021;191:1154-64. [PMID: 33964216 DOI: 10.1016/j.ajpath.2021.04.010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
409 Naveed H, Elshafeey A, Al-Ali D, Janjua E, Nauman A, Kawas H, Kaul R, Saed Aldien A, Elshazly MB, Zakaria D. The Interplay Between the Immune System, the Renin-Angiotensin-Aldosterone System (RAAS), and RAAS Inhibitors May Modulate the Outcome of COVID-19: A Systematic Review. J Clin Pharmacol 2021;61:987-1000. [PMID: 33635546 DOI: 10.1002/jcph.1852] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
410 Vu DL, Martinez-Murillo P, Pigny F, Vono M, Meyer B, Eberhardt CS, Lemeille S, Von Dach E, Blanchard-Rohner G, Eckerle I, Huttner A, Siegrist CA, Kaiser L, Didierlaurent AM. Longitudinal Analysis of Inflammatory Response to SARS-CoV-2 in the Upper Respiratory Tract Reveals an Association with Viral Load, Independent of Symptoms. J Clin Immunol 2021;41:1723-32. [PMID: 34581925 DOI: 10.1007/s10875-021-01134-z] [Reference Citation Analysis]
411 Derakhshan MA, Amani A, Faridi-Majidi R. State-of-the-Art of Nanodiagnostics and Nanotherapeutics against SARS-CoV-2. ACS Appl Mater Interfaces 2021;13:14816-43. [PMID: 33779135 DOI: 10.1021/acsami.0c22381] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
412 Lehtoranta L, Latvala S, Lehtinen MJ. Role of Probiotics in Stimulating the Immune System in Viral Respiratory Tract Infections: A Narrative Review. Nutrients 2020;12:E3163. [PMID: 33081138 DOI: 10.3390/nu12103163] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
413 Sorice M, Misasi R, Riitano G, Manganelli V, Martellucci S, Longo A, Garofalo T, Mattei V. Targeting Lipid Rafts as a Strategy Against Coronavirus. Front Cell Dev Biol 2020;8:618296. [PMID: 33614627 DOI: 10.3389/fcell.2020.618296] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
414 Esmaeilzadeh A, Elahi R. Immunobiology and immunotherapy of COVID-19: A clinically updated overview. J Cell Physiol 2021;236:2519-43. [PMID: 33022076 DOI: 10.1002/jcp.30076] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
415 [DOI: 10.1101/2020.05.21.108308] [Cited by in Crossref: 45] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
416 Zhang H, Zheng H, Zhu J, Dong Q, Wang J, Fan H, Chen Y, Zhang X, Han X, Li Q, Lu J, Tong Y, Chen Z. Ubiquitin-Modified Proteome of SARS-CoV-2-Infected Host Cells Reveals Insights into Virus-Host Interaction and Pathogenesis. J Proteome Res 2021;20:2224-39. [PMID: 33666082 DOI: 10.1021/acs.jproteome.0c00758] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
417 Chowdhury P, Barooah AK. Tea Bioactive Modulate Innate Immunity: In Perception to COVID-19 Pandemic. Front Immunol 2020;11:590716. [PMID: 33193427 DOI: 10.3389/fimmu.2020.590716] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
418 Ryu G, Shin HW. SARS-CoV-2 Infection of Airway Epithelial Cells. Immune Netw 2021;21:e3. [PMID: 33728096 DOI: 10.4110/in.2021.21.e3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
419 Pedrosa CDSG, Goto-Silva L, Temerozo JR, Souza LRQ, Vitória G, Ornelas IM, Karmirian K, Mendes MA, Gomes IC, Sacramento CQ, Fintelman-Rodrigues N, Soares VC, Dias SDSG, Salerno JA, Puig-Pijuan T, Oliveira JT, Aragão LGHS, Torquato TCQ, Veríssimo C, Biagi D, Cruvinel EM, Dariolli R, Furtado DR, Borges HL, Bozza PT, Rehen S, Souza TML, Guimarães MZP. Non-permissive SARS-CoV-2 infection in human neurospheres. bioRxiv 2021:2020. [PMID: 33052345 DOI: 10.1101/2020.09.11.293951] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
420 Komine-Aizawa S, Takada K, Hayakawa S. Placental barrier against COVID-19. Placenta 2020;99:45-9. [PMID: 32755724 DOI: 10.1016/j.placenta.2020.07.022] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
421 Kwarteng A, Asiedu E, Sakyi SA, Asiedu SO. Targeting the SARS-CoV2 nucleocapsid protein for potential therapeutics using immuno-informatics and structure-based drug discovery techniques. Biomed Pharmacother 2020;132:110914. [PMID: 33254432 DOI: 10.1016/j.biopha.2020.110914] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
422 Angelidi AM, Belanger MJ, Lorinsky MK, Karamanis D, Chamorro-Pareja N, Ognibene J, Palaiodimos L, Mantzoros CS. Vitamin D Status Is Associated With In-Hospital Mortality and Mechanical Ventilation: A Cohort of COVID-19 Hospitalized Patients. Mayo Clin Proc 2021;96:875-86. [PMID: 33714594 DOI: 10.1016/j.mayocp.2021.01.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
423 Cuspoca AF, Díaz LL, Acosta AF, Peñaloza MK, Méndez YR, Clavijo DC, Yosa Reyes J. An Immunoinformatics Approach for SARS-CoV-2 in Latam Populations and Multi-Epitope Vaccine Candidate Directed towards the World's Population. Vaccines (Basel) 2021;9:581. [PMID: 34205992 DOI: 10.3390/vaccines9060581] [Reference Citation Analysis]
424 Kim HK, Park CY, Han SN. Nutrient modulation of viral infection-implications for COVID-19. Nutr Res Pract 2021;15:S1-S21. [PMID: 34909129 DOI: 10.4162/nrp.2021.15.S1.S1] [Reference Citation Analysis]
425 Dabbish AM, Yonis N, Salama M, Essa MM, Qoronfleh MW. Inflammatory pathways and potential therapies for COVID-19: A mini review. Eur J Inflamm 2021;19:205873922110029. [DOI: 10.1177/20587392211002986] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
426 Arleo T, Tong D, Shabto J, O'Keefe G, Khosroshahi A. Clinical course and outcomes of COVID-19 in rheumatic disease patients: a case cohort study with a diverse population. Clin Rheumatol 2021;40:2633-42. [PMID: 33420870 DOI: 10.1007/s10067-021-05578-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
427 Yoo HM, Kim IH, Kim S. Nucleic Acid Testing of SARS-CoV-2. Int J Mol Sci 2021;22:6150. [PMID: 34200331 DOI: 10.3390/ijms22116150] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
428 Soosaipillai G, Wu A, Dettorre GM, Diamantis N, Chester J, Moss C, Aguilar-Company J, Bower M, Sng CC, Salazar R, Brunet J, Jones E, Mesia R, Jackson A, Mukherjee U, Sita-Lumsden A, Seguí E, Ottaviani D, Carbó A, Benafif S, Würstlein R, Carmona C, Chopra N, Cruz CA, Swallow J, Saoudi N, Felip E, Galazi M, Garcia-Fructuoso I, Lee AJX, Newsom-Davis T, Wong YNS, Sureda A, Maluquer C, Ruiz-Camps I, Cabirta A, Prat A, Loizidou A, Gennari A, Ferrante D, Tabernero J, Russell B, Van Hemelrijck M, Dolly S, Hulbert-Williams NJ, Pinato DJ. Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective. Ther Adv Med Oncol 2021;13:17588359211042224. [PMID: 34497669 DOI: 10.1177/17588359211042224] [Reference Citation Analysis]
429 Cheah IK, Halliwell B. Could Ergothioneine Aid in the Treatment of Coronavirus Patients? Antioxidants (Basel) 2020;9:E595. [PMID: 32646061 DOI: 10.3390/antiox9070595] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
430 Vepa A, Bae JP, Ahmed F, Pareek M, Khunti K. COVID-19 and ethnicity: A novel pathophysiological role for inflammation. Diabetes Metab Syndr 2020;14:1043-51. [PMID: 32640416 DOI: 10.1016/j.dsx.2020.06.056] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 14.5] [Reference Citation Analysis]
431 Liu C, Martins AJ, Lau WW, Rachmaninoff N, Chen J, Imberti L, Mostaghimi D, Fink DL, Burbelo PD, Dobbs K, Delmonte OM, Bansal N, Failla L, Sottini A, Quiros-Roldan E, Han KL, Sellers BA, Cheung F, Sparks R, Chun TW, Moir S, Lionakis MS, Rossi C, Su HC, Kuhns DB, Cohen JI, Notarangelo LD, Tsang JS; NIAID COVID Consortium., COVID Clinicians. Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19. Cell 2021;184:1836-1857.e22. [PMID: 33713619 DOI: 10.1016/j.cell.2021.02.018] [Cited by in Crossref: 19] [Cited by in F6Publishing: 26] [Article Influence: 19.0] [Reference Citation Analysis]
432 Lokhande AS, Devarajan PV. A review on possible mechanistic insights of Nitazoxanide for repurposing in COVID-19. Eur J Pharmacol 2021;891:173748. [PMID: 33227285 DOI: 10.1016/j.ejphar.2020.173748] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
433 Akinola A, Singh G, Ndjiongue A. Frequency-domain reconfigurable antenna for COVID-19 tracking. Sens Int 2021;2:100094. [PMID: 34766053 DOI: 10.1016/j.sintl.2021.100094] [Reference Citation Analysis]
434 Miele L, Napodano C, Cesario A, De Magistris A, Pocino K, Basile U, Rapaccini GL, Gasbarrini A, Grieco A. COVID-19, adaptative immune response and metabolic-associated liver disease. Liver Int 2021;41:2560-77. [PMID: 34555255 DOI: 10.1111/liv.15061] [Reference Citation Analysis]
435 Victor J, Deutsch J, Whitaker A, Lamkin EN, March A, Zhou P, Botten JW, Chatterjee N. SARS-CoV-2 triggers DNA damage response in Vero E6 cells. Biochem Biophys Res Commun 2021;579:141-5. [PMID: 34600299 DOI: 10.1016/j.bbrc.2021.09.024] [Reference Citation Analysis]
436 Saini G, Aneja R. Cancer as a prospective sequela of long COVID-19. Bioessays 2021;43:e2000331. [PMID: 33914346 DOI: 10.1002/bies.202000331] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
437 Liu W, Liu Z, Li YC. COVID-19-related myocarditis and cholinergic anti-inflammatory pathways. Hellenic J Cardiol 2021;62:265-9. [PMID: 33301863 DOI: 10.1016/j.hjc.2020.12.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
438 Wechsler H. Immunity and security using holism, ambient intelligence, triangulation, and stigmergy: Sensitivity analysis confronts fake news and COVID-19 using open set transduction. J Ambient Intell Humaniz Comput 2021;:1-18. [PMID: 34457079 DOI: 10.1007/s12652-021-03434-z] [Reference Citation Analysis]
439 Abian O, Ortega-Alarcon D, Jimenez-Alesanco A, Ceballos-Laita L, Vega S, Reyburn HT, Rizzuti B, Velazquez-Campoy A. Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening. Int J Biol Macromol 2020;164:1693-703. [PMID: 32745548 DOI: 10.1016/j.ijbiomac.2020.07.235] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 29.0] [Reference Citation Analysis]
440 Festoff BW, Dockendorff C. The Evolving Concept of Neuro-Thromboinflammation for Neurodegenerative Disorders and Neurotrauma: A Rationale for PAR1-Targeting Therapies. Biomolecules 2021;11:1558. [PMID: 34827556 DOI: 10.3390/biom11111558] [Reference Citation Analysis]
441 Masre SF, Jufri NF, Ibrahim FW, Abdul Raub SH. Classical and alternative receptors for SARS-CoV-2 therapeutic strategy. Rev Med Virol 2020;:e2207. [PMID: 33368788 DOI: 10.1002/rmv.2207] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
442 Gangitano E, Tozzi R, Gandini O, Watanabe M, Basciani S, Mariani S, Lenzi A, Gnessi L, Lubrano C. Ketogenic Diet as a Preventive and Supportive Care for COVID-19 Patients. Nutrients 2021;13:1004. [PMID: 33804603 DOI: 10.3390/nu13031004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
443 Durán-Méndez A, Aguilar-Arroyo AD, Vivanco-Gómez E, Nieto-Ortega E, Pérez-Ortega D, Jiménez-Pérez C, Hernández-Skewes KY, Montiel-Bravo G, Roque-Reyes OJ, Romero-Lechuga F, Medina-Santos D, Oriana-Román P, Flores-Hernández JR, Méndez-Coca JD, Montaño-Olmos D, Farfán-Lazos KC, Tobón-Cubillos M, Viveros-Hernández A, Sevilla-Castillo F, Hernández-Romero ÁR, Ortega-Rodríguez S, Jardínez-Vera AC, Solís-González MA, de la Medina AR, Pérez-Maldonado LM, Lagunes-Lara E, Cova-Bonilla M, Peón AN. Tocilizumab reduces COVID-19 mortality and pathology in a dose and timing-dependent fashion: a multi-centric study. Sci Rep 2021;11:19728. [PMID: 34611251 DOI: 10.1038/s41598-021-99291-z] [Reference Citation Analysis]
444 Holder K, Reddy PH. The COVID-19 Effect on the Immune System and Mitochondrial Dynamics in Diabetes, Obesity, and Dementia. Neuroscientist 2021;27:331-9. [PMID: 32981462 DOI: 10.1177/1073858420960443] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
445 Li Z, Wang Y, Ding Y, Repp L, Kwon GS, Hu Q. Cell‐Based Delivery Systems: Emerging Carriers for Immunotherapy. Adv Funct Mater 2021;31:2100088. [DOI: 10.1002/adfm.202100088] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
446 Ahmadi AR, Ayazi-Nasrabadi R. Astaxanthin protective barrier and its ability to improve the health in patients with COVID-19. Iran J Microbiol 2021;13:434-41. [PMID: 34557270 DOI: 10.18502/ijm.v13i4.6965] [Reference Citation Analysis]
447 Visacri MB, Nicoletti AS, Pincinato EC, Loren P, Saavedra N, Saavedra K, Salazar LA, Moriel P. Role of miRNAs as biomarkers of COVID-19: a scoping review of the status and future directions for research in this field. Biomark Med 2021;15:1785-95. [PMID: 34784802 DOI: 10.2217/bmm-2021-0348] [Reference Citation Analysis]
448 de Queiroz NMGP, Marinho FV, Chagas MA, Leite LCC, Homan EJ, de Magalhães MTQ, Oliveira SC. Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system. Microbes Infect 2020;22:515-24. [PMID: 32961274 DOI: 10.1016/j.micinf.2020.09.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
449 Putri C, Arisa J, Hananto JE, Hariyanto TI, Kurniawan A. Psychiatric sequelae in COVID-19 survivors: A narrative review. World J Psychiatr 2021; 11(10): 821-829 [PMID: 34733644 DOI: 10.5498/wjp.v11.i10.821] [Reference Citation Analysis]
450 Liu G, Zhu M, Zhao X, Nie G. Nanotechnology-empowered vaccine delivery for enhancing CD8+ T cells-mediated cellular immunity. Adv Drug Deliv Rev 2021;:113889. [PMID: 34364931 DOI: 10.1016/j.addr.2021.113889] [Reference Citation Analysis]
451 Nair AS. Perioperative melatonin in COVID-19 patients: benefits beyond sedation and analgesia. Med Gas Res 2022;12:41-3. [PMID: 34677150 DOI: 10.4103/2045-9912.325990] [Reference Citation Analysis]
452 Kumar R, Rathi H, Haq A, Wimalawansa SJ, Sharma A. Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19. Virus Res 2021;292:198235. [PMID: 33232783 DOI: 10.1016/j.virusres.2020.198235] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
453 Singhvi A, Barghash M, Lala A, Mitter SS, Parikh A, Oliveros E, Rollins BM, Brunjes DL, Alvarez-Garcia J, Johnston E, Ryan K, Itagaki S, Moss N, Pinney SP, Anyanwu A, Mancini D. Challenges in heart transplantation during COVID-19: A single-center experience. J Heart Lung Transplant 2020;39:894-903. [PMID: 32891266 DOI: 10.1016/j.healun.2020.06.015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
454 Almeida MQ, Mendonca BB. Adrenal Insufficiency and Glucocorticoid Use During the COVID-19 Pandemic. Clinics (Sao Paulo) 2020;75:e2022. [PMID: 32555949 DOI: 10.6061/clinics/2020/e2022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
455 Moussa YEH, Boudaoui A, Ullah S, Bozkurt F, Abdeljawad T, Alqudah MA. Stability analysis and simulation of the novel Corornavirus mathematical model via the Caputo fractional-order derivative: A case study of Algeria. Results Phys 2021;26:104324. [PMID: 34055583 DOI: 10.1016/j.rinp.2021.104324] [Reference Citation Analysis]
456 Goud PT, Bai D, Abu-Soud HM. A Multiple-Hit Hypothesis Involving Reactive Oxygen Species and Myeloperoxidase Explains Clinical Deterioration and Fatality in COVID-19. Int J Biol Sci 2021;17:62-72. [PMID: 33390833 DOI: 10.7150/ijbs.51811] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
457 Stanton BA, Hampton TH, Ashare A. SARS-CoV-2 (COVID-19) and cystic fibrosis. Am J Physiol Lung Cell Mol Physiol 2020;319:L408-15. [PMID: 32668165 DOI: 10.1152/ajplung.00225.2020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
458 Verhoef PA, Kannan S, Sturgill JL, Tucker EW, Morris PE, Miller AC, Sexton TR, Koyner JL, Hejal R, Brakenridge SC, Moldawer LL, Hotchkiss RS, Blood TM, Mazer MB, Bolesta S, Alexander SA, Armaignac DL, Shein SL, Jones C, Hoemann CD, Doctor A, Friess SH, Parker RI, Rotta AT, Remy KE. Severe Acute Respiratory Syndrome-Associated Coronavirus 2 Infection and Organ Dysfunction in the ICU: Opportunities for Translational Research. Crit Care Explor 2021;3:e0374. [PMID: 33786450 DOI: 10.1097/CCE.0000000000000374] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
459 Xiong S, Zhang L, Richner JM, Class J, Rehman J, Malik AB. Interleukin-1RA Mitigates SARS-CoV-2-Induced Inflammatory Lung Vascular Leakage and Mortality in Humanized K18-hACE-2 Mice. Arterioscler Thromb Vasc Biol 2021;41:2773-85. [PMID: 34496633 DOI: 10.1161/ATVBAHA.121.316925] [Reference Citation Analysis]
460 McClain MT, Constantine FJ, Henao R, Liu Y, Tsalik EL, Burke TW, Steinbrink JM, Petzold E, Nicholson BP, Rolfe R, Kraft BD, Kelly MS, Saban DR, Yu C, Shen X, Ko EM, Sempowski GD, Denny TN, Ginsburg GS, Woods CW. Dysregulated transcriptional responses to SARS-CoV-2 in the periphery. Nat Commun 2021;12:1079. [PMID: 33597532 DOI: 10.1038/s41467-021-21289-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
461 Zhu B, Wu Y, Huang S, Zhang R, Son YM, Li C, Cheon IS, Gao X, Wang M, Chen Y, Zhou X, Nguyen Q, Phan AT, Behl S, Taketo MM, Mack M, Shapiro VS, Zeng H, Ebihara H, Mullon JJ, Edell ES, Reisenauer JS, Demirel N, Kern RM, Chakraborty R, Cui W, Kaplan MH, Zhou X, Goldrath AW, Sun J. Uncoupling of macrophage inflammation from self-renewal modulates host recovery from respiratory viral infection. Immunity 2021;54:1200-1218.e9. [PMID: 33951416 DOI: 10.1016/j.immuni.2021.04.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
462 Morenikeji OB, Bernard K, Strutton E, Wallace M, Thomas BN. Evolutionarily Conserved Long Non-coding RNA Regulates Gene Expression in Cytokine Storm During COVID-19. Front Bioeng Biotechnol 2020;8:582953. [PMID: 33520952 DOI: 10.3389/fbioe.2020.582953] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
463 Zhou Q, MacArthur MR, He X, Wei X, Zarin P, Hanna BS, Wang ZH, Xiang X, Fish EN. Interferon-α2b Treatment for COVID-19 Is Associated with Improvements in Lung Abnormalities. Viruses 2020;13:E44. [PMID: 33396578 DOI: 10.3390/v13010044] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
464 Martinez-Urbistondo M, Mora-Vargas A, Expósito-Palomo E, Castejón R, Citores MJ, Rosado S, de Mendoza C, Baños I, Fernández-Cruz A, Daimiel L, San-Cristóbal R, Vargas JA, Martinez JA. Inflammatory-Related Clinical and Metabolic Outcomes in COVID-19 Patients. Mediators Inflamm 2020;2020:2914275. [PMID: 33273888 DOI: 10.1155/2020/2914275] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
465 Santamarina MG, Boisier D, Contreras R, Baque M, Volpacchio M, Beddings I. COVID-19: a hypothesis regarding the ventilation-perfusion mismatch. Crit Care 2020;24:395. [PMID: 32631389 DOI: 10.1186/s13054-020-03125-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 14.5] [Reference Citation Analysis]
466 Spihlman AP, Gadi N, Wu SC, Moulton VR. COVID-19 and Systemic Lupus Erythematosus: Focus on Immune Response and Therapeutics. Front Immunol 2020;11:589474. [PMID: 33193418 DOI: 10.3389/fimmu.2020.589474] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
467 Logette E, Lorin C, Favreau C, Oshurko E, Coggan JS, Casalegno F, Sy MF, Monney C, Bertschy M, Delattre E, Fonta PA, Krepl J, Schmidt S, Keller D, Kerrien S, Scantamburlo E, Kaufmann AK, Markram H. A Machine-Generated View of the Role of Blood Glucose Levels in the Severity of COVID-19. Front Public Health 2021;9:695139. [PMID: 34395368 DOI: 10.3389/fpubh.2021.695139] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
468 Neale RE, Barnes PW, Robson TM, Neale PJ, Williamson CE, Zepp RG, Wilson SR, Madronich S, Andrady AL, Heikkilä AM, Bernhard GH, Bais AF, Aucamp PJ, Banaszak AT, Bornman JF, Bruckman LS, Byrne SN, Foereid B, Häder DP, Hollestein LM, Hou WC, Hylander S, Jansen MAK, Klekociuk AR, Liley JB, Longstreth J, Lucas RM, Martinez-Abaigar J, McNeill K, Olsen CM, Pandey KK, Rhodes LE, Robinson SA, Rose KC, Schikowski T, Solomon KR, Sulzberger B, Ukpebor JE, Wang QW, Wängberg SÅ, White CC, Yazar S, Young AR, Young PJ, Zhu L, Zhu M. Environmental effects of stratospheric ozone depletion, UV radiation, and interactions with climate change: UNEP Environmental Effects Assessment Panel, Update 2020. Photochem Photobiol Sci 2021;20:1-67. [PMID: 33721243 DOI: 10.1007/s43630-020-00001-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
469 Fernández-Lázaro D, Fernandez-Lazaro CI, Mielgo-Ayuso J, Adams DP, García Hernández JL, González-Bernal J, González-Gross M. Glycophosphopeptical AM3 Food Supplement: A Potential Adjuvant in the Treatment and Vaccination of SARS-CoV-2. Front Immunol 2021;12:698672. [PMID: 34220861 DOI: 10.3389/fimmu.2021.698672] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
470 Wang MY, Zhou TY, Zhang ZD, Liu HY, Zheng ZY, Xie HQ. Current therapeutic strategies for respiratory diseases using mesenchymal stem cells. MedComm (2020) 2021;2:351-80. [PMID: 34766151 DOI: 10.1002/mco2.74] [Reference Citation Analysis]
471 Oliveira SC, de Magalhães MTQ, Homan EJ. Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets. Front Immunol 2020;11:587615. [PMID: 33193414 DOI: 10.3389/fimmu.2020.587615] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 8.5] [Reference Citation Analysis]
472 Islamoglu Y, Celik B, Kiris M. Facial paralysis as the only symptom of COVID-19: A prospective study. Am J Otolaryngol 2021;42:102956. [PMID: 33592554 DOI: 10.1016/j.amjoto.2021.102956] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
473 Hamis SJ, Macfarlane FR; School of Mathematics and Statistics, University of St Andrews, Mathematical Institute, North Haugh, St Andrews, KY16 9SS, UK. . AIMS Mathematics 2021;6:6050-86. [DOI: 10.3934/math.2021356] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
474 Zarubova J, Zhang X, Hoffman T, Hasani-Sadrabadi MM, Li S. Biomaterial-based immunoengineering to fight COVID-19 and infectious diseases. Matter 2021;4:1528-54. [PMID: 33723531 DOI: 10.1016/j.matt.2021.02.025] [Reference Citation Analysis]
475 Ferrandi PJ, Alway SE, Mohamed JS. The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies. J Appl Physiol (1985) 2020;129:864-7. [PMID: 32673162 DOI: 10.1152/japplphysiol.00321.2020] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
476 Safarzadeh M, Sadeghi S, Azizi M, Rastegari-Pouyani M, Pouriran R, Haji Molla Hoseini M. Chitin and chitosan as tools to combat COVID-19: A triple approach. Int J Biol Macromol 2021;183:235-44. [PMID: 33930442 DOI: 10.1016/j.ijbiomac.2021.04.157] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
477 Fu W, Wang W, Yuan L, Lin Y, Huang X, Chen R, Cai M, Liu C, Chen L, Zhou M, Wu K, Zhao H, Pan D, Ma J, Hong J, Zhai B, Zhang Y, Kong Z, Wang Y, Chen Y, Yuan Q, Zhu H, Cheng T, Guan Y, Xia N. A SCID mouse-human lung xenograft model of SARS-CoV-2 infection. Theranostics 2021;11:6607-15. [PMID: 33995679 DOI: 10.7150/thno.58321] [Reference Citation Analysis]
478 Cai G, Du M, Bossé Y, Albrecht H, Qin F, Luo X, Androulakis XM, Cheng C, Nagarkatti M, Nagarkatti P, Christiani DC, Whitfield ML, Amos CI, Xiao F. SARS-CoV-2 Impairs Dendritic Cells and Regulates DC-SIGN Gene Expression in Tissues. Int J Mol Sci 2021;22:9228. [PMID: 34502134 DOI: 10.3390/ijms22179228] [Reference Citation Analysis]
479 Yim J, Lim HH, Kwon Y. COVID-19 and pulmonary fibrosis: therapeutics in clinical trials, repurposing, and potential development. Arch Pharm Res 2021;44:499-513. [PMID: 34047940 DOI: 10.1007/s12272-021-01331-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
480 Dettorre GM, Dolly S, Loizidou A, Chester J, Jackson A, Mukherjee U, Zambelli A, Aguilar-Company J, Bower M, Sng CCT, Salazar R, Bertuzzi A, Brunet J, Mesia R, Sita-Lumsden A, Seguí E, Biello F, Generali D, Grisanti S, Seeva P, Rizzo G, Libertini M, Maconi A, Moss C, Russell B, Harbeck N, Vincenzi B, Bertulli R, Ottaviani D, Liñan R, Marrari A, Carmona-García MC, Chopra N, Tondini CA, Mirallas O, Tovazzi V, Fotia V, Cruz CA, Saoudi-Gonzalez N, Felip E, Roqué A, Lee AJX, Newsom-Davis T, García-Illescas D, Reyes R, Wong YNS, Ferrante D, Scotti L, Marco-Hernández J, Ruiz-Camps I, Patriarca A, Rimassa L, Chiudinelli L, Franchi M, Santoro A, Prat A, Gennari A, Van Hemelrijck M, Tabernero J, Diamantis N, Pinato DJ; OnCovid study group. Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score. J Immunother Cancer 2021;9:e002277. [PMID: 33753569 DOI: 10.1136/jitc-2020-002277] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
481 Zapata B R, Müller JM, Vásquez JE, Ravera F, Lago G, Cañón E, Castañeda D, Pradenas M, Ramírez-Santana M. Omega-3 Index and Clinical Outcomes of Severe COVID-19: Preliminary Results of a Cross-Sectional Study. Int J Environ Res Public Health 2021;18:7722. [PMID: 34360016 DOI: 10.3390/ijerph18157722] [Reference Citation Analysis]
482 Hailemichael W, Kiros M, Akelew Y, Getu S, Andualem H. Neopterin: A Promising Candidate Biomarker for Severe COVID-19. J Inflamm Res 2021;14:245-51. [PMID: 33564258 DOI: 10.2147/JIR.S290264] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
483 Lachén-Montes M, Corrales FJ, Fernández-Irigoyen J, Santamaría E. Proteomics Insights Into the Molecular Basis of SARS-CoV-2 Infection: What We Can Learn From the Human Olfactory Axis. Front Microbiol 2020;11:2101. [PMID: 33071996 DOI: 10.3389/fmicb.2020.02101] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
484 Sadeghi A, Tahmasebi S, Mahmood A, Kuznetsova M, Valizadeh H, Taghizadieh A, Nazemiyeh M, Aghebati-Maleki L, Jadidi-Niaragh F, Abbaspour-Aghdam S, Roshangar L, Mikaeili H, Ahmadi M. Th17 and Treg cells function in SARS-CoV2 patients compared with healthy controls. J Cell Physiol 2021;236:2829-39. [PMID: 32926425 DOI: 10.1002/jcp.30047] [Cited by in Crossref: 23] [Cited by in F6Publishing: 29] [Article Influence: 11.5] [Reference Citation Analysis]
485 Zhao L, Liu H, Wang Y, Wang S, Xun D, Wang Y, Cheng Y, Zhang B. Multimodal Identification by Transcriptomics and Multiscale Bioassays of Active Components in Xuanfeibaidu Formula to Suppress Macrophage-Mediated Immune Response. Engineering (Beijing) 2021. [PMID: 34815890 DOI: 10.1016/j.eng.2021.09.007] [Reference Citation Analysis]
486 Raman R, Patel KJ, Ranjan K. COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies. Biomolecules 2021;11:993. [PMID: 34356617 DOI: 10.3390/biom11070993] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
487 Rudroff T, Fietsam AC, Deters JR, Bryant AD, Kamholz J. Post-COVID-19 Fatigue: Potential Contributing Factors. Brain Sci 2020;10:E1012. [PMID: 33352638 DOI: 10.3390/brainsci10121012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
488 Chen R, Ren C, Liu M, Ge X, Qu M, Zhou X, Liang M, Liu Y, Li F. Early Detection of SARS-CoV-2 Seroconversion in Humans with Aggregation-Induced Near-Infrared Emission Nanoparticle-Labeled Lateral Flow Immunoassay. ACS Nano 2021;15:8996-9004. [PMID: 33928784 DOI: 10.1021/acsnano.1c01932] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
489 Bohn MK, Loh TP, Wang CB, Mueller R, Koch D, Sethi S, Rawlinson WD, Clementi M, Erasmus R, Leportier M, Grimmler M, Yuen KY, Mancini N, Kwon GC, Menezes ME, Patru MM, Gramegna M, Singh K, Najjar O, Ferrari M, Horvath AR, Lippi G, Adeli K; and the IFCC Taskforce on COVID-19. IFCC Interim Guidelines on Serological Testing of Antibodies against SARS-CoV-2. Clin Chem Lab Med 2020;58:2001-8. [PMID: 33027043 DOI: 10.1515/cclm-2020-1413] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 13.5] [Reference Citation Analysis]
490 Fuehner T, Renger I, Welte T, Freundt T, Gottlieb J. Silent Hypoxia in COVID-19: A Case Series. Respiration 2021;:1-5. [PMID: 34839295 DOI: 10.1159/000520083] [Reference Citation Analysis]
491 Ramadan MS, Bertolino L, Marrazzo T, Florio MT, Durante-Mangoni E; The Monaldi Hospital Cardiovascular Infection Study Group. Cardiac complications during the active phase of COVID-19: review of the current evidence. Intern Emerg Med 2021. [PMID: 34046852 DOI: 10.1007/s11739-021-02763-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
492 Flores-Pliego A, Miranda J, Vega-Torreblanca S, Valdespino-Vázquez Y, Helguera-Repetto C, Espejel-Nuñez A, Borboa-Olivares H, Espino Y Sosa S, Mateu-Rogell P, León-Juárez M, Ramírez-Santes V, Cardona-Pérez A, Villegas-Mota I, Torres-Torres J, Juárez-Reyes Á, Rizo-Pica T, González RO, González-Mariscal L, Estrada-Gutierrez G. Molecular Insights into the Thrombotic and Microvascular Injury in Placental Endothelium of Women with Mild or Severe COVID-19. Cells 2021;10:364. [PMID: 33578631 DOI: 10.3390/cells10020364] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
493 Khan A, Patrick A, Patil V, Nnochiri A, Wijayatilake S. The obstetric patient in the Covid pandemic: anaesthesia and perioperative care. Curr Opin Obstet Gynecol 2021;33:361-9. [PMID: 34402480 DOI: 10.1097/GCO.0000000000000732] [Reference Citation Analysis]
494 Guo H, Zhou L, Ma Z, Tian Z, Zhou F. Promising Immunotherapies against COVID-19. Adv Ther (Weinh) 2021;:2100044. [PMID: 34179345 DOI: 10.1002/adtp.202100044] [Reference Citation Analysis]
495 Chee J, Loh WS, Liu Z, Mullol J, Wang Y. Clinical-Pathological Correlation of the Pathophysiology and Mechanism of Action of COVID-19 - a Primer for Clinicians. Curr Allergy Asthma Rep 2021;21:38. [PMID: 34259961 DOI: 10.1007/s11882-021-01015-w] [Reference Citation Analysis]
496 Meckiff BJ, Ramírez-Suástegui C, Fajardo V, Chee SJ, Kusnadi A, Simon H, Grifoni A, Pelosi E, Weiskopf D, Sette A, Ay F, Seumois G, Ottensmeier CH, Vijayanand P. Single-cell transcriptomic analysis of SARS-CoV-2 reactive CD4 + T cells. bioRxiv 2020:2020. [PMID: 32587963 DOI: 10.1101/2020.06.12.148916] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 10.0] [Reference Citation Analysis]
497 Khan N. Possible protective role of 17β-estradiol against COVID-19. J Allergy Infect Dis 2020;1:38-48. [PMID: 33196058 DOI: 10.46439/allergy.1.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
498 Nainu F, Abidin RS, Bahar MA, Frediansyah A, Emran TB, Rabaan AA, Dhama K, Harapan H. SARS-CoV-2 reinfection and implications for vaccine development. Hum Vaccin Immunother 2020;16:3061-73. [PMID: 33393854 DOI: 10.1080/21645515.2020.1830683] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
499 Sapienza LG, Nasra K, Calsavara VF, Little TB, Narayana V, Abu-Isa E. Risk of in-hospital death associated with Covid-19 lung consolidations on chest computed tomography - A novel translational approach using a radiation oncology contour software. Eur J Radiol Open 2021;8:100322. [PMID: 33432297 DOI: 10.1016/j.ejro.2021.100322] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
500 Mello MT, Silva A, Guerreiro RC, da-Silva FR, Esteves AM, Poyares D, Piovezan R, Treptow E, Starling M, Rosa DS, Pires GN, Andersen ML, Tufik S. Sleep and COVID-19: considerations about immunity, pathophysiology, and treatment. Sleep Sci 2020;13:199-209. [PMID: 33381288 DOI: 10.5935/1984-0063.20200062] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
501 Greene MW, Roberts AP, Frugé AD. Negative Association Between Mediterranean Diet Adherence and COVID-19 Cases and Related Deaths in Spain and 23 OECD Countries: An Ecological Study. Front Nutr 2021;8:591964. [PMID: 33748170 DOI: 10.3389/fnut.2021.591964] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
502 Xu Q, Samanapally H, Nathala P, Salunkhe V, Furmanek S, Cahill MN, McGuffin T, Mohammad T, Marsili B, Petrey J, Carrico R, Ramirez J, Akca O, Clifford SP, Pahwa S, Roser L, Kong M, Huang J; Center of Excellence for Research in Infectious Diseases (CERID) Coronavirus Study Group on behalf of the COVID-19 CardioVascular Research Group (COVID-CVRG). Outcomes and Risk Factors for Cardiovascular Events in Hospitalized COVID-19 Patients. J Cardiothorac Vasc Anesth 2021:S1053-0770(21)00277-9. [PMID: 33867235 DOI: 10.1053/j.jvca.2021.03.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
503 Ter Ellen BM, Dinesh Kumar N, Bouma EM, Troost B, van de Pol DPI, van der Ende-Metselaar HH, Apperloo L, van Gosliga D, van den Berge M, Nawijn MC, van der Voort PHJ, Moser J, Rodenhuis-Zybert IA, Smit JM. Resveratrol and Pterostilbene Inhibit SARS-CoV-2 Replication in Air-Liquid Interface Cultured Human Primary Bronchial Epithelial Cells. Viruses 2021;13:1335. [PMID: 34372541 DOI: 10.3390/v13071335] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
504 Ashraf H, Soleimani A, Kazemi saeid A, Sadat Naseri A, Majidi F, Peirovi N, Karbalai Saleh S. Troponin I biomarker as a strong prognostic factor for predicting COVID-19 mortality: A systematic review. World J Meta-Anal 2021; 9(4): 342-352 [DOI: 10.13105/wjma.v9.i4.342] [Reference Citation Analysis]
505 Dufailu OA, Afriyie-Asante A, Gyan B, Kwabena DA, Yeboah H, Ntiakoh F, Asare-Werehene M. COVID-19 in Africa: an ovarian victory? J Ovarian Res 2021;14:70. [PMID: 34020688 DOI: 10.1186/s13048-021-00820-1] [Reference Citation Analysis]
506 Pannone G, Caponio VCA, De Stefano IS, Ramunno MA, Meccariello M, Agostinone A, Pedicillo MC, Troiano G, Zhurakivska K, Cassano T, Bizzoca ME, Papagerakis S, Buonaguro FM, Advani S, Muzio LL. Lung histopathological findings in COVID-19 disease - a systematic review. Infect Agent Cancer 2021;16:34. [PMID: 34001199 DOI: 10.1186/s13027-021-00369-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
507 Hu S, Wang J, Zhang Y, Bai H, Wang C, Wang N, He L. Three salvianolic acids inhibit 2019-nCoV spike pseudovirus viropexis by binding to both its RBD and receptor ACE2. J Med Virol 2021;93:3143-51. [PMID: 33580518 DOI: 10.1002/jmv.26874] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
508 Zarandi PK, Zinatizadeh MR, Zinatizadeh M, Yousefi MH, Rezaei N. SARS-CoV-2: From the pathogenesis to potential anti-viral treatments. Biomed Pharmacother 2021;137:111352. [PMID: 33550050 DOI: 10.1016/j.biopha.2021.111352] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
509 [DOI: 10.1101/2020.06.26.172924] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
510 Wittig T. [Mucociliary clearance in COVID-19 - an underestimated danger area in early phase of disease?]. MMW Fortschr Med 2021;163:21-7. [PMID: 34383284 DOI: 10.1007/s15006-021-0189-9] [Reference Citation Analysis]
511 Arancio W. ceRNA analysis of SARS-CoV-2. Arch Virol 2021;166:271-4. [PMID: 33201341 DOI: 10.1007/s00705-020-04856-4] [Reference Citation Analysis]
512 [DOI: 10.1101/2020.06.19.159053] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
513 Al-Wahaibi LH, Mostafa A, Mostafa YA, Abou-Ghadir OF, Abdelazeem AH, Gouda AM, Kutkat O, Abo Shama NM, Shehata M, Gomaa HAM, Abdelrahman MH, Mohamed FAM, Gu X, Ali MA, Trembleau L, Youssif BGM. Discovery of novel oxazole-based macrocycles as anti-coronaviral agents targeting SARS-CoV-2 main protease. Bioorg Chem 2021;116:105363. [PMID: 34555629 DOI: 10.1016/j.bioorg.2021.105363] [Reference Citation Analysis]
514 Snell-Rood EC, Smirnoff D, Cantrell H, Chapman K, Kirscht E, Stretch E. Bioinspiration as a method of problem-based STEM education: A case study with a class structured around the COVID-19 crisis. Ecol Evol 2021. [PMID: 34900221 DOI: 10.1002/ece3.8044] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
515 Sansico F, Miroballo M, Bianco DS, Tamiro F, Colucci M, Santis E, Rossi G, Rosati J, Di Mauro L, Miscio G, Mazza T, Vescovi AL, Mazzoccoli G, Giambra V, On Behalf Of Css-Covid Group. COVID-19 Specific Immune Markers Revealed by Single Cell Phenotypic Profiling. Biomedicines 2021;9:1794. [PMID: 34944610 DOI: 10.3390/biomedicines9121794] [Reference Citation Analysis]
516 Oves M, Ravindran M, Rauf MA, Omaish Ansari M, Zahin M, Iyer AK, Ismail IMI, Khan MA, Palaniyar N. Comparing and Contrasting MERS, SARS-CoV, and SARS-CoV-2: Prevention, Transmission, Management, and Vaccine Development. Pathogens 2020;9:E985. [PMID: 33255989 DOI: 10.3390/pathogens9120985] [Reference Citation Analysis]
517 Preissner KT, Fischer S, Deindl E. Extracellular RNA as a Versatile DAMP and Alarm Signal That Influences Leukocyte Recruitment in Inflammation and Infection. Front Cell Dev Biol 2020;8:619221. [PMID: 33392206 DOI: 10.3389/fcell.2020.619221] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
518 Severa M, Diotti RA, Etna MP, Rizzo F, Fiore S, Ricci D, Iannetta M, Sinigaglia A, Lodi A, Mancini N, Criscuolo E, Clementi M, Andreoni M, Balducci S, Barzon L, Stefanelli P, Clementi N, Coccia EM. Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection. PLoS Pathog 2021;17:e1009878. [PMID: 34473805 DOI: 10.1371/journal.ppat.1009878] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
519 Tiwari-Heckler S, Rauber C, Longhi MS, Zörnig I, Schnitzler P, Jäger D, Giese T, Merle U. Dysregulated Host Response in Severe Acute Respiratory Syndrome Coronavirus 2-Induced Critical Illness. Open Forum Infect Dis 2021;8:ofab019. [PMID: 33778090 DOI: 10.1093/ofid/ofab019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
520 Boudewijns R, Thibaut HJ, Kaptein SJF, Li R, Vergote V, Seldeslachts L, Van Weyenbergh J, De Keyzer C, Bervoets L, Sharma S, Liesenborghs L, Ma J, Jansen S, Van Looveren D, Vercruysse T, Wang X, Jochmans D, Martens E, Roose K, De Vlieger D, Schepens B, Van Buyten T, Jacobs S, Liu Y, Martí-Carreras J, Vanmechelen B, Wawina-Bokalanga T, Delang L, Rocha-Pereira J, Coelmont L, Chiu W, Leyssen P, Heylen E, Schols D, Wang L, Close L, Matthijnssens J, Van Ranst M, Compernolle V, Schramm G, Van Laere K, Saelens X, Callewaert N, Opdenakker G, Maes P, Weynand B, Cawthorne C, Vande Velde G, Wang Z, Neyts J, Dallmeier K. STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters. Nat Commun 2020;11:5838. [PMID: 33203860 DOI: 10.1038/s41467-020-19684-y] [Cited by in Crossref: 66] [Cited by in F6Publishing: 66] [Article Influence: 33.0] [Reference Citation Analysis]
521 Batista da Silva Galdino A, do Nascimento Rangel AH, Buttar HS, Sales Lima Nascimento M, Cristina Gavioli E, Oliveira RDP, Cavalcanti Sales D, Urbano SA, Anaya K. Bovine colostrum: benefits for the human respiratory system and potential contributions for clinical management of COVID-19. Food and Agricultural Immunology 2021;32:143-62. [DOI: 10.1080/09540105.2021.1892594] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
522 McFadyen JD, Stevens H, Peter K. The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications. Circ Res. 2020;127:571-587. [PMID: 32586214 DOI: 10.1161/circresaha.120.317447] [Cited by in Crossref: 143] [Cited by in F6Publishing: 103] [Article Influence: 71.5] [Reference Citation Analysis]
523 Ravindra NG, Alfajaro MM, Gasque V, Huston NC, Wan H, Szigeti-Buck K, Yasumoto Y, Greaney AM, Habet V, Chow RD, Chen JS, Wei J, Filler RB, Wang B, Wang G, Niklason LE, Montgomery RR, Eisenbarth SC, Chen S, Williams A, Iwasaki A, Horvath TL, Foxman EF, Pierce RW, Pyle AM, van Dijk D, Wilen CB. Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes. PLoS Biol 2021;19:e3001143. [PMID: 33730024 DOI: 10.1371/journal.pbio.3001143] [Cited by in Crossref: 16] [Cited by in F6Publishing: 32] [Article Influence: 16.0] [Reference Citation Analysis]
524 Kazancioglu S, Yilmaz FM, Bastug A, Sakallı A, Ozbay BO, Buyuktarakci C, Bodur H, Yilmaz G. Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19. Viral Immunol 2021;34:342-51. [PMID: 33264073 DOI: 10.1089/vim.2020.0166] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
525 Gibellini L, De Biasi S, Paolini A, Borella R, Boraldi F, Mattioli M, Lo Tartaro D, Fidanza L, Caro-Maldonado A, Meschiari M, Iadisernia V, Bacca E, Riva G, Cicchetti L, Quaglino D, Guaraldi G, Busani S, Girardis M, Mussini C, Cossarizza A. Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia. EMBO Mol Med 2020;12:e13001. [PMID: 33078545 DOI: 10.15252/emmm.202013001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
526 Verma A, Adhikary A, Woloschak G, Dwarakanath BS, Papineni RVL. A combinatorial approach of a polypharmacological adjuvant 2-deoxy-D-glucose with low dose radiation therapy to quell the cytokine storm in COVID-19 management. Int J Radiat Biol 2020;96:1323-8. [PMID: 32910699 DOI: 10.1080/09553002.2020.1818865] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
527 Sarda R, Swain S, Ray A, Wig N. COVID-19 associated Mucormycosis: An epidemic within a pandemic. QJM 2021:hcab165. [PMID: 34109406 DOI: 10.1093/qjmed/hcab165] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
528 Sánchez-Guijo F, García-Arranz M, López-Parra M, Monedero P, Mata-Martínez C, Santos A, Sagredo V, Álvarez-Avello JM, Guerrero JE, Pérez-Calvo C, Sánchez-Hernández MV, Del-Pozo JL, Andreu EJ, Fernández-Santos ME, Soria-Juan B, Hernández-Blasco LM, Andreu E, Sempere JM, Zapata AG, Moraleda JM, Soria B, Fernández-Avilés F, García-Olmo D, Prósper F. Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study. EClinicalMedicine 2020;25:100454. [PMID: 32838232 DOI: 10.1016/j.eclinm.2020.100454] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 24.0] [Reference Citation Analysis]
529 McArthur L, Sakthivel D, Ataide R, Chan F, Richards JS, Narh CA. Review of Burden, Clinical Definitions, and Management of COVID-19 Cases. Am J Trop Med Hyg 2020;103:625-38. [PMID: 32618260 DOI: 10.4269/ajtmh.20-0564] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
530 Masso-Silva JA, Moshensky A, Lam MTY, Odish M, Patel A, Xu L, Hansen E, Trescott S, Nguyen C, Kim R, Perofsky K, Perera S, Ma L, Pham J, Rolfsen M, Olay J, Shin J, Dan JM, Abbott R, Ramirez S, Alexander TH, Lin GY, Fuentes AL, Advani I, Gunge D, Pretorius V, Malhotra A, Sun X, Duran J, Hepokoski M, Crotty S, Coufal NG, Meier A, Alexander LEC. Increased peripheral blood neutrophil activation phenotypes and NETosis in critically ill COVID-19 patients: a case series and review of the literature. Clin Infect Dis 2021:ciab437. [PMID: 33988226 DOI: 10.1093/cid/ciab437] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
531 Eryavuz Onmaz D, Abusoglu S, Onmaz M, Yerlikaya FH, Unlu A. Development and validation of a sensitive, fast and simple LC-MS / MS method for the quantitation of favipiravir in human serum. J Chromatogr B Analyt Technol Biomed Life Sci 2021;1176:122768. [PMID: 34052564 DOI: 10.1016/j.jchromb.2021.122768] [Reference Citation Analysis]
532 Menon V, Padhy SK. Mental health among COVID-19 survivors: Are we overlooking the biological links? Asian J Psychiatr 2020;53:102217. [PMID: 32574940 DOI: 10.1016/j.ajp.2020.102217] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
533 Van Caeseele P, Bailey D, Forgie SE, Dingle TC, Krajden M; Canadian Public Health Laboratory Network., Canadian Society of Clinical Chemists., Association of Medical Microbiology and Infectious Disease Canada., Canadian Association for Clinical Microbiology and Infectious Diseases., COVID-19 Immunity Task Force. SARS-CoV-2 (COVID-19) serology: implications for clinical practice, laboratory medicine and public health. CMAJ 2020;192:E973-9. [PMID: 32753391 DOI: 10.1503/cmaj.201588] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
534 Meiler S, Schaible J, Poschenrieder F, Scharf G, Zeman F, Rennert J, Pregler B, Kleine H, Stroszczynski C, Zorger N, Hamer OW. Can CT performed in the early disease phase predict outcome of patients with COVID 19 pneumonia? Analysis of a cohort of 64 patients from Germany. Eur J Radiol 2020;131:109256. [PMID: 32919265 DOI: 10.1016/j.ejrad.2020.109256] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
535 Fang J, Wu Q, Ye F, Cai C, Xu L, Gu Y, Wang Q, Liu AL, Tan W, Du GH. Network-Based Identification and Experimental Validation of Drug Candidates Toward SARS-CoV-2 via Targeting Virus-Host Interactome. Front Genet 2021;12:728960. [PMID: 34539756 DOI: 10.3389/fgene.2021.728960] [Reference Citation Analysis]
536 Matteucci A, Massaro G, Sergi D, Bonanni M, Stifano G, Matino M, Zerillo B, Rogliani P, Romeo F. Electrocardiographic modifications and cardiac involvement in COVID-19 patients: results from an Italian cohort. J Cardiovasc Med (Hagerstown) 2021;22:190-6. [PMID: 33512975 DOI: 10.2459/JCM.0000000000001166] [Reference Citation Analysis]
537 Cheng MH, Zhang S, Porritt RA, Arditi M, Bahar I. An insertion unique to SARS-CoV-2 exhibits superantigenic character strengthened by recent mutations. bioRxiv 2020:2020. [PMID: 32511374 DOI: 10.1101/2020.05.21.109272] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
538 Jackson MR, Stevenson K, Chahal SK, Curley E, Finney GE, Gutierrez-Quintana R, Onwubiko E, Rupp A, Strathdee K, Williams K, MacLeod MKL, McSharry C, Chalmers AJ. Low-Dose Lung Radiation Therapy for COVID-19 Lung Disease: A Preclinical Efficacy Study in a Bleomycin Model of Pneumonitis. Int J Radiat Oncol Biol Phys 2021:S0360-3016(21)02720-6. [PMID: 34478832 DOI: 10.1016/j.ijrobp.2021.08.029] [Reference Citation Analysis]
539 Wang L, Rao Y, Liu X, Sun L, Gong J, Zhang H, Shen L, Bao A, Yang H. Administration route governs the therapeutic efficacy, biodistribution and macrophage targeting of anti-inflammatory nanoparticles in the lung. J Nanobiotechnology 2021;19:56. [PMID: 33632244 DOI: 10.1186/s12951-021-00803-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
540 He L, Zeng C, Zeng Y, Xu W, Li Y, Xie X, Xu W, Xia H, Tang F, Tang S, Xu L, Chen C. Antibody Responses of the First Wave of Survivors infected with SARS-CoV-2 One Year Ago. J Med Virol 2021. [PMID: 34952979 DOI: 10.1002/jmv.27551] [Reference Citation Analysis]
541 Mohapatra RK, Dhama K, Mishra S, Sarangi AK, Kandi V, Tiwari R, Pintilie L. The microbiota-related coinfections in COVID-19 patients: a real challenge. Beni Suef Univ J Basic Appl Sci 2021;10:47. [PMID: 34458380 DOI: 10.1186/s43088-021-00134-7] [Reference Citation Analysis]
542 Byttebier G, Belmans L, Alexander M, Saxberg BEH, De Spiegeleer B, De Spiegeleer A, Devreker N, Van Praet JT, Vanhove K, Reybrouck R, Wynendaele E, Fedson DS. Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs. Hum Vaccin Immunother 2021;17:2841-50. [PMID: 34047686 DOI: 10.1080/21645515.2021.1920271] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
543 Almeida A, Baixauli J, Cienfuegos JA, Valentí V, Rotellar F. Concomitant aortic, inferior mesenteric artery thrombosis and sigmoid colon perforation in severe covid-19 disease. Cir Esp 2021. [PMID: 34629480 DOI: 10.1016/j.ciresp.2021.09.013] [Reference Citation Analysis]
544 Noor H, Ikram A, Rathinavel T, Kumarasamy S, Nasir Iqbal M, Bashir Z. Immunomodulatory and anti-cytokine therapeutic potential of curcumin and its derivatives for treating COVID-19 - a computational modeling. J Biomol Struct Dyn 2021;:1-16. [PMID: 33491580 DOI: 10.1080/07391102.2021.1873190] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
545 Nemudryi A, Nemudraia A, Wiegand T, Nichols J, Snyder DT, Hedges JF, Cicha C, Lee H, Vanderwood KK, Bimczok D, Jutila M, Wiedenheft B. SARS-CoV-2 genomic surveillance identifies naturally occurring truncations of ORF7a that limit immune suppression. medRxiv 2021:2021. [PMID: 33655280 DOI: 10.1101/2021.02.22.21252253] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
546 Lindner HA, Velásquez SY, Thiel M, Kirschning T. Lung Protection vs. Infection Resolution: Interleukin 10 Suspected of Double-Dealing in COVID-19. Front Immunol 2021;12:602130. [PMID: 33746948 DOI: 10.3389/fimmu.2021.602130] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
547 Saini KS, Lanza C, Romano M, de Azambuja E, Cortes J, de Las Heras B, de Castro J, Lamba Saini M, Loibl S, Curigliano G, Twelves C, Leone M, Patnaik MM. Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy. Br J Cancer 2020;123:694-7. [PMID: 32572174 DOI: 10.1038/s41416-020-0948-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 11.0] [Reference Citation Analysis]
548 Sessa F, Bertozzi G, Cipolloni L, Baldari B, Cantatore S, D'Errico S, Di Mizio G, Asmundo A, Castorina S, Salerno M, Pomara C. Clinical-Forensic Autopsy Findings to Defeat COVID-19 Disease: A Literature Review. J Clin Med 2020;9:E2026. [PMID: 32605192 DOI: 10.3390/jcm9072026] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]
549 Youn JY, Zhang Y, Wu Y, Cannesson M, Cai H. Therapeutic application of estrogen for COVID-19: Attenuation of SARS-CoV-2 spike protein and IL-6 stimulated, ACE2-dependent NOX2 activation, ROS production and MCP-1 upregulation in endothelial cells. Redox Biol 2021;46:102099. [PMID: 34509916 DOI: 10.1016/j.redox.2021.102099] [Reference Citation Analysis]
550 Nahas SC, Meira-JÚnior JD, Sobrado LF, Sorbello M, Segatelli V, Abdala E, Ribeiro-JÚnior U, Cecconello I. INTESTINAL PERFORATION CAUSED BY COVID-19. Arq Bras Cir Dig 2020;33:e1515. [PMID: 33237160 DOI: 10.1590/0102-672020190001e1515] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
551 Rios CI, Cassatt DR, Hollingsworth BA, Satyamitra MM, Tadesse YS, Taliaferro LP, Winters TA, DiCarlo AL. Commonalities Between COVID-19 and Radiation Injury. Radiat Res 2021;195:1-24. [PMID: 33064832 DOI: 10.1667/RADE-20-00188.1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
552 Bachmann MF, Mohsen MO, Zha L, Vogel M, Speiser DE. SARS-CoV-2 structural features may explain limited neutralizing-antibody responses. NPJ Vaccines 2021;6:2. [PMID: 33398006 DOI: 10.1038/s41541-020-00264-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
553 Petito E, Falcinelli E, Paliani U, Cesari E, Vaudo G, Sebastiano M, Cerotto V, Guglielmini G, Gori F, Malvestiti M, Becattini C, Paciullo F, De Robertis E, Bury L, Lazzarini T, Gresele P; COVIR study investigators. Association of Neutrophil Activation, More Than Platelet Activation, With Thrombotic Complications in Coronavirus Disease 2019. J Infect Dis 2021;223:933-44. [PMID: 33280009 DOI: 10.1093/infdis/jiaa756] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 25.0] [Reference Citation Analysis]
554 Lombardi C, Gani F, Berti A, Comberiati P, Peroni D, Cottini M. Asthma and COVID-19: a dangerous liaison? Asthma Res Pract 2021;7:9. [PMID: 34261543 DOI: 10.1186/s40733-021-00075-z] [Reference Citation Analysis]
555 Xiao K, Yang H, Liu B, Pang X, Du J, Liu M, Liu Y, Jing X, Chen J, Deng S, Zhou Z, Du J, Yin L, Yan Y, Mou H, She Q. Antibodies Can Last for More Than 1 Year After SARS-CoV-2 Infection: A Follow-Up Study From Survivors of COVID-19. Front Med (Lausanne) 2021;8:684864. [PMID: 34336891 DOI: 10.3389/fmed.2021.684864] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
556 Khalil A, Tazeddinova D, Aljoumaa K, Kazhmukhanbetkyzy ZA, Orazov A, Toshev AD. Carotenoids: Therapeutic Strategy in the Battle against Viral Emerging Diseases, COVID-19: An Overview. Prev Nutr Food Sci 2021;26:241-61. [PMID: 34737985 DOI: 10.3746/pnf.2021.26.3.241] [Reference Citation Analysis]
557 Cervia C, Nilsson J, Zurbuchen Y, Valaperti A, Schreiner J, Wolfensberger A, Raeber ME, Adamo S, Weigang S, Emmenegger M, Hasler S, Bosshard PP, De Cecco E, Bächli E, Rudiger A, Stüssi-Helbling M, Huber LC, Zinkernagel AS, Schaer DJ, Aguzzi A, Kochs G, Held U, Probst-Müller E, Rampini SK, Boyman O. Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19. J Allergy Clin Immunol 2021;147:545-557.e9. [PMID: 33221383 DOI: 10.1016/j.jaci.2020.10.040] [Cited by in Crossref: 65] [Cited by in F6Publishing: 83] [Article Influence: 32.5] [Reference Citation Analysis]
558 Yang J, Zhang P, Cheng WX, Lu Y, Gang W, Ren G. Exposing Structural Variations in SARS-CoV-2 Evolution. Res Sq 2021:rs. [PMID: 34545355 DOI: 10.21203/rs.3.rs-800496/v1] [Reference Citation Analysis]
559 Ahmed F, Jo DH, Lee SH. Can Natural Killer Cells Be a Principal Player in Anti-SARS-CoV-2 Immunity? Front Immunol 2020;11:586765. [PMID: 33365027 DOI: 10.3389/fimmu.2020.586765] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
560 Brooks EF, Bhatt AS. The gut microbiome: a missing link in understanding the gastrointestinal manifestations of COVID-19? Cold Spring Harb Mol Case Stud 2021;7:a006031. [PMID: 33593727 DOI: 10.1101/mcs.a006031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
561 Ong E, Huang X, Pearce R, Zhang Y, He Y. Rational Design of SARS-CoV-2 Spike Glycoproteins To Increase Immunogenicity By T Cell Epitope Engineering. bioRxiv 2020:2020. [PMID: 32817949 DOI: 10.1101/2020.08.14.251496] [Reference Citation Analysis]
562 Ong E, Huang X, Pearce R, Zhang Y, He Y. Computational design of SARS-CoV-2 spike glycoproteins to increase immunogenicity by T cell epitope engineering. Comput Struct Biotechnol J 2021;19:518-29. [PMID: 33398234 DOI: 10.1016/j.csbj.2020.12.039] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
563 S SLJ, V R. Scope of adjuvant therapy using roflumilast, a PDE-4 inhibitor against COVID-19. Pulm Pharmacol Ther 2021;66:101978. [PMID: 33259924 DOI: 10.1016/j.pupt.2020.101978] [Reference Citation Analysis]
564 Malato J, Sotzny F, Bauer S, Freitag H, Fonseca A, Grabowska AD, Graça L, Cordeiro C, Nacul L, Lacerda EM, Castro-Marrero J, Scheibenbogen C, Westermeier F, Sepúlveda N. The SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) in myalgic encephalomyelitis/chronic fatigue syndrome: A meta-analysis of public DNA methylation and gene expression data. Heliyon 2021;7:e07665. [PMID: 34341773 DOI: 10.1016/j.heliyon.2021.e07665] [Reference Citation Analysis]
565 Nazarullah A, Liang C, Villarreal A, Higgins RA, Mais DD. Peripheral Blood Examination Findings in SARS-CoV-2 Infection. Am J Clin Pathol 2020;154:319-29. [PMID: 32756872 DOI: 10.1093/ajcp/aqaa108] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
566 Post N, Eddy D, Huntley C, van Schalkwyk MCI, Shrotri M, Leeman D, Rigby S, Williams SV, Bermingham WH, Kellam P, Maher J, Shields AM, Amirthalingam G, Peacock SJ, Ismail SA. Antibody response to SARS-CoV-2 infection in humans: A systematic review. PLoS One 2020;15:e0244126. [PMID: 33382764 DOI: 10.1371/journal.pone.0244126] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 25.0] [Reference Citation Analysis]
567 Boechat JL, Chora I, Morais A, Delgado L. The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives. Pulmonology 2021;27:423-37. [PMID: 33867315 DOI: 10.1016/j.pulmoe.2021.03.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
568 Alsobaie S. Understanding the Molecular Biology of SARS-CoV-2 and the COVID-19 Pandemic: A Review. Infect Drug Resist 2021;14:2259-68. [PMID: 34163190 DOI: 10.2147/IDR.S306441] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
569 Dai Y, Wang J, Jeong HH, Chen W, Jia P, Zhao Z. Association of CXCR6 with COVID-19 severity: Delineating the host genetic factors in transcriptomic regulation. bioRxiv 2021:2021. [PMID: 33619490 DOI: 10.1101/2021.02.17.431554] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
570 Gallo O. Risk for COVID-19 infection in patients with tobacco smoke-associated cancers of the upper and lower airway. Eur Arch Otorhinolaryngol 2021;278:2695-702. [PMID: 33216184 DOI: 10.1007/s00405-020-06456-z] [Reference Citation Analysis]
571 Cremonesi P, Sartini M, Spagnolo AM, Adriano G, Zsirai E, Patrone C, Cevasco I, Cristina ML. Transformation of a Ferry Ship into a Ship Hospital for COVID-19 Patients. Int J Environ Res Public Health 2020;17:E8976. [PMID: 33276601 DOI: 10.3390/ijerph17238976] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
572 Guo X, Kazanova A, Thurmond S, Saragovi HU, Rudd CE. Effective chimeric antigen receptor T cells against SARS-CoV-2. iScience 2021;24:103295. [PMID: 34693218 DOI: 10.1016/j.isci.2021.103295] [Reference Citation Analysis]
573 Lerum TV, Maltzahn NN, Aukrust P, Trøseid M, Henriksen KN, Kåsine T, Dyrhol-Riise AM, Stiksrud B, Haugli M, Blomberg B, Kittang BR, Johannessen A, Hannula R, Aballi S, Kildal AB, Eiken R, Dahl TB, Lund-Johansen F, Müller F, Rodriguez JR, Meltzer C, Einvik G, Ueland T, Olsen IC, Barratt-Due A, Aaløkken TM, Skjønsberg OH; NOR-SOLIDARITY Consortium. Persistent pulmonary pathology after COVID-19 is associated with high viral load, weak antibody response, and high levels of matrix metalloproteinase-9. Sci Rep 2021;11:23205. [PMID: 34853380 DOI: 10.1038/s41598-021-02547-x] [Reference Citation Analysis]
574 Payen D, Cravat M, Maadadi H, Didelot C, Prosic L, Dupuis C, Losser MR, De Carvalho Bittencourt M. A Longitudinal Study of Immune Cells in Severe COVID-19 Patients. Front Immunol 2020;11:580250. [PMID: 33178207 DOI: 10.3389/fimmu.2020.580250] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
575 Muhammad R, Ogunti R, Ahmed B, Munawar M, Donaldson S, Sumon M, Kibreab A, Thomas AN, Mehari A. Clinical Characteristics and Predictors of Mortality in Minority Patients Hospitalized with COVID-19 Infection. J Racial Ethn Health Disparities 2021. [PMID: 33538998 DOI: 10.1007/s40615-020-00961-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
576 Galal I, Hussein AARM, Amin MT, Saad MM, Zayan HEE, Abdelsayed MZ, Moustafa MM, Ezzat AR, Helmy RED, Abd_elaal HK, Al Massry NA, Soliman MA, Ismail AM, Kholief KMS, Fathy E, Hashem MK. Determinants of persistent post-COVID-19 symptoms: value of a novel COVID-19 symptom score. Egypt J Bronchol 2021;15. [DOI: 10.1186/s43168-020-00049-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
577 Gupta A, Madhavan MV, Poterucha TJ, DeFilippis EM, Hennessey JA, Redfors B, Eckhardt C, Bikdeli B, Platt J, Nalbandian A, Elias P, Cummings MJ, Nouri SN, Lawlor M, Ranard LS, Li J, Boyle C, Givens R, Brodie D, Krumholz HM, Stone GW, Sethi SS, Burkhoff D, Uriel N, Schwartz A, Leon MB, Kirtane AJ, Wan EY, Parikh SA. Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19. Nat Commun 2021;12:1325. [PMID: 33637713 DOI: 10.1038/s41467-021-21553-1] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 30.0] [Reference Citation Analysis]
578 Schönrich G, Raftery MJ, Samstag Y. Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression. Adv Biol Regul 2020;77:100741. [PMID: 32773102 DOI: 10.1016/j.jbior.2020.100741] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Article Influence: 31.5] [Reference Citation Analysis]
579 Zandi M, Soltani S, Fani M, Abbasi S, Ebrahimi S, Ramezani A. Severe acute respiratory syndrome coronavirus 2 and respiratory syncytial virus coinfection in children. Osong Public Health Res Perspect 2021;12:286-92. [PMID: 34719220 DOI: 10.24171/j.phrp.2021.0140] [Reference Citation Analysis]
580 Loo J, Spittle DA, Newnham M. COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms. Thorax 2021;76:412-20. [PMID: 33408195 DOI: 10.1136/thoraxjnl-2020-216243] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 25.0] [Reference Citation Analysis]
581 Hardy E, Fernandez-Patron C. Targeting MMP-Regulation of Inflammation to Increase Metabolic Tolerance to COVID-19 Pathologies: A Hypothesis. Biomolecules 2021;11:390. [PMID: 33800947 DOI: 10.3390/biom11030390] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
582 Chen R, Lan Z, Ye J, Pang L, Liu Y, Wu W, Qin X, Guo Y, Zhang P. Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration. Front Immunol 2021;12:589095. [PMID: 33995341 DOI: 10.3389/fimmu.2021.589095] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
583 Villena J, Kitazawa H. The Modulation of Mucosal Antiviral Immunity by Immunobiotics: Could They Offer Any Benefit in the SARS-CoV-2 Pandemic? Front Physiol 2020;11:699. [PMID: 32670091 DOI: 10.3389/fphys.2020.00699] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
584 [DOI: 10.1101/2020.05.18.101691] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
585 Kobat H, Elkonaissi I, Dorak MT, Nabhani-Gebara S. Management of COVID-19 in cancer patients receiving cardiotoxic anti-cancer therapy. Future recommendations for cardio-oncology. Oncol Rev 2021;15:510. [PMID: 33747366 DOI: 10.4081/oncol.2021.510] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
586 Zeiss CJ, Compton S, Veenhuis RT. Animal Models of COVID-19. I. Comparative Virology and Disease Pathogenesis. ILAR J 2021:ilab007. [PMID: 33836527 DOI: 10.1093/ilar/ilab007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
587 Sorokin AV, Karathanasis SK, Yang ZH, Freeman L, Kotani K, Remaley AT. COVID-19-Associated dyslipidemia: Implications for mechanism of impaired resolution and novel therapeutic approaches. FASEB J 2020;34:9843-53. [PMID: 32588493 DOI: 10.1096/fj.202001451] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 22.5] [Reference Citation Analysis]
588 Tang G, Huang M, Luo Y, Liu W, Lin Q, Mao L, Wu S, Xiong Z, Hou H, Sun Z, Wang F. The Dynamic Immunological Parameter Landscape in Coronavirus Disease 2019 Patients With Different Outcomes. Front Immunol 2021;12:697622. [PMID: 34777333 DOI: 10.3389/fimmu.2021.697622] [Reference Citation Analysis]
589 Thoms M, Buschauer R, Ameismeier M, Koepke L, Denk T, Hirschenberger M, Kratzat H, Hayn M, Mackens-Kiani T, Cheng J, Straub JH, Stürzel CM, Fröhlich T, Berninghausen O, Becker T, Kirchhoff F, Sparrer KMJ, Beckmann R. Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2. Science 2020;369:1249-55. [PMID: 32680882 DOI: 10.1126/science.abc8665] [Cited by in Crossref: 209] [Cited by in F6Publishing: 206] [Article Influence: 104.5] [Reference Citation Analysis]
590 Xu G, Qi F, Li H, Yang Q, Wang H, Wang X, Liu X, Zhao J, Liao X, Liu Y, Liu L, Zhang S, Zhang Z. The differential immune responses to COVID-19 in peripheral and lung revealed by single-cell RNA sequencing. Cell Discov 2020;6:73. [PMID: 33101705 DOI: 10.1038/s41421-020-00225-2] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 22.5] [Reference Citation Analysis]
591 Gradin A, Andersson H, Luther T, Anderberg SB, Rubertsson S, Lipcsey M, Åberg M, Larsson A, Frithiof R, Hultström M. Urinary cytokines correlate with acute kidney injury in critically ill COVID-19 patients. Cytokine 2021;146:155589. [PMID: 34161857 DOI: 10.1016/j.cyto.2021.155589] [Reference Citation Analysis]
592 Baral PK, Yin J, James MNG. Treatment and prevention strategies for the COVID 19 pandemic: A review of immunotherapeutic approaches for neutralizing SARS-CoV-2. Int J Biol Macromol 2021;186:490-500. [PMID: 34237371 DOI: 10.1016/j.ijbiomac.2021.07.013] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
593 Huang R, Huestis M, Gan ES, Ooi EE, Ohh M. Hypoxia and viral infectious diseases. JCI Insight 2021;6:147190. [PMID: 33830079 DOI: 10.1172/jci.insight.147190] [Reference Citation Analysis]
594 Mafra D, Cardozo LFMF, Moraes C, Moreira LSG, Teixeira KTR, Reis DCMV, Fanton S, Salarolli R, Kalantar-Zadeh K, Burrowe JD. Coronavirus Disease 2019: Quick Diet and Nutrition Guide for Patients With Chronic Kidney Disease. J Ren Nutr 2021;31:39-42. [PMID: 32952005 DOI: 10.1053/j.jrn.2020.08.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
595 Chan SL, Kudo M. Impacts of COVID-19 on Liver Cancers: During and after the Pandemic. Liver Cancer. 2020;9:491-502. [PMID: 33078127 DOI: 10.1159/000510765] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
596 Bandopadhyay A, Singh AK, Chaubey G. COVID-19: The Cause of the Manifested Cardiovascular Complications During the Pandemic. Front Cardiovasc Med 2021;8:744482. [PMID: 34778405 DOI: 10.3389/fcvm.2021.744482] [Reference Citation Analysis]
597 Thieme CJ, Anft M, Paniskaki K, Blazquez-Navarro A, Doevelaar A, Seibert FS, Hoelzer B, Konik MJ, Berger MM, Brenner T, Tempfer C, Watzl C, Meister TL, Pfaender S, Steinmann E, Dolff S, Dittmer U, Westhoff TH, Witzke O, Stervbo U, Roch T, Babel N. Robust T Cell Response Toward Spike, Membrane, and Nucleocapsid SARS-CoV-2 Proteins Is Not Associated with Recovery in Critical COVID-19 Patients. Cell Rep Med 2020;1:100092. [PMID: 32904468 DOI: 10.1016/j.xcrm.2020.100092] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 22.5] [Reference Citation Analysis]
598 Wholey WY, Yoda ST, Cheng W. Site-Specific and Stable Conjugation of the SARS-CoV-2 Receptor-Binding Domain to Liposomes in the Absence of Any Other Adjuvants Elicits Potent Neutralizing Antibodies in BALB/c Mice. Bioconjug Chem 2021. [PMID: 34775749 DOI: 10.1021/acs.bioconjchem.1c00463] [Reference Citation Analysis]
599 Chambers ES, Akbar AN. Reply. J Allergy Clin Immunol 2020;146:922-3. [PMID: 32718758 DOI: 10.1016/j.jaci.2020.06.020] [Reference Citation Analysis]
600 Velardi E, Tsai JJ, van den Brink MRM. T cell regeneration after immunological injury. Nat Rev Immunol 2021;21:277-91. [PMID: 33097917 DOI: 10.1038/s41577-020-00457-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
601 Sarkar S, Das D, Borsingh Wann S, Kalita J, Manna P. Is diabetes mellitus a wrongdoer to COVID-19 severity? Diabetes Res Clin Pract 2021;178:108936. [PMID: 34217771 DOI: 10.1016/j.diabres.2021.108936] [Reference Citation Analysis]
602 Lu S, Zhao J, Dong J, Liu H, Zhu Y, Li H, Liu L, Yang Y, Sun S, Song Y, Zhao Y, She R, Luo T, Deng H, Peng X. Effective treatment of SARS-CoV-2-infected rhesus macaques by attenuating inflammation. Cell Res 2021;31:229-32. [PMID: 32999427 DOI: 10.1038/s41422-020-00414-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
603 Rosa BA, Ahmed M, Singh DK, Choreño-Parra JA, Cole J, Jiménez-Álvarez LA, Rodríguez-Reyna TS, Singh B, Gonzalez O, Carrion R Jr, Schlesinger LS, Martin J, Zúñiga J, Mitreva M, Khader SA, Kaushal D. IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection. bioRxiv 2020:2020. [PMID: 32793903 DOI: 10.1101/2020.08.06.239798] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
604 Firacative C. Invasive fungal disease in humans: are we aware of the real impact? Mem Inst Oswaldo Cruz 2020;115:e200430. [PMID: 33053052 DOI: 10.1590/0074-02760200430] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
605 [DOI: 10.1101/2020.07.15.204404] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
606 Erickson MA, Rhea EM, Knopp RC, Banks WA. Interactions of SARS-CoV-2 with the Blood-Brain Barrier. Int J Mol Sci 2021;22:2681. [PMID: 33800954 DOI: 10.3390/ijms22052681] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
607 Villani ER, Carfì A, Di Paola A, Palmieri L, Donfrancesco C, Lo Noce C, Taruscio D, Meli P, Salerno P, Kodra Y, Pricci F, Tamburo de Bella M, Floridia M, Onder G; The Italian National Institute of Health CoVID‐19 Mortality Group. Clinical characteristics of individuals with Down syndrome deceased with CoVID‐19 in Italy—A case series. Am J Med Genet 2020;182:2964-70. [DOI: 10.1002/ajmg.a.61867] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
608 Hasselbalch HC, Skov V, Kjær L, Ellervik C, Poulsen A, Poulsen TD, Nielsen CH. COVID-19 as a mediator of interferon deficiency and hyperinflammation: Rationale for the use of JAK1/2 inhibitors in combination with interferon. Cytokine Growth Factor Rev 2021;60:28-45. [PMID: 33992887 DOI: 10.1016/j.cytogfr.2021.03.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
609 Zhou L, Huntington K, Zhang S, Carlsen L, So EY, Parker C, Sahin I, Safran H, Kamle S, Lee CM, Geun Lee C, A Elias J, S Campbell K, T Naik M, J Atwood W, Youssef E, A Pachter J, Navaraj A, A Seyhan A, Liang O, El-Deiry WS. MEK inhibitors reduce cellular expression of ACE2, pERK, pRb while stimulating NK-mediated cytotoxicity and attenuating inflammatory cytokines relevant to SARS-CoV-2 infection. Oncotarget 2020;11:4201-23. [PMID: 33245731 DOI: 10.18632/oncotarget.27799] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
610 Dhont S, Derom E, Van Braeckel E, Depuydt P, Lambrecht BN. The pathophysiology of 'happy' hypoxemia in COVID-19. Respir Res 2020;21:198. [PMID: 32723327 DOI: 10.1186/s12931-020-01462-5] [Cited by in Crossref: 114] [Cited by in F6Publishing: 96] [Article Influence: 57.0] [Reference Citation Analysis]
611 Lotfi R, Kalmarzi RN, Roghani SA. A review on the immune responses against novel emerging coronavirus (SARS-CoV-2). Immunol Res 2021;69:213-24. [PMID: 33928531 DOI: 10.1007/s12026-021-09198-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
612 Sasson JM, Campo JJ, Carpenter RM, Young MK, Randall AZ, Trappl-Kimmons K, Oberai A, Hung C, Edgar J, Teng AA, Pablo JV, Liang X, Yee A, Petri WA Jr, Camerini D. Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients. mBio 2021;12:e0122921. [PMID: 34182775 DOI: 10.1128/mBio.01229-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
613 Oja AE, Saris A, Ghandour CA, Kragten NAM, Hogema BM, Nossent EJ, Heunks LMA, Cuvalay S, Slot E, Linty F, Swaneveld FH, Vrielink H, Vidarsson G, Rispens T, van der Schoot E, van Lier RAW, Ten Brinke A, Hombrink P. Divergent SARS-CoV-2-specific T- and B-cell responses in severe but not mild COVID-19 patients. Eur J Immunol 2020;50:1998-2012. [PMID: 33073359 DOI: 10.1002/eji.202048908] [Cited by in Crossref: 31] [Cited by in F6Publishing: 38] [Article Influence: 15.5] [Reference Citation Analysis]
614 Zhang X, Gao R, Zhou Z, Tang X, Lin J, Wang L, Zhou X, Shen T. A network pharmacology based approach for predicting active ingredients and potential mechanism of Lianhuaqingwen capsule in treating COVID-19. Int J Med Sci 2021;18:1866-76. [PMID: 33746604 DOI: 10.7150/ijms.53685] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
615 Bahrampour Juybari K, Pourhanifeh MH, Hosseinzadeh A, Hemati K, Mehrzadi S. Melatonin potentials against viral infections including COVID-19: Current evidence and new findings. Virus Res 2020;287:198108. [PMID: 32768490 DOI: 10.1016/j.virusres.2020.198108] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 14.0] [Reference Citation Analysis]
616 Zhang H, Shao B, Dang Q, Chen Z, Zhou Q, Luo H, Yuan W, Sun Z. Pathogenesis and Mechanism of Gastrointestinal Infection With COVID-19. Front Immunol 2021;12:674074. [PMID: 34858386 DOI: 10.3389/fimmu.2021.674074] [Reference Citation Analysis]
617 Mahmud-Al-Rafat A, Muzammal Haque Asim M, Taylor-Robinson AW, Majumder A, Muktadir A, Muktadir H, Karim M, Khan I, Mainul Ahasan M, Morsaline Billah M. A combinational approach to restore cytokine balance and to inhibit virus growth may promote patient recovery in severe COVID-19 cases. Cytokine 2020;136:155228. [PMID: 32822911 DOI: 10.1016/j.cyto.2020.155228] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
618 Rinchai D, Syed Ahamed Kabeer B, Toufiq M, Tatari-Calderone Z, Deola S, Brummaier T, Garand M, Branco R, Baldwin N, Alfaki M, Altman MC, Ballestrero A, Bassetti M, Zoppoli G, De Maria A, Tang B, Bedognetti D, Chaussabel D. A modular framework for the development of targeted Covid-19 blood transcript profiling panels. J Transl Med 2020;18:291. [PMID: 32736569 DOI: 10.1186/s12967-020-02456-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
619 Buzhdygan TP, DeOre BJ, Baldwin-Leclair A, Bullock TA, McGary HM, Khan JA, Razmpour R, Hale JF, Galie PA, Potula R, Andrews AM, Ramirez SH. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier. Neurobiol Dis 2020;146:105131. [PMID: 33053430 DOI: 10.1016/j.nbd.2020.105131] [Cited by in Crossref: 57] [Cited by in F6Publishing: 75] [Article Influence: 28.5] [Reference Citation Analysis]
620 Tan LY, Komarasamy TV, Rmt Balasubramaniam V. Hyperinflammatory Immune Response and COVID-19: A Double Edged Sword. Front Immunol 2021;12:742941. [PMID: 34659238 DOI: 10.3389/fimmu.2021.742941] [Reference Citation Analysis]
621 Li CY. Can Glycine Mitigate COVID-19 Associated Tissue Damage and Cytokine Storm? Radiat Res 2020;194:199-201. [PMID: 32942307 DOI: 10.1667/RADE-20-00146.1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
622 Molnar Z, Bakker J. Attenuating hyperinflammation in COVID-19: A change in paradigm? J Crit Care 2020;60:334-6. [PMID: 32741525 DOI: 10.1016/j.jcrc.2020.07.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
623 Dąbrowska E, Galińska-Skok B, Waszkiewicz N. Depressive and Neurocognitive Disorders in the Context of the Inflammatory Background of COVID-19. Life (Basel) 2021;11:1056. [PMID: 34685427 DOI: 10.3390/life11101056] [Reference Citation Analysis]
624 Ventero MP, Moreno-Perez O, Molina-Pardines C, Paytuví-Gallart A, Boix V, Escribano I, Galan I, González-delaAleja P, López-Pérez M, Sánchez-Martínez R, Merino E, Rodríguez JC. Nasopharyngeal Microbiota as an early severity biomarker in COVID-19 hospitalised patients: a retrospective cohort study in a Mediterranean area. J Infect 2021:S0163-4453(21)00647-2. [PMID: 34963638 DOI: 10.1016/j.jinf.2021.12.030] [Reference Citation Analysis]
625 Dziedzic A, Saluk-Bijak J, Miller E, Niemcewicz M, Bijak M. The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis. Int J Mol Sci 2021;22:1804. [PMID: 33670394 DOI: 10.3390/ijms22041804] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
626 Su H, Ma C, Li H. Anti-infection mechanism of phosphodiesterase-5 inhibitors and their roles in coronavirus disease 2019 (Review). Exp Ther Med 2021;21:320. [PMID: 33732293 DOI: 10.3892/etm.2021.9751] [Reference Citation Analysis]
627 Swaim CD, Dwivedi V, Perng YC, Zhao X, Canadeo LA, Harastani HH, Darling TL, Boon ACM, Lenschow DJ, Kulkarni V, Huibregtse JM. 6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro. iScience 2021;24:103213. [PMID: 34632326 DOI: 10.1016/j.isci.2021.103213] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
628 Agrati C, Sacchi A, Bordoni V, Cimini E, Notari S, Grassi G, Casetti R, Tartaglia E, Lalle E, D'Abramo A, Castilletti C, Marchioni L, Shi Y, Mariano A, Song JW, Zhang JY, Wang FS, Zhang C, Fimia GM, Capobianchi MR, Piacentini M, Antinori A, Nicastri E, Maeurer M, Zumla A, Ippolito G. Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19). Cell Death Differ. 2020;27:3196-3207. [PMID: 32514047 DOI: 10.1038/s41418-020-0572-6] [Cited by in Crossref: 66] [Cited by in F6Publishing: 70] [Article Influence: 33.0] [Reference Citation Analysis]
629 Kohmer N, Westhaus S, Rühl C, Ciesek S, Rabenau HF. Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays. J Clin Virol 2020;129:104480. [PMID: 32505777 DOI: 10.1016/j.jcv.2020.104480] [Cited by in Crossref: 105] [Cited by in F6Publishing: 88] [Article Influence: 52.5] [Reference Citation Analysis]
630 Ahmad F, Kannan M, Ansari AW. Role of SARS-CoV-2 -induced cytokines and growth factors in coagulopathy and thromboembolism. Cytokine Growth Factor Rev 2021:S1359-6101(21)00079-4. [PMID: 34750061 DOI: 10.1016/j.cytogfr.2021.10.007] [Reference Citation Analysis]
631 Wang Z, Xiang L, Lin F, Cai Z, Ruan H, Wang J, Liang J, Wang F, Lu M, Cui W. Inhaled ACE2-engineered microfluidic microsphere for intratracheal neutralization of COVID-19 and calming of the cytokine storm. Matter 2021. [PMID: 34693277 DOI: 10.1016/j.matt.2021.09.022] [Reference Citation Analysis]
632 Junqueira C, Crespo Ã, Ranjbar S, Lewandrowski M, Ingber J, de Lacerda LB, Parry B, Ravid S, Clark S, Ho F, Vora SM, Leger V, Beakes C, Margolin J, Russell N, Kays K, Gehrke L, Adhikari UD, Henderson L, Janssen E, Kwon D, Sander C, Abraham J, Filbin M, Goldberg MB, Wu H, Mehta G, Bell S, Goldfeld AE, Lieberman J. SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine release. Res Sq 2021:rs. [PMID: 34401873 DOI: 10.21203/rs.3.rs-153628/v1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
633 Cabaro S, D'Esposito V, Di Matola T, Sale S, Cennamo M, Terracciano D, Parisi V, Oriente F, Portella G, Beguinot F, Atripaldi L, Sansone M, Formisano P. Cytokine signature and COVID-19 prediction models in the two waves of pandemics. Sci Rep 2021;11:20793. [PMID: 34675240 DOI: 10.1038/s41598-021-00190-0] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
634 McQuaid C, Brady M, Deane R. SARS-CoV-2: is there neuroinvasion? Fluids Barriers CNS 2021;18:32. [PMID: 34261487 DOI: 10.1186/s12987-021-00267-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
635 Sarfraz A, Hasan Siddiqui S, Iqbal J, Ali SA, Hasan Z, Sarfraz Z, Iqbal NT. COVID-19 age-dependent immunology and clinical outcomes: implications for vaccines. J Dev Orig Health Dis 2021;:1-7. [PMID: 34284839 DOI: 10.1017/S2040174421000398] [Reference Citation Analysis]
636 Zhou Y, Hou Y, Shen J, Kallianpur A, Zein J, Culver DA, Farha S, Comhair S, Fiocchi C, Gack MU, Mehra R, Stappenbeck T, Chan T, Eng C, Jung JU, Jehi L, Erzurum S, Cheng F. A Network Medicine Approach to Investigation and Population-based Validation of Disease Manifestations and Drug Repurposing for COVID-19. ChemRxiv 2020. [PMID: 32676577 DOI: 10.26434/chemrxiv.12579137] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
637 Hara T, Yamamura K, Sakai Y. The up-to-date pathophysiology of Kawasaki disease. Clin Transl Immunology 2021;10:e1284. [PMID: 33981434 DOI: 10.1002/cti2.1284] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
638 Cueno ME, Imai K. Structural Comparison of the SARS CoV 2 Spike Protein Relative to Other Human-Infecting Coronaviruses. Front Med (Lausanne) 2020;7:594439. [PMID: 33585502 DOI: 10.3389/fmed.2020.594439] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
639 Brunsdon P, Saluja B, Sahajwalla C. Clinical Pharmacology Considerations for Developing Small-Molecule Treatments for COVID-19. J Clin Pharmacol 2020;60:1147-54. [PMID: 32579707 DOI: 10.1002/jcph.1697] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
640 Cortés-ferré HE, Guajardo-flores D, Romero-de La Vega G, Gutierrez-uribe JA. Recovery of Capsaicinoids and Other Phytochemicals Involved With TRPV-1 Receptor to Re-valorize Chili Pepper Waste and Produce Nutraceuticals. Front Sustain Food Syst 2021;4:588534. [DOI: 10.3389/fsufs.2020.588534] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
641 Uversky VN, Elrashdy F, Aljadawi A, Ali SM, Khan RH, Redwan EM. Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How? J Neurosci Res 2021;99:750-77. [PMID: 33217763 DOI: 10.1002/jnr.24752] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
642 Pelaia C, Calabrese C, Garofalo E, Bruni A, Vatrella A, Pelaia G. Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence. Int J Mol Sci 2021;22:3059. [PMID: 33802761 DOI: 10.3390/ijms22063059] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
643 Kwon CY, Kwak HY, Kim JW. Using Mind-Body Modalities via Telemedicine during the COVID-19 Crisis: Cases in the Republic of Korea. Int J Environ Res Public Health 2020;17:E4477. [PMID: 32580396 DOI: 10.3390/ijerph17124477] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
644 Bime C, Casanova NG, Nikolich-Zugich J, Knox KS, Camp SM, Garcia JGN. Strategies to DAMPen COVID-19-mediated lung and systemic inflammation and vascular injury. Transl Res 2021;232:37-48. [PMID: 33358868 DOI: 10.1016/j.trsl.2020.12.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
645 Soliman AT, Prabhakaran Nair A, Al Masalamani MS, De Sanctis V, Abu Khattab MA, Alsaud AE, Sasi S, Ali EA, Ola A H, Iqbal FM, Nashwan AJ, Fahad J, El Madhoun I, Yassin MA. Prevalence, clinical manifestations, and biochemical data of type 2 diabetes mellitus versus nondiabetic symptomatic patients with COVID-19: A comparative study. Acta Biomed 2020;91:e2020010. [PMID: 32921708 DOI: 10.23750/abm.v91i3.10214] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
646 Baay M, Lina B, Fontanet A, Marchant A, Saville M, Sabot P, Duclos P, Vandeputte J, Neels P. SARS-CoV-2: Virology, epidemiology, immunology and vaccine development. Biologicals 2020;66:35-40. [PMID: 32600951 DOI: 10.1016/j.biologicals.2020.06.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
647 Gong Y, Qin S, Dai L, Tian Z. The glycosylation in SARS-CoV-2 and its receptor ACE2. Signal Transduct Target Ther 2021;6:396. [PMID: 34782609 DOI: 10.1038/s41392-021-00809-8] [Reference Citation Analysis]
648 Charoenkwan P, Chiangjong W, Nantasenamat C, Hasan MM, Manavalan B, Shoombuatong W. StackIL6: a stacking ensemble model for improving the prediction of IL-6 inducing peptides. Brief Bioinform 2021:bbab172. [PMID: 33963832 DOI: 10.1093/bib/bbab172] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
649 Valdés P, Rovira A, Guerrero J, Morales Á, Rovira M, Martínez C. Managing the pandemic from the radiology department's point of view. Radiologia (Engl Ed) 2020;62:503-14. [PMID: 33213870 DOI: 10.1016/j.rx.2020.10.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
650 Ling XC, Kang EY, Lin JY, Chen HC, Lai CC, Ma DH, Wu WC. Ocular manifestation, comorbidities, and detection of severe acute respiratory syndrome-coronavirus 2 from conjunctiva in coronavirus disease 2019: A systematic review and meta-analysis. Taiwan J Ophthalmol. 2020;10:153-166. [PMID: 33110745 DOI: 10.4103/tjo.tjo_53_20] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
651 Cheng MH, Porritt RA, Rivas MN, Krieger JM, Ozdemir AB, Garcia G Jr, Arumugaswami V, Fries BC, Arditi M, Bahar I. A monoclonal antibody against staphylococcal enterotoxin B superantigen inhibits SARS-CoV-2 entry in vitro. Structure 2021:S0969-2126(21)00121-0. [PMID: 33930306 DOI: 10.1016/j.str.2021.04.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
652 Sanyal S. How SARS-CoV-2 (COVID-19) spreads within infected hosts - what we know so far. Emerg Top Life Sci 2020;4:371-8. [PMID: 33269805 DOI: 10.1042/ETLS20200165] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
653 Manosso LM, Arent CO, Borba LA, Ceretta LB, Quevedo J, Réus GZ. Microbiota-Gut-Brain Communication in the SARS-CoV-2 Infection. Cells 2021;10:1993. [PMID: 34440767 DOI: 10.3390/cells10081993] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
654 Abers MS, Delmonte OM, Ricotta EE, Fintzi J, Fink DL, de Jesus AAA, Zarember KA, Alehashemi S, Oikonomou V, Desai JV, Canna SW, Shakoory B, Dobbs K, Imberti L, Sottini A, Quiros-Roldan E, Castelli F, Rossi C, Brugnoni D, Biondi A, Bettini LR, D'Angio' M, Bonfanti P, Castagnoli R, Montagna D, Licari A, Marseglia GL, Gliniewicz EF, Shaw E, Kahle DE, Rastegar AT, Stack M, Myint-Hpu K, Levinson SL, DiNubile MJ, Chertow DW, Burbelo PD, Cohen JI, Calvo KR, Tsang JS, Su HC, Gallin JI, Kuhns DB, Goldbach-Mansky R, Lionakis MS, Notarangelo LD; NIAID COVID-19 Consortium. An immune-based biomarker signature is associated with mortality in COVID-19 patients. JCI Insight 2021;6:144455. [PMID: 33232303 DOI: 10.1172/jci.insight.144455] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 53.0] [Reference Citation Analysis]
655 Buckland MS, Galloway JB, Fhogartaigh CN, Meredith L, Provine NM, Bloor S, Ogbe A, Zelek WM, Smielewska A, Yakovleva A, Mann T, Bergamaschi L, Turner L, Mescia F, Toonen EJM, Hackstein CP, Akther HD, Vieira VA, Ceron-Gutierrez L, Periselneris J, Kiani-Alikhan S, Grigoriadou S, Vaghela D, Lear SE, Török ME, Hamilton WL, Stockton J, Quick J, Nelson P, Hunter M, Coulter TI, Devlin L, Bradley JR, Smith KGC, Ouwehand WH, Estcourt L, Harvala H, Roberts DJ, Wilkinson IB, Screaton N, Loman N, Doffinger R, Lyons PA, Morgan BP, Goodfellow IG, Klenerman P, Lehner PJ, Matheson NJ, Thaventhiran JED; CITIID-NIHR COVID-19 BioResource Collaboration., MRC-Toxicology Unit COVID-19 Consortium. Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report. Nat Commun 2020;11:6385. [PMID: 33318491 DOI: 10.1038/s41467-020-19761-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 10.0] [Reference Citation Analysis]
656 Flanagan KL, Best E, Crawford NW, Giles M, Koirala A, Macartney K, Russell F, Teh BW, Wen SC. Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines. Front Immunol 2020;11:579250. [PMID: 33123165 DOI: 10.3389/fimmu.2020.579250] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 12.0] [Reference Citation Analysis]
657 [DOI: 10.1101/2020.08.31.20185082] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
658 Souza ASQ, Sousa JAC, Pinto CS, Alves Filho EG, Pereira RCA, Brito ES, Canuto KM, Leal LKAM. Untargeted GC/MS-based approach for identification of anti-inflammatory alkaloids from Hippeastrum elegans (Amaryllidaceae) using a human neutrophil model. J Pharm Biomed Anal 2021;199:114061. [PMID: 33845386 DOI: 10.1016/j.jpba.2021.114061] [Reference Citation Analysis]
659 Land WG. Role of DAMPs in respiratory virus-induced acute respiratory distress syndrome-with a preliminary reference to SARS-CoV-2 pneumonia. Genes Immun 2021;22:141-60. [PMID: 34140652 DOI: 10.1038/s41435-021-00140-w] [Reference Citation Analysis]
660 Manavalan B, Basith S, Lee G. Comparative analysis of machine learning-based approaches for identifying therapeutic peptides targeting SARS-CoV-2. Brief Bioinform 2021:bbab412. [PMID: 34595489 DOI: 10.1093/bib/bbab412] [Reference Citation Analysis]
661 Onodi F, Bonnet-Madin L, Meertens L, Karpf L, Poirot J, Zhang SY, Picard C, Puel A, Jouanguy E, Zhang Q, Le Goff J, Molina JM, Delaugerre C, Casanova JL, Amara A, Soumelis V. SARS-CoV-2 induces human plasmacytoid pre-dendritic cell diversification via UNC93B and IRAK4. bioRxiv 2021:2020. [PMID: 33442685 DOI: 10.1101/2020.07.10.197343] [Cited by in Crossref: 8] [Article Influence: 8.0] [Reference Citation Analysis]
662 Lammers T, Sofias AM, van der Meel R, Schiffelers R, Storm G, Tacke F, Koschmieder S, Brümmendorf TH, Kiessling F, Metselaar JM. Dexamethasone nanomedicines for COVID-19. Nat Nanotechnol 2020;15:622-4. [PMID: 32747742 DOI: 10.1038/s41565-020-0752-z] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 29.5] [Reference Citation Analysis]
663 Rzymski P, Nowicki M, Mullin GE, Abraham A, Rodríguez-Román E, Petzold MB, Bendau A, Sahu KK, Ather A, Naviaux AF, Janne P, Gourdin M, Delanghe JR, Ochs HD, Talmadge JE, Garg M, Hamblin MR, Rezaei N. Quantity does not equal quality: Scientific principles cannot be sacrificed. Int Immunopharmacol 2020;86:106711. [PMID: 32585609 DOI: 10.1016/j.intimp.2020.106711] [Cited by in Crossref: 36] [Cited by in F6Publishing: 20] [Article Influence: 18.0] [Reference Citation Analysis]
664 Chandler LC, Yusuf IH, McClements ME, Barnard AR, MacLaren RE, Xue K. Immunomodulatory Effects of Hydroxychloroquine and Chloroquine in Viral Infections and Their Potential Application in Retinal Gene Therapy. Int J Mol Sci 2020;21:E4972. [PMID: 32674481 DOI: 10.3390/ijms21144972] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
665 Dos Santos WG. Impact of virus genetic variability and host immunity for the success of COVID-19 vaccines. Biomed Pharmacother 2021;136:111272. [PMID: 33486212 DOI: 10.1016/j.biopha.2021.111272] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 25.0] [Reference Citation Analysis]
666 Huang L, Shi Y, Gong B, Jiang L, Zhang Z, Liu X, Yang J, He Y, Jiang Z, Zhong L, Tang J, You C, Jiang Q, Long B, Zeng T, Luo M, Zeng F, Zeng F, Wang S, Yang X, Yang Z. Dynamic blood single-cell immune responses in patients with COVID-19. Signal Transduct Target Ther 2021;6:110. [PMID: 33677468 DOI: 10.1038/s41392-021-00526-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
667 Galbraith MD, Kinning KT, Sullivan KD, Baxter R, Araya P, Jordan KR, Russell S, Smith KP, Granrath RE, Shaw J, Dzieciatkowska M, Ghosh T, Monte AA, D'Alessandro A, Hansen KC, Bennett TD, Hsieh EWY, Espinosa JM. Seroconversion stages COVID19 into distinct pathophysiological states. medRxiv 2020:2020. [PMID: 33330890 DOI: 10.1101/2020.12.05.20244442] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
668 Cano EJ, Fonseca Fuentes X, Corsini Campioli C, O'Horo JC, Abu Saleh O, Odeyemi Y, Yadav H, Temesgen Z. Impact of Corticosteroids in Coronavirus Disease 2019 Outcomes: Systematic Review and Meta-analysis.Chest. 2021;159:1019-1040. [PMID: 33129791 DOI: 10.1016/j.chest.2020.10.054] [Cited by in Crossref: 31] [Cited by in F6Publishing: 38] [Article Influence: 15.5] [Reference Citation Analysis]
669 Vastrad B, Vastrad C, Tengli A. Bioinformatics analyses of significant genes, related pathways, and candidate diagnostic biomarkers and molecular targets in SARS-CoV-2/COVID-19. Gene Rep 2020;21:100956. [PMID: 33553808 DOI: 10.1016/j.genrep.2020.100956] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
670 Icenogle T. COVID-19: Infection or Autoimmunity. Front Immunol 2020;11:2055. [PMID: 33042116 DOI: 10.3389/fimmu.2020.02055] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
671 Asdaq SMB, Rajan A, Damodaran A, Kamath SR, Nair KS, Zachariah SM, Sahu RK, Fattepur S, Sreeharsha N, Nair A, Jacob S, Albahrani HA, Alkhaldi EH, Mohzari Y, Alrashed AA, Imran M. Identifying Mucormycosis Severity in Indian COVID-19 Patients: A Nano-Based Diagnosis and the Necessity for Critical Therapeutic Intervention. Antibiotics (Basel) 2021;10:1308. [PMID: 34827246 DOI: 10.3390/antibiotics10111308] [Reference Citation Analysis]
672 Pérez-Raya F, Cobos-Serrano JL, Ayuso-Murillo D, Fernández-Fernández P, Rodríguez-Gómez JA, Almeida Souza A. COVID-19 impact on nurses in Spain: a considered opinion survey. Int Nurs Rev 2021;68:248-55. [PMID: 34004014 DOI: 10.1111/inr.12682] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
673 Mattioli M, Fustini E, Gennarini S. Heart transplant recipient patient with COVID-19 treated with tocilizumab. Transpl Infect Dis 2020;22:e13380. [PMID: 32573990 DOI: 10.1111/tid.13380] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
674 Chazal N. Coronavirus, the King Who Wanted More Than a Crown: From Common to the Highly Pathogenic SARS-CoV-2, Is the Key in the Accessory Genes? Front Microbiol 2021;12:682603. [PMID: 34335504 DOI: 10.3389/fmicb.2021.682603] [Reference Citation Analysis]
675 Darestani MN, Akbari A, Yaghobee S, Taheri M, Akbari S, Guven Y. COVID-19 Pandemic and Periodontal Practice: The Immunological, Clinical, and Economic Points of View. BioMed Research International 2022;2022:1-10. [DOI: 10.1155/2022/3918980] [Reference Citation Analysis]
676 Atzrodt CL, Maknojia I, McCarthy RDP, Oldfield TM, Po J, Ta KTL, Stepp HE, Clements TP. A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2. FEBS J 2020;287:3633-50. [PMID: 32446285 DOI: 10.1111/febs.15375] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 12.0] [Reference Citation Analysis]
677 Gallo O, Trotta M, Orlando P, Maggiore G, Bicci E, Locatello LG. SARS-CoV-2 in upper and lower airway samples of a laryngectomized patient: New insights and many lessons. Oral Oncol 2020;107:104841. [PMID: 32527570 DOI: 10.1016/j.oraloncology.2020.104841] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
678 Xiao F, Han M, Zhu X, Tang Y, Huang E, Zou H, Jiang Q, Lu L. The immune dysregulations in COVID-19: Implications for the management of rheumatic diseases. Mod Rheumatol 2021;31:927-32. [PMID: 33427554 DOI: 10.1080/14397595.2020.1868673] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
679 Silveira MM, Moreira GMSG, Mendonça M. DNA vaccines against COVID-19: Perspectives and challenges. Life Sci 2021;267:118919. [PMID: 33352173 DOI: 10.1016/j.lfs.2020.118919] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 14.0] [Reference Citation Analysis]
680 Tabish TA, Hamblin MR. Multivalent nanomedicines to treat COVID-19: A slow train coming. Nano Today 2020;35:100962. [PMID: 32922510 DOI: 10.1016/j.nantod.2020.100962] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 9.5] [Reference Citation Analysis]
681 Lim JA, Thahir A, Amar Korde V, Krkovic M. The Impact of COVID-19 on Neck of Femur Fracture Care: A Major Trauma Centre Experience, United Kingdom. Arch Bone Jt Surg 2021;9:453-60. [PMID: 34423096 DOI: 10.22038/abjs.2020.50429.2502] [Reference Citation Analysis]
682 Lynch SM, Guo G, Gibson DS, Bjourson AJ, Rai TS. Role of Senescence and Aging in SARS-CoV-2 Infection and COVID-19 Disease. Cells 2021;10:3367. [PMID: 34943875 DOI: 10.3390/cells10123367] [Reference Citation Analysis]
683 Inchingolo AD, Dipalma G, Inchingolo AM, Malcangi G, Santacroce L, D'Oria MT, Isacco CG, Bordea IR, Candrea S, Scarano A, Morandi B, Del Fabbro M, Farronato M, Tartaglia GM, Balzanelli MG, Ballini A, Nucci L, Lorusso F, Taschieri S, Inchingolo F. The 15-Months Clinical Experience of SARS-CoV-2: A Literature Review of Therapies and Adjuvants. Antioxidants (Basel) 2021;10:881. [PMID: 34072708 DOI: 10.3390/antiox10060881] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
684 Pimlott N, Agarwal P, McCarthy LM, Luke MJ, Hum S, Gill S, Heisey R. Clinical learnings from a virtual primary care program monitoring mild to moderate COVID-19 patients at home. Fam Pract 2021;38:549-55. [PMID: 33340398 DOI: 10.1093/fampra/cmaa130] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
685 Situmorang DDB, Ifdil I, Wati CLS, Mamahit HC, Papu YM. Cycling Therapy for Reducing Psychological Problems of Patients With COVID-19: As an Alternative Treatment After Recovery. Infect Dis Clin Pract (Baltim Md) 2021;29:e490. [PMID: 34803357 DOI: 10.1097/IPC.0000000000001061] [Reference Citation Analysis]
686 Iturrieta-Zuazo I, Rita CG, García-Soidán A, de Malet Pintos-Fonseca A, Alonso-Alarcón N, Pariente-Rodríguez R, Tejeda-Velarde A, Serrano-Villar S, Castañer-Alabau JL, Nieto-Gañán I. Possible role of HLA class-I genotype in SARS-CoV-2 infection and progression: A pilot study in a cohort of Covid-19 Spanish patients. Clin Immunol 2020;219:108572. [PMID: 32810602 DOI: 10.1016/j.clim.2020.108572] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 14.0] [Reference Citation Analysis]
687 Majumdar S, Verma R, Saha A, Bhattacharyya P, Maji P, Surjit M, Kundu M, Basu J, Saha S. Perspectives About Modulating Host Immune System in Targeting SARS-CoV-2 in India. Front Genet 2021;12:637362. [PMID: 33664772 DOI: 10.3389/fgene.2021.637362] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
688 Barbosa JR, de Carvalho Junior RN. Polysaccharides obtained from natural edible sources and their role in modulating the immune system: Biologically active potential that can be exploited against COVID-19. Trends Food Sci Technol 2021;108:223-35. [PMID: 33424125 DOI: 10.1016/j.tifs.2020.12.026] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 14.0] [Reference Citation Analysis]
689 Li W, Yue H. Thymidine Phosphorylase Is Increased in COVID-19 Patients in an Acuity-Dependent Manner. Front Med (Lausanne) 2021;8:653773. [PMID: 33829029 DOI: 10.3389/fmed.2021.653773] [Reference Citation Analysis]
690 Hasanagic S, Serdarevic F. Potential role of memantine in the prevention and treatment of COVID-19: its antagonism of nicotinic acetylcholine receptors and beyond. Eur Respir J 2020;56:2001610. [PMID: 32554535 DOI: 10.1183/13993003.01610-2020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
691 Caronna E, Pozo-Rosich P. Headache during COVID-19: Lessons for all, implications for the International Classification of Headache Disorders. Headache 2021;61:385-6. [PMID: 33522600 DOI: 10.1111/head.14059] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
692 Subbarayan K, Ulagappan K, Wickenhauser C, Bachmann M, Seliger B. Immune Interaction Map of Human SARS-CoV-2 Target Genes: Implications for Therapeutic Avenues. Front Immunol 2021;12:597399. [PMID: 33796097 DOI: 10.3389/fimmu.2021.597399] [Reference Citation Analysis]
693 Zwart SR, Smith SM. Vitamin D and COVID-19: Lessons from Spaceflight Analogs. J Nutr 2020;150:2624-7. [PMID: 32710111 DOI: 10.1093/jn/nxaa233] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
694 Khan S, Shafiei MS, Longoria C, Schoggins J, Savani RC, Zaki H. SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-κB pathway. bioRxiv 2021:2021. [PMID: 33758854 DOI: 10.1101/2021.03.16.435700] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
695 [DOI: 10.1101/2020.07.23.217703] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
696 Laroni A, Schiavetti I, Sormani MP, Uccelli A. COVID-19 in patients with multiple sclerosis undergoing disease-modifying treatments. Mult Scler 2020;:1352458520971817. [PMID: 33205695 DOI: 10.1177/1352458520971817] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
697 Yasmin F, Najeeb H, Naeem A, Dapke K, Phadke R, Asghar MS, Shah SMI, De Berardis D, Ullah I. COVID-19 Associated Mucormycosis: A Systematic Review from Diagnostic Challenges to Management. Diseases 2021;9:65. [PMID: 34698143 DOI: 10.3390/diseases9040065] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
698 Ahmad T, Chaudhuri R, Joshi MC, Almatroudi A, Rahmani AH, Ali SM. COVID-19: The Emerging Immunopathological Determinants for Recovery or Death. Front Microbiol 2020;11:588409. [PMID: 33335518 DOI: 10.3389/fmicb.2020.588409] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
699 Meckiff BJ, Ramírez-Suástegui C, Fajardo V, Chee SJ, Kusnadi A, Simon H, Grifoni A, Pelosi E, Weiskopf D, Sette A, Ay F, Seumois G, Ottensmeier CH, Vijayanand P. Single-Cell Transcriptomic Analysis of SARS-CoV-2 Reactive CD4 + T Cells. SSRN 2020;:3641939. [PMID: 32742242 DOI: 10.2139/ssrn.3641939] [Cited by in Crossref: 25] [Cited by in F6Publishing: 8] [Article Influence: 12.5] [Reference Citation Analysis]
700 Yalcin AD, Yalcin AN. Future perspective: biologic agents in patients with severe COVID-19. Immunopharmacol Immunotoxicol 2021;43:1-7. [PMID: 32883116 DOI: 10.1080/08923973.2020.1818770] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
701 Santaniello A, Vigone B, Beretta L. Letter to the editor: Immunomodulation by phosphodiesterase-4 inhibitor in COVID-19 patients. Metabolism 2020;110:154300. [PMID: 32574572 DOI: 10.1016/j.metabol.2020.154300] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
702 [DOI: 10.1101/2020.05.07.20093914] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
703 King A, Vail A, O'Leary C, Hannan C, Brough D, Patel H, Galea J, Ogungbenro K, Wright M, Pathmanaban O, Hulme S, Allan S. Anakinra in COVID-19: important considerations for clinical trials. Lancet Rheumatol 2020;2:e379-81. [PMID: 32835233 DOI: 10.1016/S2665-9913(20)30160-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 13.0] [Reference Citation Analysis]
704 Bumiller-Bini V, de Freitas Oliveira-Toré C, Carvalho TM, Kretzschmar GC, Gonçalves LB, Alencar NM, Gasparetto Filho MA, Beltrame MH, Winter Boldt AB. MASPs at the crossroad between the complement and the coagulation cascades - the case for COVID-19. Genet Mol Biol 2021;44:e20200199. [PMID: 33729332 DOI: 10.1590/1678-4685-GMB-2020-0199] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
705 Gebremeskel S, Schanin J, Coyle KM, Butuci M, Luu T, Brock EC, Xu A, Wong A, Leung J, Korver W, Morin RD, Schleimer RP, Bochner BS, Youngblood BA. Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody. Front Immunol 2021;12:650331. [PMID: 33777047 DOI: 10.3389/fimmu.2021.650331] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
706 Cusenza F, Davino G, D'Alvano T, Argentiero A, Fainardi V, Pisi G, Principi N, Esposito S. Silence of the Lambs: The Immunological and Molecular Mechanisms of COVID-19 in Children in Comparison with Adults. Microorganisms 2021;9:330. [PMID: 33562210 DOI: 10.3390/microorganisms9020330] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
707 Kanimozhi G, Pradhapsingh B, Singh Pawar C, Khan HA, Alrokayan SH, Prasad NR. SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models. Front Pharmacol 2021;12:638334. [PMID: 33967772 DOI: 10.3389/fphar.2021.638334] [Reference Citation Analysis]
708 Puhm F, Flamand L, Boilard E. Platelet extracellular vesicles in COVID-19: Potential markers and makers. J Leukoc Biol 2021. [PMID: 34730839 DOI: 10.1002/JLB.3MIR0221-100R] [Reference Citation Analysis]
709 Dong M, He F, Deng Y. How to Understand Herd Immunity in the Context of COVID-19. Viral Immunol 2021;34:174-81. [PMID: 33351708 DOI: 10.1089/vim.2020.0195] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
710 Salvati L, Biagioni B, Vivarelli E, Parronchi P. A gendered magnifying glass on COVID-19. Clin Mol Allergy 2020;18:14. [PMID: 32774170 DOI: 10.1186/s12948-020-00129-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
711 Paltrinieri S, Giordano A, Stranieri A, Lauzi S. Feline infectious peritonitis (FIP) and coronavirus disease 19 (COVID-19): Are they similar? Transbound Emerg Dis 2021;68:1786-99. [PMID: 32985113 DOI: 10.1111/tbed.13856] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
712 Azimirad M, Noori M, Raeisi H, Yadegar A, Shahrokh S, Asadzadeh Aghdaei H, Bentivegna E, Martelletti P, Petrosillo N, Zali MR. How Does COVID-19 Pandemic Impact on Incidence of Clostridioides difficile Infection and Exacerbation of Its Gastrointestinal Symptoms? Front Med (Lausanne) 2021;8:775063. [PMID: 34966759 DOI: 10.3389/fmed.2021.775063] [Reference Citation Analysis]
713 Catalano A. COVID-19: Could Irisin Become the Handyman Myokine of the 21st Century? COVID 2020;1:32-41. [DOI: 10.2174/2666796701999200617154655] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
714 Lai JW, Cheong KH. Superposition of COVID-19 waves, anticipating a sustained wave, and lessons for the future. Bioessays 2020;42:e2000178. [PMID: 33040355 DOI: 10.1002/bies.202000178] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
715 Kaklamanos A, Belogiannis K, Skendros P, Gorgoulis VG, Vlachoyiannopoulos PG, Tzioufas AG. COVID-19 Immunobiology: Lessons Learned, New Questions Arise. Front Immunol 2021;12:719023. [PMID: 34512643 DOI: 10.3389/fimmu.2021.719023] [Reference Citation Analysis]
716 Hafezi B, Chan L, Knapp JP, Karimi N, Alizadeh K, Mehrani Y, Bridle BW, Karimi K. Cytokine Storm Syndrome in SARS-CoV-2 Infections: A Functional Role of Mast Cells. Cells 2021;10:1761. [PMID: 34359931 DOI: 10.3390/cells10071761] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
717 Kohmer N, Westhaus S, Rühl C, Ciesek S, Rabenau HF. Clinical performance of different SARS-CoV-2 IgG antibody tests. J Med Virol 2020;92:2243-7. [PMID: 32510168 DOI: 10.1002/jmv.26145] [Cited by in Crossref: 62] [Cited by in F6Publishing: 69] [Article Influence: 31.0] [Reference Citation Analysis]
718 Wang S, Jiang N, Shi W, Yin H, Chi X, Xie Y, Hu J, Zhang Y, Li H, Chen JL. Co-infection of H9N2 Influenza A Virus and Escherichia coli in a BALB/c Mouse Model Aggravates Lung Injury by Synergistic Effects. Front Microbiol 2021;12:670688. [PMID: 33968006 DOI: 10.3389/fmicb.2021.670688] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
719 Moazzam M, Sajid MI, Shahid H, Butt J, Bashir I, Jamshaid M, Shirazi AN, Tiwari RK. Understanding COVID-19: From Origin to Potential Therapeutics. Int J Environ Res Public Health 2020;17:E5904. [PMID: 32823901 DOI: 10.3390/ijerph17165904] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
720 Anka AU, Tahir MI, Abubakar SD, Alsabbagh M, Zian Z, Hamedifar H, Sabzevari A, Azizi G. Coronavirus disease 2019 (COVID-19): An overview of the immunopathology, serological diagnosis and management. Scand J Immunol 2021;93:e12998. [PMID: 33190302 DOI: 10.1111/sji.12998] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
721 Rajamanickam A, Kumar NP, Padmapriyadarsini C, Nancy A, Selvaraj N, Karunanithi K, Munisankar S, Bm S, Renji RM, Ambu TC, Venkataramani V, Babu S. Latent tuberculosis co-infection is associated with heightened levels of humoral, cytokine and acute phase responses in seropositive SARS-CoV-2 infection. J Infect 2021;83:339-46. [PMID: 34329676 DOI: 10.1016/j.jinf.2021.07.029] [Reference Citation Analysis]
722 Chatterjee S, Sengupta T, Majumder S, Majumder R. COVID-19: a probable role of the anticoagulant Protein S in managing COVID-19-associated coagulopathy. Aging (Albany NY) 2020;12:15954-61. [PMID: 32826388 DOI: 10.18632/aging.103869] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
723 Dölken L, Stich A, Spinner CD. Remdesivir for Early COVID-19 Treatment of High-Risk Individuals Prior to or at Early Disease Onset-Lessons Learned. Viruses 2021;13:963. [PMID: 34067381 DOI: 10.3390/v13060963] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
724 Zhou QA, Kato-Weinstein J, Li Y, Deng Y, Granet R, Garner L, Liu C, Polshakov D, Gessner C, Watkins S. Potential Therapeutic Agents and Associated Bioassay Data for COVID-19 and Related Human Coronavirus Infections. ACS Pharmacol Transl Sci 2020;3:813-34. [PMID: 33062950 DOI: 10.1021/acsptsci.0c00074] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
725 Lee AC, Castaneda G, Li WT, Chen C, Shende N, Chakladar J, Taub PR, Chang EY, Ongkeko WM. COVID-19 Severity Potentially Modulated by Cardiovascular-Disease-Associated Immune Dysregulation. Viruses 2021;13:1018. [PMID: 34071557 DOI: 10.3390/v13061018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
726 Schütz D, Ruiz-Blanco YB, Münch J, Kirchhoff F, Sanchez-Garcia E, Müller JA. Peptide and peptide-based inhibitors of SARS-CoV-2 entry. Adv Drug Deliv Rev 2020;167:47-65. [PMID: 33189768 DOI: 10.1016/j.addr.2020.11.007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 13.5] [Reference Citation Analysis]
727 Sinha S, Kundu CN. Cancer and COVID-19: Why are cancer patients more susceptible to COVID-19? Med Oncol 2021;38:101. [PMID: 34302557 DOI: 10.1007/s12032-021-01553-3] [Reference Citation Analysis]
728 Ren J, Zhang Y, Liu S, Li X, Sun X. Detailed Analyses of the Expression Patterns of Potential Severe Acute Respiratory Syndrome Coronavirus 2 Receptors in the Human Heart Using Single-Nucleus RNA Sequencing. Front Cardiovasc Med 2021;8:757362. [PMID: 34917662 DOI: 10.3389/fcvm.2021.757362] [Reference Citation Analysis]
729 Shrivastava S, Chelluboina S, Jedge P, Doke P, Palkar S, Mishra AC, Arankalle VA. Elevated Levels of Neutrophil Activated Proteins, Alpha-Defensins (DEFA1), Calprotectin (S100A8/A9) and Myeloperoxidase (MPO) Are Associated With Disease Severity in COVID-19 Patients. Front Cell Infect Microbiol 2021;11:751232. [PMID: 34746027 DOI: 10.3389/fcimb.2021.751232] [Reference Citation Analysis]
730 Panossian A, Brendler T. The Role of Adaptogens in Prophylaxis and Treatment of Viral Respiratory Infections. Pharmaceuticals (Basel) 2020;13:E236. [PMID: 32911682 DOI: 10.3390/ph13090236] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
731 Burtscher J, Cappellano G, Omori A, Koshiba T, Millet GP. Mitochondria: In the Cross Fire of SARS-CoV-2 and Immunity. iScience 2020;23:101631. [PMID: 33015593 DOI: 10.1016/j.isci.2020.101631] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 11.5] [Reference Citation Analysis]
732 [DOI: 10.1101/2020.05.06.079830] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
733 Meftahi GH, Jangravi Z, Sahraei H, Bahari Z. The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of "inflame-aging". Inflamm Res. 2020;69:825-839. [PMID: 32529477 DOI: 10.1007/s00011-020-01372-8]&nb